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Abstract
Trypanosomiasis places a considerable burden on both human and animal health
across much of sub-Saharan Africa. Appreciation of the neglected burden of
trypanosomiasis led to a European Union funded programme called Farming in
Tsetse Controlled Areas (FITCA); within Uganda this programme put in place
measures to attempt the control of both animal and human trypanosomiasis.
This thesis begins by examining the history of trypanosomiasis control in Uganda
over the past century before exploring a contemporary control treatment programme
implemented in four districts of Uganda by FITCA in 2002. The impact of this
programme was monitored over the course of a year by the determination of
trypanosome prevalence in cattle using molecular diagnostic techniques (PCR) at a
number of sites in the treated districts of Uganda. In addition, incidence of sleeping
sickness in the human population before and after the intervention programme were
monitored by recording and analysing sleeping sickness cases reported to district
health centres. A spatial analytical framework was used to investigate disease
clustering on a year-by-year basis with reference to FITCA intervention sites.
Prior to the implementation of the control programme, the prevalence of
trypanosome infection in cattle across the study area was 16%; post-intervention,
trypanosome infection levels had fallen to 9%. In particular, post-intervention levels
of T. brucei s.l. dropped in all districts and overall the proportion of these infections
that were attributed to human infective T. b. rhodesiense reduced from 33% to less
than 10%. Analysis indicates that the cost per percentage decrease in the prevalence
of cattle trypanosomiasis achieved by the programme was US$2,193. Statistical and
spatial analysis observed no impact of the FITCA intervention on either the
incidence or distribution of reported sleeping sickness cases, although different
patterns were observed in epidemic and endemic areas.
Trypanosomiasis remains a neglected disease making it imperative that any resources
donated for its control are used wisely by employing optimal control strategies to
obtain maximum results at minimal cost. The efficacy of the FITCA Uganda
programme is discussed with reference to how the programme may be improved, and
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Trypanosomes are unicellular, flagellate, kinetoplastid protozoans that are obligate
parasites (Cox, 1993). Although the majority of trypanosomes are non-pathogenic,
several members of this genus cause important veterinary and medical diseases
(Stevens & Brisse, 2004). In sub-Saharan Africa two sub-species of T. brucei s.l. (T
.b. gambiense and T. b. rhodesiense) cause Human African Trypanosomiasis (HAT,
also known as sleeping sickness) whilst several species are the aetiological agents of
significant parasitic disease in domestic ruminants, suids, equids and dogs (Table




Ruminants Suids Equids Dogs
T. vivax + +
T. brucei + + +
T. congolense + +
T. simiae +
T. evansi + +
T. equiperdum +
T. suis +
Table 1.1 - Pathogenic trypanosome species of significant veterinary importance in sub-Saharan
Africa. This table is adapted from (Desquesnes & Davila, 2002)
Tsetse flies (genus Glossina, order Diptera) serve as vectors for the transmission of
these pathogenic African trypanosomes to their hosts with the exception of T.evansi
which is mechanically transmitted by biting flies, T. vivax which can be transmitted
by both tsetse and other biting flies and T. equiperdum which is a sexually
transmitted disease). As they are transmitted in the saliva of tsetse during
haematophagy, African trypanosomes are classified as salivarian (Hoare, 1964).
Trypanosomes take approximately 20-40 days to develop in the tsetse host (Dale et
al., 1995) and the fly can remain infectious for the rest of its life, around 5-6 weeks
in the field (Welburn & Maudlin, 1999). Tsetse flies are found exclusively in Africa
in a belt that stretches between 14°N to 29°S of the equator (Barrett et al., 2003),
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covering a vast swathe of sub-Saharan Africa. Due to the specific conditions of
temperature, humidity and vegetation that are required for their survival, tsetse flies
are not present uniformly throughout the 'tsetse belt' but are restricted to habitat
pockets (Pepin & Meda, 2001). Consequently, the incidence of trypanosomiasis is
spatially-discrete and in HAT approximately 300 separate active disease foci are
recognised (Figure 1.1) (Cattand et al., 2001).
Figure 1.1 - Map of Africa showing the T. b. rhodesiense foci (red) and T. b. gambiense foci
(yellow) geographically separated by the rift valley, shown on a digital elevation model (USCS
digital elevation model), image reproduced w ith kind permission of (Welburn et al., 2001a)
1.2 The impact and importance of human African trypanosomiasis
HAT has a disproportional affect on marginalised and poor rural populations and has
been considerably neglected in the recent past (Barrett et al., 2003; Welburn et al.,
2006). At the time of large-scale decolonization of Africa in the 1960s, HAT had
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been largely brought under control, then, during the second half of the 20th century
there was a dramatic increase in the incidence of the disease (Barrett, 1999), and
HAT was judged to be a category 1 resurgent disease by WHO/TDR (Remme et al.,
2002). In the past few years the number of reported HAT cases has decreased
(WHO, 2006). However it is difficult to be certain this is a true reflection of
successful control or some other stochastic factor (Fevre et al., 2006a). There are
two distinct forms of sleeping sickness, which are geographically separated by a line
that closely approximates to that of the Great Rift Valley (Figure 1.1). In eastern and
southern Africa T. brucei rhodesiense causes an acute disease whilst in western and
central Africa T. brucei gambiense causes a chronic disease. Uganda is unique in
being the only country in which both forms of the disease are present, with T. b.
gambiense in the north-west and T. b. rhodesiense occurring in the south-east of the
country (Welburn et al., 2006) as shown in Figure 1.2. Currently the T. b.
rhodesiense focus is spreading (see Figure 1.2) leading to concerns that the two foci
may merge (Picozzi et al., 2005).
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Figure 1.2 - Map of Uganda showing the T. b. rhodesiense and T. b. gambiense foci within the
country. The newly affected areas shown in red are affected by T. b. rhodesiense the first case of
which was recorded in 2004
It is estimated that 60 million people living in 36 countries in sub-Saharan Africa are
at risk from sleeping sickness (World Health Organization, 1998a), a disease which
is invariably fatal if left untreated. In 2002, the World Health Organisation (WHO)
recorded 48,000 deaths from sleeping sickness (World Health Organization, 2004).
However, as most cases of sleeping sickness effect the rural population where levels
of screening of the at-risk population are relatively low (<10%), it is assumed that
there is substantial under-reporting. In 1998, WHO estimated that only 27,000 out
of 300,000 sleeping sickness cases were reported in the Democratic Republic of the
Congo, and similarly in Angola where observers expected >100,000 cases only 8,000
were reported (Barrett et al., 2003). Results from a recent study in Uganda have
indicated that 12 deaths due to sleeping sickness go undetected for every 1 reported
(Odiit et al., 2005). A recent estimate by WHO has suggested that up to half a
million people in sub-Saharan Africa may be carrying T. brucei s.l. infections
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(Barrett et al., 2003), although others have suggested this is an overestimation (Pepin
& Meda, 2001). T. b. rhodesiense is less significant in terms of numbers than T. b.
gambiense across sub-Saharan Africa as a whole, but it remains a significant problem
at local and regional levels (Fevre et al., 2006a). Due to the severity of the disease
and the greater likelihood of infection of agriculturally active members of rural
communities, it has devastating effects of the socio-economic viability of affected
families and places a major burden on the rural poor (Fevre et al., 2005; Odiit et al.,
2005). During the intermittent epidemics of sleeping sickness that occur, the disease
has severe social and economic effects and can devastate the rural populations of
entire regions (Kuzoe, 1993). Sleeping sickness causes loss of 1.6 - 2.05 million
disability-adjusted life years (DALYs) (Pepin & Meda, 2001; Welburn et al., 2006),
which is an equitable measure of disease burden (Murray, 1994). This places
sleeping sickness third behind malaria and schistosomiasis in terms of impact of
parasitic diseases in sub-Saharan Africa (Cattand et al., 2001).
1.3 The importance of animal trypanosomiasis
The diseases caused by trypanosome infections of livestock have had a profound
effect on human settlement and economic development across large parts of sub-
Saharan Africa. Currently, trypanomiasis is one of the major constraints on the
development of animal production in sub-Saharan Africa, and causes annual losses
of approximately US$1.3 billion due to reduction in livestock product yields and by
devaluing farmers investments (Kristjanson et al., 1999). Farmers themselves
perceive it as major impediment to keeping livestock (Swallow, 2000). The most
socio-economically significant animal trypanomiasis is that of cattle (also known as
nagana). It is estimated that 50-70 million cattle are at risk from nagana (Geerts &
Holmes, 1998), whilst in some areas the disease has prevented the use of grasslands
for cattle rearing. As cattle provide important sources of nutrition and draught
power, they are integral to the adoption of efficient mixed agriculturally practices,
and in many African societies serve as a 'living bank' that can be sold in times of
hardship, nagana has important repercussions for human health and welfare (Geake,
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2001; Welburn et al., 2006). Furthermore, as is discussed below, cattle can act as a
major reservoir for human infective T. b. rhodesiense.
1.4 The zoonotic potential of trypanosomes
Zoonoses are defined as 'disease and their agents which are naturally transmitted
between (other) vertebrate species and man' (WHO, 1959). Globally zoonotic
disease are responsible for new emerging disease and re-emergence of existing
disease (Meslin, 1997), indeed 62% of all human pathogens are classified as zoonotic
(Taylor et al., 2001) and many newly emerging and re-emerging diseases (e.g.
Rabies, Tuberculosis, Marburg virus, Ebola) are zoonotic.
T. b. gambiense is generally considered to be a non-zoonotic disease although recent
work has demonstrated that domestic pigs (Simo et al., 2006) and a variety of wild
animals (Njiokou et al., 2006) can harbour the pathogen. In contrast, it is well
recognised that T. b. rhodesiense is a zoonosis and can infect a wide range of both
domestic and wild animals (see Table 1.2).
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Wild hosts Reference
Bushbuck (Kinghorn, 1925; Ileisch et al., 1958)
Hartebeast (Geigy etal., 1971; Geigy et al., 1975)
Warthog (Awan, 1971; Awan, 1979)
Hyena (Awan, 1971; Geigy et al.. 1971;Onyango etal., 1973; Geigy et al., 1975;
Awan, 1979)
Lion (Awan, 1971;Geigy etal., 1971; Onyango et al., 1973; Geigy etal., 1975;
Awan, 1979)
Impala (Mulla & Rickman, 1988)
Zebra (Mulla & Rickman, 1988)
Waterbuck (Kinghorn, 1925; Awan, 1971; Geigy et al., 1971; Geigy et al., 1975;
Awan, 1979)
Domestic hosts
Cattle (Onyango etal., 1966)
Pig (Waiswa et al., 2003)
Dog (Gibson & Gashumba, 1983)
Table 1.2 - Reservoir hosts of T. b. rhodesiense, examples of both wild and domestic reservoir
hosts identified by investigation into naturally occurring infections. Table adapted from (Leak,
1999).
In particular cattle are being increasingly identified as an important reservoir host for
T. b. rhodesiense. Research in Uganda has shown that domestic livestock are a
crucial factor in the way the parasite is spread to humans as T. b. rhodesiense is 5
times more likely to be transmitted by a cattle-tsetse-human cycle, than a human-
tsetse-human cycle (Figure 1.3) (Hide et al., 1996). Work in Uganda has indicated
that the recent T. b. rhodesiense epidemic in Soroti district originated from the
movement of infected cattle (Fevre et al., 2001) and it has been suggested that the
1900-1920 Ugandan epidemic may also have arisen from large scale movement of
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infected cattle (Koerner et al., 1995; Fevre et al., 2004) which has led to a postulated
role for cattle in the eruption of T. b. rhodesiense epidemics. Reservoir hosts, either
domestic or wild, are thought to be responsible for the inter-epidemic maintenance of
the parasite; Fairbairn and colleagues in 1948, made this suggestion when they
hypothesised that the HAT epidemics in Tanzania from 1922 - 1948 had probably
represented spill over infections from wild animal reservoirs (Fairbairn, 1948).
Figure 1.3 shows the importance of cattle in the lifecycle of T. b. rhodesiense in
eastern Uganda. The probability that an infected tsetse fly acquires a T. b.
rhodesiense infection from infected cattle is five times more likely than acquiring it
from an infected person (probability from cattle = 0.0026, probability from human =
0.0005). This highlights the importance that cattle play in the lifecycle of T. b.
rhodesiense in eastern Uganda. Additionally it was also recently demonstrated that
despite the chronic nature of T. brucei s.l. infections in cattle, T. b. brucei can still be
readily transmitted (Van den Bossche et al., 2005). Indeed a single trypanosome is
sufficient to cause a tsetse infection (Maudlin & Welburn, 1989), although T. b.







Figure 1.3 - The lifecycle of T. b. rtiodesiense showing the importance of cattle as a reservoir in
Uganda, plm is the probability of tsetse fly feeding on man,pic is the probability of tsetse fly
feeding on cattle, the infection rate of T. b. rhodesieitse in human is Infm and in cattle Infc. p2m
is the probability that a tsetse fly acquires a T. b. rhodesiense infection from a human and p2c is
the probability that a tsetse fly acquires the infection from cattle, pi is the proportion of tsetse
blood meals from other sources. Image adapted from (Hide et al., 1996).
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1.5 Pathology
1.5.1 Immune evasion strategy
Trypanosomes, like other pathogens need to evade clearance by the host immune
system. Trypanosomes remain extra-cellular and are thus exposed to multiple arms
of the immune system. Protection from the host immune response is afforded by
variable surface glycoproteins (VSGs) which form a sophisticated evasion
mechanism capable of evading both innate and adaptive immune responses. VSGs
are glycosylphosphatidylinositol (GPI) anchored molecules that form a dense
monolayer of identical proteins (homodimers) protecting against complement
mediated lysis (Cox, 1993). There is an exceptional high rate of VSG and surface-
membrane recycling which is probably essential for the rapid internalisation of
bound antibody and complement (Engstler et al., 2004). Sequencing of the T. b.
brucei genome is nearly completed and currently there are 1700 VSGs identified
(Berriman et al., 2005). The vast majority of VSG genes are clustered in
subtelomeric arrays - clusters of 3 - 250 VSG copies (Berriman et al., 2005),
however, many are also found at the extremity of telomeres - particularly of mini-
chromosomes (Van der Ploeg et al., 1984). It is generally believed that the function
of mini-chromosome is to provide a large repertoire of VSGs (Pays, 2006). From the
VSG repertoire an individual trypanosome will only express one VSG at any given
time, all but one of the VSGs are therefore transcriptionally silent, this is known as
mono-allelic expression.
VSGs are only expressed when in specialised telomeric loci called expression sites
(ES) (Sheader et al., 2003). The exact number of ES transcription sites remains
unknown however, in T. b. brucei there are estimated to be approximately 20 (Pays
et al., 2001; Becker et al., 2004). Transcription can start in different ES
simultaneously but is abortive in all bar one, allowing for mono-allelic expression
(Vanhamme et al., 2000). This is due to the recruitment of RNA processing
machinery, although how this is regulated remains unknown (Pays et al., 2006).
Transcription in ES is polycistronic with up to 20 expression site associated genes
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(ESAGs) (such as SRA, a gene that will be discussed further in Chapter 4) in
addition to the VSGs. During infection, the VSG being expressed is changed
repeatedly. The mechanism regulating VSG switching between ES remains
unknown but it has been suggested that it may be linked to cellular stress (Pays et al.,
2006). Only a small membrane distal portion of VSGs bearing limited antigenic
epitopes are exposed. These exposed epitopes exhibit a high degree of variability
between different VSGs. This means that switching VSG expression offers a
mechanism to evade any antibody response that the host's immune system may have
developed. VSG switching may be due to either transcriptional switching between
different ES or switching the resident VSG in ES by DNA recombination (Pays,
2005). There is a semi-predictable hierarchy of VSGs expression, which may be
explained by the fact that DNA recombination is more likely between sequences
sharing similarity (Morrison et al., 2005).
1.5.2 Pathology ofHAT
There are two types of human sleeping sickness caused by different agents and
presenting with two distinct clinical syndromes. T. b. rhodesiense sleeping sickness
is characterised by a rapid progression to severe disease and it is often termed an
acute infection. T. b. gambiense sleeping sickness is often described as a chronic
infection as this form of the disease is characterised by a long asymptomatic stage or
with mild clinical symptoms that can persist for many months before progressing to
severe disease. Early symptoms in T. b. gambiense infection are usually mild and
often unnoticed. There are two clinical stages in both forms of sleeping sickness;
stage 1 or early and stage 2 or late. In stage 1 the parasites are circulating and
proliferating in the blood and lymph of the patient; stage 2 the parasites invade the
central nervous system. Then in the absence of treatment the patient will inevitably
die. The paragraphs below detail both stage 1 and 2 in T. b. rhodesiense and T. b.
gambiense sleeping sickness.
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Stage 1 follows the inoculation of the parasites into the host by the tsetse fly, at the
site of the bite there is a local parasite proliferation which can cause an inflammatory
nodule or ulceration called a chancre (Moore et al., 2002). This localised
inflammation is seen in approximately 50% of T. b. rhodesiense cases but rarely in T.
b. gambiense (Barrett et al, 2003). The chancre resolves three to four weeks after
infection. Following inoculation, the parasite spreads to local lymph nodes and into
the bloodstream, termed the haemolymphatic stage (Stich et al., 2002) whereby the
disease progresses from localised symptoms to a generalised infection. Symptoms
include headache, general malaise and an undulating fever. The fevers generally
occur in an irregular pattern over many weeks, following the 'waves' of parasite
multiplication in the blood. In T. b. rhodesiense infections, these early symptoms
can be very severe causing pancarditis, pericardial effusion and pulmonary oedema
(cardio-pulmonary pathology) and approximately one in ten patients will die unless
they have rapid access to treatment (Stich et al., 2002). T. b. gambiense infections
are insidious in the early stages and often go unrecognised or misdiagnosed. A
characteristic sign of this infection is Winterbottom's sign; a posterior cervical
lymphadenopathy, this symptom has even been used as an identification tool in some
surveillance programmes (Cook & Zumla, 2002). Other more generalised signs of a
T. b. gambiense infection are a circinate rash, pruritis and generalised oedema.
Over time, the disease proceeds to stage 2 when parasites infect the internal organs
and cross the blood brain barrier to invade the central nervous system (CNS). Stage
2 occurs within a few weeks in a T. b. rhodesiense infection but after a period of
several months or even years in T. b. gambiense infection. The parasite invasion into
the CNS results in acute encephalopathy. The general symptoms associated with this
invasion are headache and mental changes, including reduced higher mental
function, difficulties with concentration and the patient's increasing inability to cope
with their surroundings. This eventually results in a somnolent state which gave the
disease its common name, then seizures, coma and death (Kennedy, 2004). Patients
can quickly deteriorate if not treated and in the case of T. b. rhodesiense infection
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over 80% of deaths occur within 6 months of the onset of illness (Odiit et al., 1997).
Essentially, T. b. gambiense infections follow the same sequence of infection stages
but with a different rate of progression (Sternberg, 2004); progression to the late
stage of disease may take several months or longer and late stage CNS infections can
last years (Barrett et al., 2003).
There is a spectrum of disease severity associated with T. b. rhodesiense between
countries in southern East Africa, e.g. Zambia and Malawi and countries further
north, e.g. Uganda and Kenya. In the southern area the pathology of the disease has
a more chronic type of progression (MacLean et al., 2004). Genetic characterisations
of T. b. rhodesiense have shown differences between northern and southern isolates
(Hide et al., 1991; Gibson, 2002). The difference in severity of the disease has been
linked to differences in the host immune responses to the parasites (MacLean et al.,
2004).
1.5.3 Pathology of cattle trypanosomiasis
Nagana is the term commonly used to refer to a complex of diseases caused by the
Trypanosoma spp. transmitted to domestic livestock by Glossina species. The
distribution of Nagana across Africa corresponds with the distribution of the tsetse
fly. T. congolense and T. vivax are the major pathogenic species in African cattle
and although T. b. brucei is generally less pathogenic it has been associated with
significant disease in exotic cattle (Wellde et al., 1989). Experimental data on
trypanosomiasis infection typically shows three clinical stages: acute, stabilisation
and chronic, however, in field situations the situation can be more complex. Clinical
pathology in cattle can range from acute disease leading to death in three to four
weeks to a more common chronic condition lasting for years (Taylor & Authie,
2004). The acute disease phase is associated with a continuous reduction in
haemoglobin concentration and packed red cell volume (PCV) resulting in anaemia.
It is the anaemia which is correlated to a loss in the productive performance of the
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cattle. The clinical signs associated with animal trypanosomiasis include anaemia,
weight loss, roughness of hair coat, enlargement of peripheral lymph nodes, pyrexia,
abortion, reduced milk yield and eventually death (Eisler et al., 2004). Many African
cattle survive the acute phase and develop chronic disease. Chronically infected
cattle suffer from cachexia; productivity and reproductive functions are impaired.
1.6 Diagnosis
1.6.1 Diagnosis of HAT
The simplest approach to trypanosome detection is by the direct observation of fresh
blood between a cover slip and a slide, using a medium magnification (usually a dry
objective of 40x and eye pieces of 5 - lOx). This method is accurate at or above
concentrations of 104 parasites per ml (Uilenberg, 1998). Trypanosomes are either
seen directly or indirectly by the movement of the blood cells. To increase the
likelihood of observing a parasite in a blood film various concentration methods can
be used of which the simplest is the buffy coat method which can improve detection
levels by microscopy to 500 parasites per ml (Uilenberg, 1998). Thick or thin
smears can be produced and examined, a thin smear can be used to identify some of
the different trypanosome species by morphology but this relies on a highly
experienced technician. Determining the stage of disease before treatment is
essential as drug regimes vary for first and second stage treatments of both T. b.
rhodesiense and T. b. gambiense. Currently the only way to establish the stage of a
patient is to do a lumbar puncture (Bouteille et al., 2003). The sample of cerebral
spinal fluid is then examined under a microscope for the presence of trypanosomes;
if parasites are identified within this sample, or the white cell blood count is greater
than 5 cells per pi, or there is an increased protein count greater than 370 mg/litre
(World Health Organization, 1998b) then the patient is deemed to be in stage 2.
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Determining whether a human infection is caused by T. b. rhodesiense or T. b.
gambiense is not simple. There is no field test for T. b. rhodesiense and diagnosis is
based on geographical locale, e.g. a patient with trypanosomiasis in south east
Uganda would be treated for T. b. rhodesiense. However, in the future this
assumption may not be possible as there are concerns that the foci of T. b.
rhodesiense and T. b. gambiense within Uganda may merge (Picozzi et al., 2005).
There is a serological test for T. b. gambiense (Magnus et al., 1978), known as the
card agglutination test for trypanosomiasis (CATT). This is a fast and simple
agglutination assay for the detection of T. b. gambiense specific antibodies which
costs approximately $0.40 per test and can be done in the field without electricity or
specialised staff giving results in 10 minutes (Pepin & Meda, 2001). This test is
directed against a specific variant antigen (VAT) on the surface, LiTat 1.3 and is now
routinely used in mass screening campaigns (Buscher et al., 1999; Robays et al.,
2004) However, it has been reported that there are a small number of T. b.
gambiense variants that do not express the specific test antigen (Enyaru et al., 1998).
The CATT test cannot be used to detect T. b. rhodesiense due to the absence of LiTat
1.3 from its antigenic reservoir (Enyaru et al., 1999). There can also be a problem in
the treatment of individuals which are CATT positive but parasitologically negative;
in these situations a CATT titration is performed and a study in Angola
recommended the treatment of individuals with an end titre of greater than 1/8
(Simarro et al., 1999). The CATT system is also used for the diagnosis of a different
species of trypanosome, T. evansi, a major enzoonotic disease of horses (Claes et al.,
2002) and camels (Gutierrez et al., 2000). The test is based on the variable antigen
type (VAT) RoTat 1.2 which was isolated from a water buffalo in Indonesia in 1982
and has been seen in all type II T. evansi which have been isolated (Verloo et al.,
2001), however it cannot be used on type I T. evansi found in Kenya (Ngaira et al.,
2003; Ngaira et al., 2004).
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1.6.1.1 Molecular tests for HAT
Molecular tests can demonstrate the presence of DNA sequences specific to the
parasites, techniques such as polymerase chain reaction (PCR) can be used for
diagnosis and species identification in a research setting, however they are not
currently practical for widespread field use (Chappuis et al., 2005). In reality, the
equipment needed and the cost of these techniques, make it unlikely that they will be
available to any rural African hospital in the near future.
PCR that targets repetitive sequences of DNA can be very sensitive with a detection
limit around 0.1 trypanosome per ml of cattle blood (Masake et al., 2002) or 25
trypanosomes per ml of human blood (Kanmogne et al., 1996). The difference
observed in the sensitivity between tests carried out in human and cattle blood are the
result of factors in human blood that inhibit the PCR (Contamin et al., 1995). In
theory, PCR can be applied to any sample that may contain trypanosome DNA;
whole blood, buffy coat, lymph or CSF. The discovery of the serum resistance
associated (SRA) protein, a VSG type protein which resists lysis by human serum
(Xong et al., 1998) has allowed the development of a diagnostic PCR test for T. b.
rhodesiense (Welburn et al., 2001b; Radwanska et al., 2002a); this diagnostic test is
discussed in more detail in Chapter 4. One of the first T. b. gambiense specific PCR
tests used a gene sequence for the VSG surface protein, AgTat 11.17 (Bromidge et
al., 1993). This was effective for isolates taken from Ivory Coast, Nigeria, Congo,
Cameroon, Democratic Republic of Congo and Sudan, however later testing of T. b.
gambiense isolates collected from Moyo in northern Uganda showed that the
sequence was absent (Enyaru et al., 1992). The discovery of the T. b. rhodesiense
specific SRA sequence (Xong et al., 1998) which encodes for an atypical VSG,
prompted searches for a similar sequence in T. b. gambiense. A sequence named T.
b. gambiense specific glycoprotein (TgsGP) was found to be present in all the tested
strains of T. b. gambiense and absent from T. b. rhodesiense and T. b. brucei strains
(Berberof et al., 2001) and was used to develop a T. b. gambiense specific PCR
(Radwanska et al., 2002b).
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1.6.2 Diagnosis of cattle trypanosomiasis
Bovine trypanosomiasis is characterised as a production disease which means that
diagnosis and treatment are, increasingly, the responsibility of the farmer in
decentralised systems (Eisler et al., 2004). This means that the majority of people
involved with the diagnosis and treatment of trypanosomiasis rely wholly on physical
examination of clinical signs (listed in section 1.5.2). Ultimately a presumptive
diagnosis of trypanosomiasis is made on the basis of clinical signs and following the
administration of treatment, a positive response is taken as confirmation of the
diagnosis (Eisler et al., 2004) and to aid this approach a low cost diagnostic aid has
recently been developed (Eisler et al., 2007). However, there are diagnostic tests
which can be used. Microscopy, as described in section 1.6.1, can be used although
this is not sensitive enough to detect low levels of parasitemia. More advanced
methods can also be employed, these include: inoculation of blood from a suspected
case into a 'clean' animal, culture, immunological diagnosis and molecular
techniques. These methods are in reality only used for research purposes and
molecular techniques are used for diagnosis of trypanosomiasis in this thesis (see
Chapter 3 and 4). Until a diagnostic method can be developed which costs less than
the price of treatment for trypanosomiasis (approximately $1) and is easy to use in
the field, they are of little use to a poor rural farmer in Africa.
1.7 Treatment
1.7.1 Treatment of HAT
There are currently four drugs licensed for treatment ofHAT, these are pentamidine,
suramin, melarsoprol and eflornithine. Three of these drugs were developed in the
first half of the twentieth century and given their severe side effects, it is likely that
they would not pass current drug safety standards for the development of new drugs
(Fairlamb, 1990). The treatment regime for HAT depends on the species causing the
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infection and on the stage of disease in the patient. Pentamidine is the stage 1
treatment for T. b. gambiense and is administered by an intramuscular injection
(Burchmore et al., 2002). The drug was first introduced in 1937 and is associated
with some minor side effects, including skin irritation, nausea, vomiting and more
rarely serious side effects including hypoglycemia, hypocalcemia and renal failure
(Pepin & Milord, 1994). The early stage treatment for T. b. rhodesiense is suramin
which is administered by slow intravenous injection and can be found in the blood
for up to 3 months, giving suramin one of the longest half-life's in human
chemotherapy (Pepin & Milord, 1994). Suramin was discovered in 1921 and is an
analogue of some of the first drugs used to try to treat sleeping sickness at the turn of
the 19th century: trypan blue and trypan red (Docampo & Moreno, 2003). Suramin is
generally well tolerated with renal toxicity the most common associated problem, but
this is usually mild (Docampo & Moreno, 2003), also there are rare cases of
exfoliative dermatitis (May & Allolio, 1991).
Stage 2 of both T. b. rhodesiense and T. b. gambiense are more difficult to treat; due
to the location of parasites in the CNS drugs must cross the blood brain barrier.
Melarsoprol is the only drug which can be used to treat stage 2 T. b. rhodesiense and
is administered by slow intravenous injection. Melarsoprol which was discovered in
1949 is an arsenical derivative and can be used to treat stage 2 T. b. gambiense. This
drug is associated with severe side effects which include reactive encephalopathy
that is fatal in 3-10% of cases (Pepin & Milord, 1994; Braakman et al., 2006) and
surviving patients can experience long lasting neurological damage (Kumar et al.,
2006). For the treatment of stage 2 T. b. gambiense another treatment called
eflorinthine or difluromethylornithine (DFMO) was registered for use in 1990. This
drug has none of the side effects associated with melarsoprol and would ideally be
used as a first line treatment or at least in patients that have a reaction to melarsoprol
(Kuzoe, 1993). Unfortunately the use of this drug has been severely restricted by
cost and treatment regime. The price to treat one patient, without including medical
equipment and fluids, is estimated at $350 (Burri & Brun, 2003).
Chapter 1 19
There have been some reports of drug resistance in the treatment of human African
trypanosomiasis, although as patients are hospitalised for the duration of treatment
there are less problems of under-dosing or incorrect administration (Matovu et al.,
2001). However, adverse reactions to drugs and or the invasive diagnostic
techniques, e.g. lumbar puncture can mean that individual patients may refuse to
complete the treatment regime or consent to follow up investigations (Bacchi, 1993).
Consequently, in recent years reports of treatment failure for melarsoprol have
increased. In Uganda, relapse rates of up to 30% for T. b. gambiense have been
reported (Legros et al., 1999). This is a grave situation as melarsoprol is the first line
treatment for late stage T. b. gambiense and the only treatment for late stage T. b.
rhodesiense.
There is an urgent need for the development of new drugs for HAT however, as the
market for sleeping sickness drugs is limited to Africa, the prospect of low financial
gains has made the pharmaceutical industry reluctant to invest the money necessary
for the research and development of new drugs. In fact only two new drugs have
emerged for trypanosomiasis in recent years, cymelarsen for the treatment of T.
evansi and eflornithine for the treatment of T. b. gambiense (Anene et al., 2001).
However, the high cost involved in producing eflornithine meant that the continuing
manufacture of the drug could not be guaranteed, in fact in 1995 the pharmaceutical
company Aventis announced it would not continue production (Boseley, 2001). This
problem was temporarily solved in 2002 when Aventis agreed to donate the drug to
the World Health Organization, who donates it to specialist treatment centres in
endemic regions (World Health Organization, 2002) - this has secured its production
until 2007. There is, however, some hope that the situation may improve as the Bill
and Melinda Gates Foundation recently donated $15.1 million to a consortium of
researchers to develop new drugs to fight sleeping sickness (Fuller, 2000).
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1.7.2 Treatment of animal trypanosomiasis
There are currently three drugs available on the market for use against
trypanosomiasis in domestic livestock: diminazene aceturate, homidium bromide and
isometamidium chloride. All of these drugs have been on the market for more than
20 years and remain popular with farmers because they are cheap, widely available
and easy to use. Isometamidium chloride exhibits a prophylactic action due to its
ability to stay in the circulation for up to 3 months post-treatment (Eisler et al.,
2004). In recent years there have been attempts to enhance and extend the
prophylactic action of isometamidium chloride using sustained release devices
(SRD), which on average sustained protection for three times as long (Geerts et al.,
1997). These devices are expensive so in an attempt to reduce costs, field trials were
done with a cheaper type of device. These results were promising, showing reduced
re-infection rates of trypanosomes in cattle with SRD's, however the tests were
carried out on N'Dama cattle and have not yet been tried out on any other breeds
(Geerts et al., 1999).
Trypanocidal drugs for animals are a widespread and well established method of
trypanosomiasis control in most African countries. It is estimated that 35 million
doses are administered each year (Geerts & Holmes, 1998), which shows the use of
these drugs has proved to be a sustainable method for trypanosomiasis control for the
individual farmer. The benefits of their use has been shown using production
parameters, for example, in a study in Kenya lactation yields were shown to be
directly related to prophylactic drug use (Itty et al., 1995). Prophylactic drug use
against trypanosomiasis in a well managed herd could certainly allow animals to stay
healthy and productive. Unfortunately, across much of sub-Saharan Africa, cattle are
kept by small scale subsistence farmers who do not have the money or management
techniques required to employ this strategy.
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The drugs used against animal trypanosomiasis have been in use for a considerable
length of time and multiple types of resistance have been demonstrated to these in
cattle (Peregrine, 1994) from all the regions where they are commonly used (Matovu
et al., 2001). The emergence of drug resistant trypanosomes is considered a very
serious problem in trypanosomiasis control (Anene et al., 2001) as the control of
bovine trypanosomiasis relies almost entirely on the administration of trypanocidal
drugs (Eisler et al., 2004). In the past, the distribution and administration of
trypanocidal drugs was strictly controlled by government veterinary departments
(Chapter 2). However, with a growing environment of privatisation and
deregulation, trypanocides are now more freely available from local pharmacies,
drug stores and markets from where they are in many cases purchased and
administered by the farmers themselves (Geerts et al., 2001). The availability and
low cost of these drugs has led to growing concern that the effectiveness of
trypanocides as a control method will be severely affected by rising levels of drug
resistance.
A large scale study in Zambia showed almost 50% of tested isolates taken from T.
congolense infected cattle were resistant to either isometamidium chloride or
diminazene aceturate with the majority, 34% resistant to isometamidium chloride
(Sinyangwe et al., 2004). The authors suggested that the high prevalence of
isometamidium chloride resistance could be attributed to large scale block treatments
using isometamidium chloride in the 1980's. In a study in Ethiopia, where
trypanosomiasis is considered one of the major constraints to cattle production, 23%
of T. congolense cattle infections were shown to be resistant to isometamidium
chloride at a dose rate of l.Omg/kg body weight (Afewerk et al., 2000); the authors
suggested that the widespread misuse of this drug had contributed to the
development of resistance.
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1.8 Control of trypanosomiasis
Attempts to control trypanosomiasis began at the start of the twentieth century; in
colonial times these were extremely vigorous and included the forced movement of
human populations, the destruction of game animals and extensive clearing of tsetse
habitat. In some situations these extreme measures were effective and by the early
1950's sleeping sickness had been brought under control (Barrett, 1999). Colonial
rule began to dwindle in the late 1950s when many African countries gained
independence. Unfortunately, in many cases this strive for independence brought
political and social unrest. This coupled with worsening economies meant that there
were no longer the resources necessary to continue the types of large scale control
programmes implemented under colonial rule (Kuzoe, 1993). This has lead, over the
past 50 years, to a resurgence of HAT (Smith et al., 1998; Barrett, 1999) through a
recrudescence of old foci and in some areas the spread of disease from these foci into
new areas (Fevre et al., 2001). In many of the countries affected by sleeping
sickness the total annual health budget is less that $10 per head of population
(Kuzoe, 1993); in Uganda the annual per capita spending on health is only $8
(Wendo, 2002). This means that countries must depend at least partially if not totally
on external aid to maintain sleeping sickness control programmes. This situation has
lead to many problems; sleeping sickness is a regional disease of the rural poor and
although it has the potential to cause devastating epidemics, the annual numbers of
reported cases are low compared to other diseases in sub-Saharan Africa which
means that sleeping sickness control programmes do not hold much appeal for
international donors (Kuzoe, 1993). Additionally, in the 1990's there was a
generalised move away from top down, large-scale funded control programmes and a
movement toward the idea of private good to public good (Torr et al., 2005), which
has resulted in less donor interest in funding large scale intervention programmes
administered through government departments.
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1.8.1 Vector control
Due to the difficulties of treating hosts, especially humans, for trypanosomiasis the
principal approach to controlling disease has been an attempt to halt transmission by
the insect vector (Schofield & Maudlin, 2001). The reproductive biology of the
tsetse makes it a good control target. Tsetse flies are K-strategists, their low
reproductive rate complemented by a high survival rate, adapted for efficient
exploitation of their habitat (Hargrove, 2004). Female flies are larviparous, which
means that after mating, a single egg develops over a period of 12-14 days in the
uterus, and is nourished by 'milk glands'. When fully developed, the larvae weigh
more than the female. This large input of resources means a female produces no
more than 12 eggs in a lifetime (Molyneux, 1993). To put this low reproductive rate
into context, an Anopheles mosquito, the vector of malaria, will lay thousands of
eggs in a lifetime. Therefore control methods targeted against tsetse flies can quickly
reduce the number of vectors, and the low reproductive rate means it can take a long
time for the population to recover. One of the first methods used to reduce the tsetse
fly population was the destruction of natural tsetse habitat. This focused on clearing
large areas of vegetation in an attempt to remove the flies resting sites and general
habitat and was done extensively in Uganda around the shores of Lake Victoria (this
Ugandan control strategy will be discussed in Chapter 2). Although these methods
did have profound effects on tsetse fly and trypanosomiasis distribution in some
areas they were devastating to the local ecology.
1.8.1.1 Aerial spraying
The advent of DDT and other persistent insecticides meant that the flies themselves
could be targeted with the most successful spraying campaigns completed from the
air. Aerial spraying was adopted the 1970's and 1980's (Holmes, 1997) and
involved the release of insecticides as aerosols from low flying aircraft. Normal
practice is five repeat applications over 60 days to cover the pupal period of the
tsetse fly (Allsopp, 2001). Botswana has used aerial spraying as a strategy against
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tsetse flies in the Okavango Delta since the early 1970's and although the area was
consistently sprayed from 1972 - 1991 tsetse flies were never entirely eliminated
(Hargrove, 2003). Until recently it had been very difficult for the spraying planes to
fully cover the target areas. The pilots are required to fly in long straight rows over
the entire area, usually at night, due to meterological conditions. It is extremely
difficult to ensure that no areas are over or under-dosed using traditional navigation
tools, however the use of GIS technology allowed precise and accurate spraying over
the 16000km2 target area in the Okavango Delta (Wireless, 2003). This sequential
aerosol technique (SAT) was used very successfully in conjunction with odour-bated
targets to knock down the tsetse fly population (Mudo, 2003). This method requires
skilled personnel, sophisticated equipment and substantial funding. This is a top
down approach which is expensive, unsustainable and involves no participation from
the affected communities. Additionally, unless the sprayed areas are rigorously
surveyed and barriers maintained against re-invasion then the extensive resources
needed may be wasted (Hargrove, 2003).
1.8.1.2 Ground spraying
Spraying can also be done on the ground which uses slightly less resources. This
focuses on the application of a residual insecticide to specific areas where tsetse flies
are known to rest. The chemicals used can remain lethal to tsetse flies for over 60
days, longer than the maximum pupation period (Holmes, 1997). Although DDT and
other organochlorides were used in the past to successfully control tsetse flies, it
became politically and environmentally unacceptable to continue their use (Curtis &
Lines, 2000). However, in 2006 both WHO and USAID have reversed their stance
on the use of DDT in the fight against malaria and accepted that it can be used in a
controlled manner to great effect (Mandavilli, 2006). Although this is unlikely to
herald a change for trypanosomiasis control, the use ofDDT against mosquitoes
involves limited spraying within homes whereas against the tsetse fly involves
widescale spraying over large areas of land. An alternative is the use of synthetic
pyrethroids. There are, however, other disadvantages to this type of control method.
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Ground spraying requires a degree of country-wide infrastructure, vehicles and
spraying equipment need to be maintained, supervision, planning and gaining access
to remote areas are all essential to minimise the risk of tsetse re-invasion of a sprayed
area (Hargrove et al., 2000). This all requires substantial funding at a national level.
Despite these limitations, ground spraying has been used with success in Nigeria,
where tsetse flies were eradicated from a 200,000km' area (Jordan, 1978). This
success makes ground spraying the only proven method of large scale tsetse
eradication. The removal of the tsetse fly in this area was combined with an
immediate exploitation of the cleared land for agriculture, driven by the expanding
population in Nigeria. This land use change significantly reduced the risk of re-
invasion as the tsetse flies' natural habitat had been destroyed by development. That
situation is probably unique in Africa as population densities in other areas are lower
and the demand for land is lower (Jordan, 1978), however this situation is changing
as populations and land pressures increase.
1.8.1.3 Tsetse traps
Traps and targets are used as simple vector control methods to reduce the numbers of
tsetse flies in the area and can also be used to monitor reductions in tsetse fly
numbers using any of the control methods discussed in this section. Early studies
showed that tsetse were more often found on dark rather than light surfaces
(Saunderson, 1911; Simpson, 1911; Swynerton, 1933; Swynerton, 1936). Abetter
understanding of the role of coloured surfaces in the attraction of tsetse flies was
possible by using electric nets (Vale, 1982b; Vale, 1982a). It was Challier and
colleages in 1977 that found that a combination of royal blue and black cloth
increased the numbers of tsetse trapped within a biconical trap (Challier et al., 1977).
Today traps, targets or screens are made from this combination of blue and black
materials. The most basic of these are screens which are simply a piece of
insecticide treated cloth hung in a tsetse infected area and when the flies land on the
screen they pick up a lethal dose of insecticide.
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Different size and shapes of traps have been developed over the years to enhance the
capture of different tsetse fly species (Leak, 1999). The advantage of using a trap
over the simpler screens is that the captured tsetse flies can be counted and this can
be used to show local communities that the traps work and can also be used to
monitor any impact on the fly population. The first bi-conical traps were developed
and shown to be effective against riverine species of Glossina spp. (Allsopp, 1984).
However, a study around the same time demonstrated that conventional traps failed
to catch many of the tsetse flies visiting them and that tsetse flies were attracted to a
stationary animal by its odour (Vale, 1980). This led to the use of attractants. Since
that time carbon dioxide, acetone, butanone, l-octen-3-ol, p-cresol, 4-methylphenol,
3-n propylphenol and cow urine have been shown to act as attractants. A
comprehensive review of different bait technologies developed for attracting tsetse
flies has been published by Green (Green, 1994). The traps treated with attractants
still work in the same way but flies attracted to the traps or targets collect a lethal
dose of insecticide.
1.8.1.4 Live bait
Another application method for insecticides is on domestic livestock, particularly
cattle. Insecticides can be applied to these animals by dips, pour-ons or sprays. The
tsetse flies are still attracted to the treated animal and will be killed by the insecticide
when they land to feed; this method is termed the live bait technique. In areas where
there are large numbers of cattle this is the simplest, cheapest and most effective
method of tsetse control (Hargrove, 2003). The principle of this method is similar to
baited tsetse traps, previously mentioned, and has been used with varying degrees of
success in Burkina Faso (Bauer et al., 1995), Tanzania (Fox et al., 1993) and
Ethiopia (Rowlands et al., 2001) to name a few examples. However, there are some
difficulties in relying on this as a principal method of tsetse control. Factors which
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influence the density, location and movement of cattle have little to do with the needs
of a tsetse control programme.
1.8.1.5 Sterile insect technique (SIT)
Finally, a method of tsetse control which has provided heated debate within the
trypanosomiasis and tsetse research community over the last few years is the sterile
insect technique (SIT). This requires the rearing and subsequent release of sterile
male tsetse flies into the environment following reduction of tsetse population using
one of the aforementioned methods (Allsopp, 2001). Irradiated sterile males are
released into the environment and mate normally with female flies depositing sterile
sperm. As female tsetse flies only mate once in their lifetime there is no possibility
of any female fertilised by a sterile male, producing any offspring (Hargrove &
Williams, 1998), so the fly population can be very quickly affected. There is
currently only one example of a successful tsetse fly elimination of G. austeni
campaign using SIT, a trial on the island of Zanzibar (Bailey, 1998). Although this
trial was shown to be effective there are a variety of factors about Zanzibar which
differ from mainland Africa. The most obvious and probably the most important of
these is that Zanzibar is a small island, geographically isolated and so unlikely to
have had any problems with re-infestation (Vale & Torr, 2005). Despite these
concerns SIT has been seen by the Pan African Tsetse and Trypanosomiasis
Eradication Campaign (PATTEC) as an essential tool in the eradication of tsetse
from Africa (Kabayo, 2002; Kabayo, 2005).
1.8.2 Control of reservoir hosts
In conjunction with early attempts to control tsetse through the destruction of their
habitats was the depletion of natural tsetse fly hosts. The animals on which tsetse
flies feed include a long list of wild game animals, various species of ungulates, bush
pig, warthog, giraffe, buffalo etc. In certain areas these animals were systematically
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hunted in an attempt to starve the tsetse into eradication. This was an enthusiastic
policy in Uganda where the elimination of these wild hosts was approached with
military fervour; this strategy is further discussed in Chapter 2.
1.8.2.1 Treatment of cattle as a reservoir host
As treatments became available for animal hosts it was possible to treat infected or at
risk animals rather than have to cull, however these treatments are generally
restricted to domestic animals. The treatment of cattle is important not only as
means to improve the welfare and productivity of animals by eliminating
trypanosomiasis but also as a preventative measure against HAT. The movement of
cattle in Uganda has been strongly implicated in the spread of T. b. rhodesiense to
previously uninfected areas (Koerner et al., 1995; Hide et al., 1996; Welburn et al.,
2001a). A new outbreak of sleeping sickness in the late 1990's was linked to the
movement of cattle through a specific cattle market (Fevre et al., 2001). The
treatment of cattle with trypanocides is very popular; over 35 million doses are sold
each year (Geerts & Holmes, 1997) with treatment mostly carried out by individual
farmers rather than part of a larger control strategy. In this way these livestock
keepers can use an effective, easy affordable treatment which benefits their own
animals and requires no dependence on others (Torr et al., 2005). Treatment of
domestic livestock can also be used as part of an integrated control programme
against human disease and this is essential in the control of T. b. rhodesiense.
Mathematical models published by Welburn and colleagues showed the relative
effects of a control programme based on the treatment of human cases with no
intervention against the cattle reservoir and the effect of chemoprophylaxis on the
cattle reservoir (Figure 1.4)(Welburn et al., 2001a). This model showed that in the
scenario where the only control measure was the treatment of human cases there
would be little effect on the reproduction rate of T. b. rhodesiense (Figure 4a). On
the other hand, if the intervention efforts were directed towards the animal reservoir
chemoprophylactically clearing infection from cattle this would have a substantial
effect on the reproductive rate of T. b. rhodesiense (Figure 4b). However, the model
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shows the most effective intervention against both T. b. rhodesiense and T. b.
gambiense is the removal of the tsetse population (Figure 4c).
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Figure 1.4 - Graphs showing mathematical models of the impact on RO of different control
strategies on both T. b. rhodesiense and T. b. gambiense (with and without an animal reservoir),
(a) shows the predicted impact of treating only human cases, (b) the impact of treating livestock
and (c) the impact of reducing tsetse flies. Figure reproduced with kind permission of (Welburn
etal., 2001a)
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1.8.2.2 Use of trypanotolerant cattle
A different type of approach to the problem of trypanosomiasis is the use of naturally
tolerant breeds of cattle. It has been well recognised that some native African breeds
of cattle are more tolerant to trypanosomiasis and can survive a level of infection that
would kill a more susceptible breed. The best known of these is the West African
N'dama breed, which has been demonstrated to have trypanotolerance (Murray et al.,
1981). However, these breeds are not immune to the parasites and will still succumb
to very heavy trypanosome infections and as these animals are still infected this
approach they would still act as a reservoir for human-infective T. b. rhodesiense.
The distribution of these breeds is generally limited to West Africa and despite
attempts to encourage their rearing in other areas, they remain unpopular due to their
small size and lower productivity (Holmes, 1997). Consequently it seems unlikely
that the rearing of these cattle will ever be adopted on a larger scale in east Africa
therefore this cannot be seen as a practical control option.
1.8.2.3 Surveillance
In terms of a HAT epidemic it is essential to detect the outbreaks early and
surveillance is a useful tool to prevent the spread and impact of this disease (Cattand
et al., 2001). Surveillance of the human population is important for T. b. gambiense
because there is a long asymptomatic period of the infection in humans, throughout
which time the disease can be transmitted. There are two approaches to surveillance,
either passive or active. Passive surveillance is probably the most common, this
occurs when a patient who is suspected to have HAT is referred to a specialist centre
for diagnosis and treatment. The non-specific nature of the early symptoms of T. b.
gambiense infection means that active surveillance is necessary to have any impact
on the progression of an epidemic. Active surveillance is the active screening of a
seemingly healthy population for the disease. This can be achieved by sleeping
sickness diagnostic centres operating active case finding initiatives in the
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surrounding community; this involves testing healthy individuals in an attempt to
find early cases and reduce the probability of transmission. The most effective
method of surveillance is the use of mobile case finding units. These units can move
throughout the country targeting known risk areas, testing everyone in a village and
treating any infected individuals (Cattand et al., 2001). This approach was used very
successfully in the Democratic Republic of Congo where at the height of surveillance
operations, 250 units covered the main risk areas resulting in a decrease in new cases
from 33,502 reported cases in 1930 to 11,837 in 1940 (Ekwanzala et al., 1996).
Unfortunately due to the unstable political system this operation collapsed and in the
1990's the numbers of new cases of sleeping sickness in the Congo was thought to
have returned back to levels seen pre 1930 (Van Nieuwenhove et al., 2001). Since
1998 control efforts intensified and a concerted effort backed by renewed donor
interest has led to a major reduction in the incidence of sleeping sickness within the
country, although fears remain over the consequences of any future removal of
international aid (Lutumba et al., 2005).
Due to the differing pathology of T. b. rhodesiense infections, little can be achieved
by extensive active screening of the human population. Passive surveillance is
employed for case finding and suspected cases are then referred to a specialist centre
for diagnosis and treatment. However the active screening of the villages or focal
areas with more than one case of T. b. rhodesiense could be very effective in
detecting cases and saving lives. This is especially true when HAT is occurring in
new areas where people cannot recognise the symptoms; early stages are confused
with malaria and late stages with HIV/AIDS (Pers. comm. Dr Alan Mpairwe, Lwala
hospital, Kaberamaido district, Uganda). In T. b. rhodesiense affected areas it would
be useful to be able to screen cattle or other animals hosts to assist with the targeting
of control strategies, but unfortunately at this time there is no cheap and easy field
diagnostic to show infections with T. b. rhodesiense.
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1.9 Farming in tsetse controlled areas (FITCA)
Recognising the substantial impact that trypanosomiasis places on the economic
output of East Africa, the European Union (EU) in the late 1990s provided
substantial funding for a programme called Farming In Tsetse Controlled Areas
(FITCA). This was a regional programme of the African Union/Inter African Bureau
for animal resources (AU/IBR). The programme consists of three large national
projects in Kenya, Uganda, Ethiopia and two smaller projects in Rwanda and
Tanzania. FITCA was funded by the European Development Fund (EU) who
allocated 20 million Euros (EU Newsletter Uganda, 2004). To combat the movement
of infected tsetse flies and prevent the re-infestation of intervention zones, the
FITCA programme focused on a large geographical area spanning the borders of
numerous countries. The FITCA approach aimed to engage the communities in
tsetse control to enable livestock keeping, increase agricultural productivity and
enable communities to continue the control after the end of the project (EU
Newsletter Uganda, 2004) and as such it was not solely a tsetse/ trypanosomiasis
control project.
The overall objective of FITCA was
"To contribute to the socio-economic development of the region through
coordination ofnational activities to ensure sustainable rural
development to improve the well being of the rural population and the
health of livestock through sustainable rural development and to improve
the implementation capacity in the countries concerned."
(EU Newsletter Uganda, 2004)
The chosen approach was an integration of vector surveillance and control, disease
surveillance and treatment, as well as the introduction of crop farming and livestock
development in the hope that these activities would control and prevent re-infestation
by tsetse and trypanosomiasis. National programmes interpreted the overall
objective in different ways to suit their development needs and different realities but
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for the purposes of this thesis, I will be discussing only the FITCA Uganda
programme and specifically those aspects directly concerned with interventions
designed to control trypanosomiasis.
1.9.1 The FITCA Uganda programme
FITCA Uganda worked in 12 districts in the eastern part of the country, covering an
area of approximately 52,029km , 6 million people and 900,000 head of cattle (EU
Newsletter Uganda, 2004). This encompassed the traditional Busoga focus of
sleeping sickness within the country and includes two areas which have more
recently been affected with sleeping sickness - Tororo (from 1988) and Soroti (from
1998). In total the area covered by FITCA covered the following districts: Mukono,
Kayunga, Kamuli, Jinja, Mayuge, Bugiri, Busia, Tororo, Mbale and Pallisa and
Soroti (Figure 1.5). Soroti was not in the initial list of districts to be involved in this
programme, however due to the ongoing human sleeping sickness epidemic (Fevre et





| Districts within the FITCA programme
j Lake and swamp areas
180
hb kilometers
Figure 1.5 - Map of Uganda showing districts involved in the FITCA programme
1.9.1.1 Implementation of the FITCA Uganda programme
The FITCA programme was implemented throughout eastern Uganda using, to a
great extent, the existing administrative network and in particular for mass
treatments, the district veterinary services. Districts comprise the largest
administration unit in Uganda and there are currently 55 districts. Each district is sub
divided into counties, sub-counties, parishes and villages (Figure 1.6). Each level of
administration fits into a hierarchical management structure with local community
(LC) leadership. Leadership is democratically elected by the local population and
forms the local government.
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Figure 1.6 - Shows administrative structure of Uganda
Veterinary services are also organised on a district level. Each district has an
experienced, veterinary trained individual - the District Veterinary Officer (DVO).
The DVO has responsibility for all veterinary care and control of veterinary or
zoonotic diseases in that district. On the staff of the DVO are veterinary officers
(VOs). These are veterinary trained individuals who are responsible for sub-counties
(usually more than one), although this varies with staffing levels. In addition there
are animal husbandry officers (AHO) who assist the VOs. These individuals do not
have a veterinary degree, but have received some technical training. The structure of
the Uganda veterinary service currently allows for comprehensive cover of the
veterinary needs in each district however, the effectiveness of this cover does vary
from one district to another, and as a rule, the system is under-resourced.
1.9.1.2 FITCA baseline survey
In the initial stages of the project (July-Sept 2001), FITCA Uganda carried out a
survey to assess the prevalence and distribution of animal trypanosomes in domestic
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cattle herds in southeast Uganda (FITCA Uganda Quarterly report, July 1st -
September 30th 2001). This then allowed FITCA to prioritise control activities based
on the trypanosomiasis risk assessment (FITCA working paper). The survey was
carried out by taking blood samples from a subset of cattle selected randomly in each
of the FITCA districts. The survey identified numbers and species of trypanosomes
by microscopy techniques. The results from this survey are shown in Table 1.3.
District No. of
samples




Bugiri 761 0.4% 1.4% 7.1% 1.4% 10.4%
Busia 627 0.8% 2.7% 4.9% 0.8% 9.3%
Iganga 1795 0.1% 2.0% 7.4% 0.9% 10.4%
Jinja 687 2.0% 0.0% 5.2% 0.3% 7.6%
Kamuli 1756 1.1% 0.1% 0.8% 0.8% 2.8%
Kayunga 1016 1.4% 0.3% 0.2% 0.0% 1.9%
Mayuge 897 2.6% 1.0% 5.6% 0.2% 9.4%
Mbale 1000 0.0% 1.5% 5.0% 0.6% 7.1%
Mukono 1173 0.9% 0.4% 2.5% 0.0% 3.8%
Pallisa 1156 0.4% 0.0% 0.3% 1.0% 1.6%
Tororo 1400 1.6% 2.6% 3.4% 0.7% 8.2%
Total 12,268 1.0% 1.1% 3.7% 0.6% 6.3%
Table 1.3 - Results of FITCA trypanosomiasis survey in cattle by microscopy
Following this initial prevalence survey, data were compared to reported cases of
human sleeping sickness from 1996 (FITCA Uganda Quarterly report, October 1st to
December 31st 2001). Subsequently, each sub-county within each district in the
surveyed area was classified as high, medium or low risk. High risk areas were
defined as sub-counties where cases of human sleeping sickness had been found.
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Medium risk was an area with a high level of trypanosomes (over 5%) found in cattle
but no human sleeping sickness cases. Low-risk referred to areas which had low
levels of animal trypanosomes (less than 5%) and no human cases. Areas with no
evidence of trypanosomes or where no data had been collected were given a no risk
status. A total of 12,268 heads of cattle were surveyed by microscopy over the
FITCA area, with the exception of Soroti which was not included in the survey. This
data was used to generate a map (Figure 1.7) showing the high risk sub-counties
where the trypanosomiasis control interventions were targeted.
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Figure 1.7 - Map showing high, medium and low risk sub-counties within the FITCA area
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Within these defined high-risk areas (shown in red on Figure 1.7) FITCA attempted
to treat all heads of cattle with a single dose of isometamidium chloride or
diminazene aceturate for clinical cases. Isometamidium chloride was preferentially
used as it has prophylactic properties whereby it can remain active in the
bloodstream of the animal for 3 months (Holmes et al., 2004). In addition to mass
treatment, FITCA Uganda planned to distribute insecticide to designated farmers
groups which would be used under a cost recovery scheme run by the farmers
themselves. The groups were given one litre of insecticide which they were
responsible for distributing at cost to farmers, allowing the aim of promoting
affordable, sustainable insecticide use within the community.
1.10 Thesis aims
The overall aim of this thesis is to investigate the impact of the large scale
trypanosomiasis control programme implemented in Uganda by FITCA in 2002.
One of the main methods of trypanosomiasis control implemented by FITCA was a
single dose of trypanocide administered to all cattle within designated high-risk
areas. The research presented in this thesis is based on a description of the
prevalence of trypanosomiasis both pre- and post-intervention within the targeted
cattle population. Cattle were sampled from four districts within the FITCA Uganda
intervention area and PCR was used as a sensitive diagnostic technique to determine
the presence of T. vivax, T. congolense savannah, T. brucei s.l. and T. b. rhodesiense
within samples. The effect of the FITCA intervention programme on reported cases
of human sleeping sickness in the intervention districts is also established by
monitoring hospital records and examining the incidence and geographical
distribution of cases pre- and post- intervention. The outline of this thesis is as
follows:
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Chapter 2 comprises a historical review of the various approaches that have been
used to control sleeping sickness in Uganda since the first recognised major epidemic
at the turn of the 19th century. A record of the major discoveries and their impact on
the techniques applied to control sleeping sickness and animal trypanosomiasis
within Uganda will be discussed. The majority of the data in this Chapter are based
on records gathered from veterinary, medical and trypanosomiasis control reports
located in the National Archives in Entebbe, Uganda and supplemented by published
articles relating to the history of trypanosomiasis in Uganda. This Chapter aims to
put into context the ongoing battle against trypanosomiasis in Uganda and examine
whether any lessons can be learned from previous attempts to control this disease.
Chapters 3, 4 and 5 switch focus to a contemporary control programme and examine
the recent intervention against sleeping sickness and animal trypanosomiasis
implemented by FITCA Uganda. Chapter 3 focuses on the impact of the FITCA
intervention on animal trypanosomiasis within the targeted cattle population. The
prevalence of T. vivax, T. congolense savannah and T. brucei s.l. in cattle within the
FITCA intervention areas are established by molecular diagnostic techniques at three
time points: pre-intervention baseline, three months post-intervention, and one year
post-intervention. These data constitute one of the largest trypanosome surveillance
programmes based on molecular diagnosis to date, with over 3,500 cattle sampled.
In addition to establishing the impact of the FITCA programme on cattle
trypanosome prevalence, the cost of undertaking such a programme will be estimated
and discussed.
In Uganda, cattle are a major reservoir of human infective T. b. rhodesiense, making
it imperative that the prevalence of this deadly pathogen is accurately assessed.
Chapter 4 applies additional molecular analyses to those samples identified as T.
brucei s.l. in Chapter 3 to establish what portion of T. brucei s.l. infections are the
human-infective sub-species T. b. rhodesiense. The prevalence of T. b. rhodesiense
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over the course of the intervention is determined and the impact of the FITCA
intervention programme will be discussed to establish if zoonotic control as
implemented by FITCA can be effective in reducing the risk of human infection.
Chapter 5 continues analysing the impact of the FITCA intervention on human health
by monitoring the incidence of reported sleeping sickness cases in two of the districts
included in the intervention. The numbers and geographical distribution of newly
reported sleeping sickness cases are described over a five and a half year period,
between January 2000 and July 2005. Spatial analysis is used to investigate disease
clustering on a year-by-year basis. Finally, the number and location of cases
reported pre-intervention are compared to those reported post-intervention to
determine if any major differences can be observed. The aim of this Chapter is to
assess if the FITCA Uganda intervention, aimed at cattle, had any effect on human
health by reducing the reported numbers of sleeping sickness cases within
intervention areas.
Chapter 6 comprises a final discussion where the overall impact of the FITCA
Uganda intervention programme on both animal and human health will be discussed.
The FITCA intervention will be discussed with reference to past intervention
strategies to establish how the programme may be improved and whether cattle
treatment represents the optimal strategy for trypanosomiasis control in Uganda in
terms of efficacy. Trypanosomiasis remains a considerable threat to both human and
animal health in much of sub-Saharan Africa making it imperative that affordable,
sustainable control measures are implemented before the situation worsens.
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2 Chapter 2:




Trypanosomes have had a huge impact on socio-economic development in sub-
Saharan Africa (Shaw, 2004) and even before these parasites were discovered, the
tsetse fly was associated with disease (Bruce, 1895). The magnitude of the disease
burden imposed by trypanosomes first became apparent when various colonial
powers tried to venture into the interior of Africa during the second half of the 19th
century (Pepin & Meda, 2001). The missionaries and scientists who led these
expeditions into the 'dark heart of Africa' encountered many problems; the
'travellers disease' (malaria) killed explorers and the 'tsetse fly disease' killed the
pack animals and horses (Lyons, 1992). As a consequence, the tsetse fly and the yet
unknown trypanosome delayed the exploration and subsequent colonisation of Africa
until the 19th Century (Knight, 1971; Maudlin, 2006). Recognition of the challenges
represented by these diseases and the drive to explore and exploit the resources of the
African continent prompted the development ofmany tropical research institutes
throughout the main colonial powers in Europe. "These natural enemies of
colonisation had to be defeated and so began an era of intensive research into the
African diseases" (Lyons, 1992).
In her 1992 book "The colonial disease", Lyons argues that colonial attempts to
control sleeping sickness lead to the development of vertical health care systems
focused on the large scale control of disease; the effects of which influence health
care provision in present day sub-Saharan Africa. At independence when the funds
were no longer available to support the large institutions that had evolved in the
colonial era, health care services broke down and local clinics which could have
maintained a more basic level of health care were absent.
In short, the massive investments in sleeping sickness control taken by the colonial
authorities could not be maintained by newly independent African states and
subsequently sleeping sickness control programmes broke down in the 1960's and
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1970's (Barrett, 1999). At this time, the new governments had a myriad of other
problems from economic and political, to the ideological issues of nation building in
an independent Africa; health care and particularly the control of sleeping sickness
were sidelined (Nugent, 2004). Disease control and healthcare in general are
moulded by the will of politics, society, and economics, as much as advances in
scientific achievements (Maudlin, 2006). Therefore approaches to the control of
human African trypanosomiasis and animal trypanosomiasis have been throughout
history guided by government systems and economic imperatives as well as scientific
development.
2.1.1 Aims of the chapter
In the forthcoming Chapters of this thesis, the impacts of the recent FITCA control
programme for both human African trypanosomiasis (sleeping sickness) and cattle
trypanosomiasis (nagana) in Uganda are evaluated. Since the discovery of
trypanosomes at the turn of the 20th century, various control strategies have been
employed to control trypanosomiasis. The aim of this chapter is to provide a
historical context for the FITCA programme in Uganda by discussing some of the
main control methods implemented in the past 100 years in areas of the country we
now know to have been affected with T. b. rhodesiense (Koerner et al., 1995).
A large proportion of the information presented in this chapter was compiled using
source materials collected from the National Uganda Archives in Entebbe, Uganda,
visited by the author for the period of one month in April 2004. The National
Archives are the depository of all official documents published by, first the colonial
and then the independent government of Uganda. Due to a lack of resources
cataloguing of these archives is incomplete and often not well ordered which meant
that is was difficult to access all relevant material on the subject matter.
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2.2 Discovery of trypanosomiasis
The first accounts of the disease now known as sleeping sickness were made in 1721
by John Atkins, a naval surgeon, in West Africa (Maudlin, 2006). However, the fact
that slave traders routinely rejected slaves with swelling of the posterior cervical
lymph nodes a clinical symptom associated with HAT in West Africa, (known as
Winterbottom's sign following his description in 1792) suggests that the symptoms
of this disease had been known about prior to this time (Maudlin, 2006). There is
also evidence that the Portuguese were aware from as early as the 15th century of a
disease that dramatically reduced the life expectancy of their horses in Africa
(Reader, 1997). However, the nature of these diseases was unknown and initial
investigations into sleeping sickness did not necessarily consider an infectious agent;
diet, exposure to strong sun injuring the brain and lethargy due to racial differences
were all cited as potential factors (Davies, 1968). Even as late as the end of the 19th
century, the eminent scientist Patrick Manson incorrectly identified a filarial worm
(.Filaria perstans now known as Mansonella perstans) as a potential causative agent
of sleeping sickness (Bruce & Nabarro, 1903) thereby causing some confusion in the
early days of the investigations into sleeping sickness in Africa (Haynes, 2000).
Sir David Bruce identified the first trypanosome in 1894, remarking on the 'curiously
shaped objects' found on examination of cattle blood films while investigating an
outbreak of nagana in northern Zululand. Injection of blood infected with these
'objects', later termed trypanosomes, into healthy dogs and horses resulted in the
development of pathology, confirming Koch's postulates and identifying these
parasites as the aetiological agent of the disease (Bruce, 1895). Soon after this in
1901, Everett Dutton identified the first human-infective trypanosome in a European
patient in West Africa (Dutton, 1902), and termed it Trypanosoma gambiense (now
identified as T. brucei gambiense, the cause of West African sleeping sickness).
Also in 1901, Aldo Castellani identified trypanosomes in the blood and cerebrospinal
fluid of a patient with sleeping sickness in Uganda (Castellani, 1903) and termed this
parasite Trypanosoma ugandense. However, it was subsequently assumed that the
parasite present in Uganda was the same species identified by Dutton in West Africa
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(Bruce & Nabarro, 1903), and so this name was not adopted. In 1910, Stephens and
Fantham described a novel trypanosome species in a sample taken in Northern
Rhodesia (Stephens & Fantham, 1910), which they named Trypanosoma rhodesiense
(now termed T. brucei rhodesiense, the causative agent of East African sleeping
sickness). Retrospective analysis by Fevre and colleagues (Fevre et al., 2004)
indicates that the parasite identified by Castellani was not T. brucei gambiense but
rather T. brucei rhodesiense and consequently this species should perhaps be termed
T. ugandense in honour of Castellani who first identified the new species (Koerner et
al., 1995). Discussions of the nomenclature are, however, beyond the scope of this
thesis.
2.3 History of sleeping sickness in Uganda
The first reports of a widespread epidemic of an unknown disease in Uganda were
received by the British Government in early 1901 (Christy, 1903) with cases
admitted to the main missionary run hospital in Mengo (Cook, 1901). However, the
number of cases reported rapidly became overwhelming and following appeals to the
governing authorities, the Chief Medical Officer of the protectorate was dispatched
to investigate the disease. He reported that 20,000 people had already succumbed to
the sleeping sickness disease, corroborating the reports by patients from Busoga
district that the disease they called 'Mgota' was prevalent (Christy, 1903). The
rapidity with which the epidemic had erupted alarmed the authorities and at the
instigation of the Foreign Office the Royal Society appointed a Commission to
investigate the cause of the disease.
By 1903 the Commission had concluded that (i) sleeping sickness was caused by a
species of trypanosome and (ii) trypanosomes were transmitted by a species of tsetse
fly (Bruce & Nabarro, 1903). As described above, there was, and remains, some
controversy over the species of trypanosome responsible for the 1901 Ugandan
sleeping sickness epidemic, with Castellani reporting the presence of a novel
trypanosome species in Uganda in 1901 (Castellani et al 1903), whilst Bruce, his
Chapter 2 46
colleague in the Commission, concluded that the causal pathogen was the same as
that previously found in West Africa by Dutton (1902). Morphologically T. b.
gambiense and T. b. rhodesiense are identical and it was not until the discovery of
SRA and the development of molecular techniques to detect its expression that it was
possible to definitively distinguish between the two species (Xong et al., 1998).
The first epidemic continued until 1920 (Langlands, 1967), although this date varies
according to different sources. However, the numbers of reported sleeping sickness
cases had begun to decline from 1905, when the first annual mortality figures were
published and continued to do so except for a resurgence of the disease in 1909 and
1910 (Figure 2.1). The total number of deaths resulting from the epidemic is
difficult to determine as in the earliest years of the epidemic many deaths would have
been unrecorded and data collection was often very rudimentary. One method
described is the presentation by individuals to their chief with a number of twigs to
show how many members of their family had perished (Langlands, 1967). Evidence
shows that even today there is a substantial underreporting of sleeping sickness cases
in Uganda (Fevre et al., 2005; Odiit et al., 2005), and it must be anticipated that 100
years ago the situation would have been no better (Maudlin, 2006). It has been
estimated that the epidemic would have realistically claimed approximately 200,000
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Figure 2.1 - Total numbers of sleeping sickness cases reported from 1905 to 1924, figures taken
from Annual Medical records of the Ugandan Protectorate
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Further sleeping sickness epidemics occurred in Uganda in 1940-1945 (MacKichan,
1944), 1970- 1989 (Okiria, 1985; Welbum et al., 2006) (Figure 2.2) and 1998-
present day (Fevre et al., 2001). All three of these epidemics have been associated
with East African sleeping sickness caused by T. b. rhodesiense (Koemer et al.,
1995; Fevre et al., 2004; Maudlin, 2006). During the inter-epidemic periods there
have been periods of stability with a focus of disease caused by T. b. gambiense in
the north-west of the country and another focus of disease caused by T. b.
rhodesiense in the south and east. A concerning feature of the ongoing epidemic is
the encroaching proximity of the two foci and the implications the overlap of the two
forms of the disease will have on management of clinical cases (Picozzi et al., 2005).
9000
Figure 2.2 - Numbers of recorded cases of sleeping sickness in Uganda from 1905 to 1998,
figures taken from national Ugandan archives and WHO country reports
2.4 Response to the first epidemic
The first Royal Society Commission report observed that people involved in
agricultural labour were particularly susceptible to contracting the disease (Christy,
1903). Cultivation of cash-crops was seen as integral to the economy of the Ugandan
Protectorate and therefore sleeping sickness was perceived to be a significant
impediment to economic development because colonial authorities were intending to
use the productive lands of Uganda as a source for raw materials (e.g. cotton)
(Maudlin, 2006). This may account for the apparently disproportionate devotion of
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resources to control of sleeping sickness in comparison to other diseases present in
Uganda at the time (Figure 2.3).
Figure 2.3 - Comparison of the numbers of recorded deaths from sleeping sickness and plague
between 1910 and 1932. N.B. this time period is after the highest numbers of cases reported in
the first epidemic, but illustrates that after 1910 during the continuing severe control measures
against sleeping sickness there were very low numbers of recorded sleeping sickness deaths
compared to other diseases. Numbers of reported deaths were taken from Annual Medical
Reports of the Protectorate of Uganda.
The early observations made by the Royal Society Commission were fundamental to
the development of strategies against the novel pathogen. By 1906 a comprehensive
list of sleeping sickness control measures were introduced and strictly enforced in
Uganda. Included in these were a suite of measures that attempted to reduce the
number of the tsetse fly vector such as (i) the direct killing or catching flies, (ii) the
indirect killing of tsetse by destroying their habitats and breeding grounds i.e. by
clearing jungle and undergrowth, especially in the various fly-areas connected with
human concourse or traffic and (iii) by diminishing or destroying their food supplies
in the form of culling game animals (Flodges & Will, 1906).
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Other measures introduced attempted to prevent or minimise the opportunity for
human/ tsetse contact, for example (i) the removal of huts, villages, markets etc from
within the local fly range, (ii) protection of the person by clothing and "education of
the natives to resist and avoid bites of the fly" (Hodges & Will, 1906), (iii) regulation
or selection of hours for certain occupations within the fly range and (iv) protection
of employees exposed in their occupation to attack of the fly (Hodges &Will, 1906).
Attempts to restrict the geographical spread of potentially infected people were also
reflected in these regulations by (i) surveillance of travellers, traders and emigrants
from epidemic area, and especially of their settlement or residence in or in contact
with non-infected fly ranges or potential epidemic areas and (ii) the regulation and
surveillance of camping places, transport stations etc. on traffic routes by land and
water, including effective clearing or diversion where these come in contact with fly
ranges (Hodges &Will, 1906). The attitude of the authorities to the contact between
local people and tsetse was summed up some years later as "only persons free from
trypanosomes may enter land not free from Glossina " (Director of Medical and
Sanitary services, 1928). However, in the early days of the epidemic the main
method of control employed was the segregation of the sick and dying.
2.4.1 Isolation of the sick and dying
Initially local quarantine of sick individuals within their communities was suggested
as a form of isolation control. However, with the early clinical stages of disease
difficult to identify, and the epidemiology of the disease not definitively
characterised this was difficult to effectively maintain. It was therefore decided that
sick individuals from every community in direct contact with the tsetse flies would
be moved to sleeping sickness camps located in areas free from flies (Hodges, 1905).
Removal and segregation of infected persons was, unsurprisingly, met with
resistance from the local population (Hodges & Will, 1906).
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Four isolation camps located at Busiro, Chegwe, Busu (on the mainland) and Sesse
Island had been established by the colonial authorities by December of 1907
(Sleeping sickness news, 1908). Sick individuals were to enter the camps of their
"own free will" and settlement of the sick "anywhere outside of the fly-infested
districts" was an acceptable alternative (Sleeping sickness news, 1908). By the end
of November 1909 these camps had received 6,619 patients with only 800 patients
still surviving (Hodges, 1910a), remembering that at this time there was no curative
treatment. Publications concerning the institution of sleeping sickness camps in
other countries such as the Belgian Congo (Lyons 1992) and Sudan (Hunt & Bloss,
1945) show that this strategy was not unique to Uganda.
Treatment was administered to the patients within these camps; however there were
no known curative agents. Various treatment regimes based on use of organic arsenic
were trialled but even the most effective of these secured an apparent success rate of
only 2-3% (Hodges, 1910a). It appears that, from a patient's point of view, the most
beneficial observations made at this time were that care, cleanliness, good feeding
and proper attention may have prolonged life for a considerable period.
Consequently, patients interned at the camps inevitably died and, in the absence of
any evident protection or cure, attendance of the sleeping sickness camps held little
appeal for the local people. In a letter written in 1910 to the Chief medical secretary,
Dr Pugh, a medical officer at one of the camps, makes it clear that he believes that
the use of isolation camps could no longer be effective. "Owing to the fact that the
majority of the cases which were treated at the former camp have since died, the
native have no faith in the treatment, and say that since they cannot be cured they
would rather die in their own villages...so great is their objection to leaving their
own villages, that I am firmly convinced unless forcible methods are used to make
them come here, very little work can be done in this camp." (Pugh, 1910)
2.4.2 Removal of the population
During his time in Uganda with the Royal Society Sleeping Sickness Commission,
Christy observed that the outbreak was concentrated along the northern shores of
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Lake Victoria. At this early stage in the epidemic there was no spread inland, in
Christy's words "This area consists ofa narrow strip ofcoast line, at its widest not
more than 10 miles, stretching along the shores of Victoria Nyanza for a distance of
over 250 miles" (Christy, 1903). During a later expedition Bruce compiled a map
detailing the correlation between prevalence of the disease and proximity to lake
shore (Figure 2.4)
Figure 2.4 - Map showing the location of reported sleeping sickness cases in 1903. The red dots
show confirmed sleeping sickness cases and the black dots show areas where surveys were
carried out but there were no cases (Bruce & Nabarro, 1903)
In 1906, it was decided to evacuate the entire population from the shore of Lake
Victoria and by December 1907 "all in habitants, infect or not, had been cleared out
ofa two-mile belt all around the north-west shore ofLake Victoria and allowed to
settle inland" (Sleeping Sickness News, 1908). This evacuation policy was later
extended to the islands in Lake Victoria (declaration by Hesketh Bell in 1909,
reported by (Hodges, 1910b)) and with the spread of the epidemic, to the populations
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on the shores of other lakes and the river Nile (Hodges, 1910b). The scale of
population movements enforced by this policy were considerable - in 1909 alone
over 24,000 people were re-located (Hodges, 1910b).
In conjunction with the depopulation of the specified areas several regulations were
introduced to minimise human entrance into the depopulated areas. This included the
prohibition of the collection of rubber within two-miles of Lake Victoria, restriction
of fishing activities and canoe traffic on Lake Victoria (and subsequently other
Lakes) and the banning of vessels from touching "the mainland except at an
authorised landing-place" (Hodges, 1910b). A government officer was appointed to
maintain the depopulated area and fines and penalties were issued for breach of these
regulations (Sleeping sickness News, 1908).
2.4.3 Targeting the tsetse
Christy made numerous observations relating the incidence of sleeping sickness with
proximity to wooded or forested areas (Christy. 1903). Notably disease was most
common amongst people who worked in the fields whilst people living in villages
were less affected by the disease and people resident in "populous centres were
practically exempt from the disease". Subsequent studies reported by Bruce and
Nabarro (1903) identified that tsetse fly vector was "only found on the shore of the
lake where there is forest" (Bruce & Nabarro, 1903). Consequently attempts to
eliminate the tsetse by destruction of its habitat from the shores of Lake Victoria
were incorporated into the sleeping sickness control efforts. Figure 2.5 illustrates the
guidelines which were used to clear the lake shores; in 1911 it was emphasised that
"undergrowth, namely shrubs, bushes, vines, creepers and tall grass must all be
cleared" (Anon, 1911). The graduation of severity of vegetation clearing from the
Lake shore outwards reflects the observation that the proximity to the shore was
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Figure 2.5- Schematic diagram showing the guidelines published in 1911 for clearing the
vegetation around Lake Victoria, (Anon, 1911).
Another recommendation made in the 1906 Sleeping Sickness Commission Report
was the destruction of the main food supply of tsetse flies in the Ugandan
protectorate (Hodges & Will, 1906). At this time the main food source for tsetse
flies across the country were game animals, e.g. buffalo, species of antelope,
warthog, bushpig etc (Hodges & Will, 1906). Despite the early suspicions that
sleeping sickness in east Africa was a zoonotic disease (Bruce et al., 1910), the
elimination of game at this time was not an attempt to remove a reservoir host of
sleeping sickness but to starve the tsetse vector.
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2.5 Continued applications of control strategies from the first
epidemic
In the 1913 Annual Medical and Sanitary Report, sleeping sickness was reported to
have ceased to be a major cause of mortality. However, it was stated that the decline
in the disease was in response to the strict control measures that had been put in
place and the Chief Medical Officer observed that, "these measures are in many
ways a serious check to the country, but there appears to be as yet no chance of
relaxing them to any extent" (Annual Medical Report, 1913). In the years and
decades following the epidemic many of the control measures implemented were
maintained and amended as deemed appropriate by the authorities.
Continued monitoring of the incidence of sleeping sickness cases and the control
measures relating to human activity in the post-epidemic period were co-ordinated by
the Medical Officer in Charge of Sleeping Sickness. During regular "safaris" to the
various infected areas the Medical Officer in Charge of Sleeping Sickness reviewed
the current situation, discussed activities with the local government officers, made
recommendations regarding control measures and frequently conducted large scale
medical examinations. Buxton in 1947 comments on the use of "African dispensers
trained in the use ofmicroscopes" for active medical surveillance in the Busoga area
following the 1940-1945 epidemic (Buxton, 1947): similar surveillance was still
being carried out by Sleeping Sickness Orderlies in the early post-colonial era
(Abaru, 1985).
During the sleeping sickness epidemic in 1940-1943, the authorities again evacuated
people from the shore of Lake Victoria and resurrected the sleeping sickness camp as
a means of segregating and accommodating infected people. (MacKichan, 1944).
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After the resolution of the first Ugandan epidemic it was considered that in the
British possessions in East and Southern Africa "from the economic point of view,
trypanomiases ofdomestic stock immeasurably more important than is
trypanomiases ofman" (Yorke, 1920). Consequently much effort was directed
towards the control of the tsetse fly as a means of controlling both nagana and
sleeping sickness (Maudlin, 2006).
In 1947 a separate Department for Tsetse Control was established to co-ordinate
activities and achieve the dual goals of halting the advance of the tsetse fly into the
protectorate that had been occurring in the 1930's and early 1940's and of reclaiming
newly invaded country from the fly. Previous Reports from this department reveal
the militaristic mindset that was adopted with frequent use of terms such as
'salients', 're-inforcements', 'out-flanking' and 'operational areas'. The two main
methods of control employed were game slaughter and destruction of the tsetse
habitat, which were generally used in conjunction.
Although it was appreciated that game formed the main reservoir host of cattle
infective trypanosomes (Buxton, 1947), game slaughter was principally applied to
deprive the tsetse fly of its principal food source in areas to be 'cleared' of tsetse and
also as a means of preventing tsetse re-invasion by transportation during game
movements. Although game clearance as a form of tsetse control was generally
regarded as "distasteful and regrettable" and even "morally objectionable"
(Buxton, 1947) the reclamation of 7,000 sq. miles of Ugandan territory from the
tsetse fly by 1959 was achieved "chiefly by use of the game elimination method"
(Annual Tsetse Control Report, 1959). Game destruction was accomplished both by
deployment of departmental hunters and by permitting local populations to hunt. The
number of game animals killed was recorded in detail in the department's annual
reports - by 1955 (i.e. after eight years of operations by the department) 46,167 game
animals had been killed (Annual Tsetse Control Report, 1955). Due to the success
attributed to game elimination as a means of controlling tsetse it was not abandoned
until 1971 (Okoth, 1999).
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Habitat clearance was achieved both by department work gangs and by encouraging
local populations to do 'late grass burning'. However, the latter often proved
unsuccessful and there are complaints in the 1954 Annual Veterinary Report about
local people carrying out grass burnings too early in the season, "despite numerous
attempts through local leaders to prevent burning until the grass is very dry"
(Annual Veterinary Report, 1954). Another frequently encountered problem noted in
the Tsetse Control Department Reports was the failure to persuade people to settle in
cleared areas, making continuing control of bush re-growth in reclaimed areas a
serious drain of available resources. Such problems highlight the difficulties
encountered during the application of top-down control measures employed by the
colonial authorities, and of applying control with little regard for social structures
and habits.
In Western Uganda, the East African Trypanomiasis Research Organisation
(EATRO) had attempted to use intensified 'discriminative' clearing (i.e. clearing
only vegetation directly associated with tsetse) in 1958 (Annual Research Report,
1958). Although a successful discriminative clearing project on the shores of Lake
Victoria had been described previously (Buxton, 1947), this project was failing to
cope with the expanding problem of tsetse flies in the area and it was decided that the
best way to improve the situation was a return to game elimination in the area
(Annual Veterinary Report, 1959). However, it was noted in this same year that a
more acceptable alternative control alternative should be identified (Annual
Veterinary Report, 1959).
Habitat management, although significantly supplanted by the development of
insecticides (see section below) continued to be used as a control method into the
post-colonial era (Abaru, 1985).
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2.6 Development of chemical treatments
2.6.1 Treatment of humans
Upon their development in the 1920's, effective treatments for sleeping sickness
were rapidly incorporated in the medical control programmes. After initial trials of
Tryparsamide (an arsenical based compound) in 1924, its use in treatment of
sleeping sickness cases was widely cited the following year and Tryparsamide
treatment centres established in Uganda (Annual Medical Report, 1925). The
availability of an effective treatment offered an opportunity for control to be less
reliant on physical separation of humans from trypanosome infected tsetse and it was
even suggested that using Tryparsamide as a prophylactic could enable people to
temporarily re-enter infective areas (Annual Medical Report, 1925). However, it was
acknowledged that such a scheme was not possible due to excessive supervision
requirements (Annual Medical Report, 1925).
During the 1940-1945 epidemic in Busoga people evacuated from the shore of Uake
Victoria and those thought to be at risk from the disease received prophylactic
injections of antrypol now known as suramin (MacKichan 1994). Buxton (1947)
describes how following this epidemic "African dispensers capable of treating
cases" were employed in the Busoga region as part of the control effort. Continuing
use of human treatments is central to control of sleeping sickness in Uganda and is
currently funded by the World Health Organization and drugs are donated by certain
pharmaceutical companies (Barrett et al., 2003).
2.6.2 Treatment of cattle
Bovine trypanosomiases were a significant problem impeding the economic
development of the livestock in the Ugandan protectorate (Annual Veterinary Report,
1932). A survey conducted on 15,572 cattle in 1923 demonstrated trypanomiasis to
be by far the most prevalent bovine disease (Figure 2.6). During the 1930's and
1940's trypanomiases continued to exact a heavy toll on the Ugandan cattle industry
with statements such as "In 1944 some 11,000 cattle in Bugere died of
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trypanomiasis" revealing the extent of the problem (Annual Veterinary report,
1945). However, in the absence of an effective treatment, control of the disease in
these decades was reliant on tsetse control measures and quarantine of infected cattle
herds.
Following field trials in the late 1940's the trypanocidal drug Antrycide dimethyl
sulphate became a core component of a veterinary trypanosomiasis control policy in
Uganda. The initial objective of this policy was to eradicate endemic bovine
trypanosomiases in the tsetse-free areas by 'block' treatment of herds and in the first
three and half years of this policy over % of a million cattle had been treated (Annual
Veterinary Report, 1953). Despite early optimism, this objective was never realised
and control of bovine trypanomiasis became a persistent problem. In subsequent
years treatment of large numbers of animals with Antrycide dimethyl sulphate and
later diminazene aceturate, Quinaldines and Phinanthridines (Annual Reports of the
department of Veterinary Services and Animal Industry Veterinary 1954 - 1971) was
predominantly administered to limit the extents of outbreaks.
Figure 2.6 - Graph showing the relative importance of trypanosomiasis in cattle in 1923, figures
from (Annual Veterinary Report, 1932)
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2.7 Insecticides
In Uganda a specialist department for tsetse control was formed in 1947 - prior to
this time tsetse control had been the responsibility of the veterinary department
(Annual Veterinary Report, 1947). Before insecticides were used, the tsetse control
department continued to rely on the clearing of vegetation and the destruction of
game. In an attempt to preserve areas which had been cleared of vegetation and
game de-flying pickets were established on their boundaries. These were manned
stations where tsetse flies would be removed from people or vehicles. In 1953, an
example of one such picket in the Northern Province reported that 21 vehicles, 6,677
cyclists and 4,569 pedestrians were examined in a 3 month period and only 20 G.
morsitans were captured (Annual Tsetse Control Report, 1953). These pickets were
still in use into the late 1960's in the south of Uganda near the shores of Uake
Victoria (I. Maudlin, pers. comm., University of Edinburgh).
With the advent of insecticides the technology became available to change the
approach to tsetse control in Africa. The first insecticide to become widely available
was DDT (dichlorodipheyltrichloroethane) which was released for non-military use
in 1945 (Allsopp & Hursey, 2004). Although DDT was first synthesised in 1874 its
insecticidal properties were not discovered until the 1930's by Paul Muller (West &
Campbell, 1950). DDT is cheaply produced and persists in the environment for a
long time, which makes it a popular choice for controlling pests but an equally
controversial choice for environmental reasons (Turusov et al., 2002). DDT and
other organochloridses became an essential part of tsetse and trypanosomiasis control
for over 40 years (Allsopp & Hursey, 2004).
2.7.1 Ground Spraying
Ground spraying was adopted in some areas of Uganda in the 1950's (Annual Tsetse
Control Report, 1953) in a variety of different ways, one example of this is detailed
below.
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In Uganda in 1955, a new programme was initiated which was the first attempt in the
Protectorate to control tsetse by insecticidal treatments (Annual Tsetse Control
Report, 1955). The method used had been development in Kenya in the Nyando
river system in Nyanza Province, where a 4.5% DDT solution was sprayed onto
riverside vegetation (Annual Tsetse Control Report, 1955). Experiments in Uganda
were carried out to establish which of the following methods would be most
effective:
(a) Hand spraying of river bank vegetation.
(b) The use of DDT treated hessian curtains (Chorley curtains) strung across
an infested river at quarter mile intervals.
The insecticide used was Arkotine a proprietary Shell product which is a miscible oil
containing 18% DDT. For both treatments this concentrate was diluted to 4.5%
weight/ volume solution of DDT. The method applied for treatment of river bank
vegetation was that the sprayer to walk along in the river and spray all the waterside
fringing vegetation reached with a four foot spray lance. The predetermined rate of
application (based on the work in Kenya) was 201bs (9.1kg) of DDT per mile of
river. Successive applications were made every 2 weeks for a total of 8 weeks.
The method applied for Chorley curtains was to sew the Hessian lengths onto the
wire so as to form a T-shaped cross section across the river. It was noted that the
river valley was more of a V shape, so the curtains were not drawn tight but allowed
to sag to a height of 6 feet from the water. A roof was constructed by sewing sticks
into the hessian. Each curtain was sprayed once a week for a period of 9 weeks,
including both sides of the curtain and the underside of the roof. Rates of application
were 2 gallons per 500sq feet (9.1 litres per 4.6km") of spraying. A comparison
















Figure 2.7 - Comparison of the of the different application methods of DDT to eliminate G.
palpalis (now known as G. fuscipes) from riverside vegetation in Uganda. (Annual Tsetse
Control Report, 1955)
This experiment was hampered by the fact that the river used in the spraying
technique had much lower numbers of flies. However, the report states that "the
rapid and seemingly complete success of the spraying led to the embarkation ofa full
scale field trial ofDDT in the Tororo area". Costs listed in the 1955 Annual Tsetse
Control Department report spraying of infested rivers in Tororo with DDT cost £69
per mile but these were due to the high observation levels required in an
experimental applications. They estimated that the actual cost would be £45 per
mile.
2.7.2 Aerial spraying
The first field trial of aerial spraying in Uganda took place in 1953, in cooperation
with the colonial insecticide unit covering an area in Lango district in the Northern
Province (Annual Tsetse Control Report, 1955). The aerial spraying unit operated
throughout the year and despite being a field experiment the results were very
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promising. However, there are no further reports of aerial spraying in Uganda until
the 1980's.
In 1988. large areas of the Busoga region were sprayed with an aerial application of
endosulfan, which was repeated in 1990 (Welburn et al., 2006). This was carried out
in response to the ongoing sleeping sickness epidemic of the early 1980's in Busoga
which was linked to civil disturbances in the 1970's (Berrang-Ford et al., 2006;
Welburn et al., 2006). The number of sleeping sickness cases between 1976 and
1992 is shown in Figure 2.8 along with the timings of the aerial applications of
insecticide. The aerial spraying carried out in 1980 appears to have had a dramatic
effect on the numbers of sleeping sickness cases. However, the number of cases
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Figure 2.8 - Graph showing the number of reported sleeping sickness cases in south east
Uganda during the years in which aerial spraying was undertaken as well as when tsetse
trapping and medical surveillance was being undertaken. Image kindly provided by Ian
Maudlin.
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2.7.3 Traps and bait technologies
The use of bait to assist in the capture of tsetse flies for research purposes was used
extensively in Uganda and indeed in a 1952 Annual Tsetse Control Report, there is
mention of using a cow as bait for tsetse with 'fly-boys' positioned to catch any
attracted tsetse (Annual Tsetse Control Report, 1952). Fly-boys were also employed
in surveys to assess the number of tsetse in an area - they used either themselves or
an animal as bait and would complete transects through an area collecting as many
tsetse as they could. Interestingly in 1938 a vehicle was used as bait for tsetse flies
(Annual Veterinary Report, 1938) as a useful tool for eliminating G. morsitans from
cleared areas in the Ankole region, "the main problem is eliminating the stragglers
which remain after the main concentrations and densities have been broken up.
Various methods have been tried but the most successful is using a motor car as a
lure. The car moves at slow speed with attendantfly boys at thefront and back,
when a tsetse lands on the car it is captured by the fly boys. It cannot however be
used to any great extent owing to the expense and the strain on the car and driver"
(Annual Veterinary Report, 1938).
By the 1960's the general view was that baits were only useful as survey devices and
research tools (Vale & Torr, 2004). However, there was concern about the
destructive nature and environmental impact of bush clearing, game destruction,
wide scale use of persistent insecticides, and an awareness of the need for alternative
methods. Many studies were undertaken examining the basic responses of tsetse
flies to various stimuli including: distinguishing visual from olfactory attractants
(Vale, 1974), attraction to wavelengths of light from different fabric (Green, 1988)
and the effect of different odour attractants (Hall et al., 1984; Vale et ai, 1986),
although artificial attractants have only proved to be half as effective as natural odour
suggesting more research remains to be completed (Hargrove et al., 1995). Different
traps have now been developed for different tsetse species (Kappmeier, 2000; Belete
et al., 2004) and have been used extensively for both survey and research purposes
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(de la Rocque et ah, 2005) (Hendrickx et ah, 2001) and control (Vale et ah, 1988;
Lancien, 1991).
Trapping using Lancien traps was carried out extensively in the Busoga region of
Uganda between 1987 and 1993 (see Figure 2.8) and reported to have been a great
success (Lancien, 1991; Smith et al., 1998), however it is be difficult to determine if
the reduction in tsetse was due to trapping or its combination with aerial spraying.
2.7.4 Insecticide treated cattle
In the late 1960's a variety of insecticides were tested on cattle in Zimbabwe,
however, none remained effective on tsetse for more than a week after application
(Vale & Torr, 2004). In the late 1980's deltamethrin was tested on cattle
(Thompson, 1987) leading to large scale field trials (Thompson et ah, 1991) and
subsequent use. Recent research has shown that only insecticide treating larger cattle
within a herd can be an effective way to protect the whole herd from trypanosomiasis
(Torr & Mangwiro, 2000). Additionally, feeding studies on cattle have shown that
tsetse preferentially feed on the legs and belly so the animal can be effectively
protected by treating only these parts with insecticide (Torr et ah, 2001). This has
the advantage of reducing the cost of insecticide application to individual farmers.




Since the beginning of the 20th century numerous strategies have been employed in
attempts to control disease caused by trypanosomes. The selection of these strategies
has depended on a variety of criteria including economics, politics and prioritization
as well scientific knowledge.
The scale of the first sleeping sickness epidemic ensured that control of the disease
became a priority for the colonial administration. The attitude of the colonial
government enabled the implementation of control measures that to the modern
perspective appear extreme. However, by wide-scale forced evacuation of
populations from tsetse-infested areas, enactment of regulations that placed severe
restrictions on the movement and daily occupations of the inhabitants of Uganda and
extensive efforts to eradicate tsetse by a combination of tsetse habitat destruction and
elimination of game animals, the first epidemic was brought under control. This
achievement using relatively rudimentary measures founded on limited scientific
understanding of the disease illustrates how strict centralised governance can be
effective in controlling disease in the absence of advanced technology. Subsequently,
the importance of bovine trypanosomiasis to the economy of the protectorate
guaranteed that the colonial authorities continued efforts to control trypanosomes,
primarily through the medium of eradicating the tsetse vector. Such expansive efforts
required considerable financial support justified by the perceived significance of the
disease to successful colonisation.
In the immediate post-colonial era many of the control measures were sustained.
However, with the advent of political instability in the early 1970's many, if not all
of these measures collapsed. Following the return of relative political stability in the
1980's insufficient financial resources of the government meant that healthcare
funding predominantly became the domain of external donor funding. Consequently,
donor ideology was imposed on trypanosomiasis control, including environmental
considerations and socio-political sensitivities, these limitations also applied to the
Chapter 2 66
FITCA programme discussed in this thesis. Therefore, measures that had been
successfully applied in the past, such as bush clearing, game elimination and
indiscriminate use of residual insecticides were deemed to be unacceptable.
Additionally the rise of the HIV/AIDS epidemic in sub-Saharan Africa meant that
the majority of available funds were dedicated to control of this devastating disease.
Changing development ideologies have advocated the use of community based
projects which require the active participation of community groups in the
implementation of disease control activities (Dransfield & Brightwell, 2004).
Trypanosomiasis is increasingly seen primarily as a livestock disease responsible for
hindering economic development (Torr et al., 2005). Consequently, there is a trend
to promote schemes that use veterinary treatments (e.g. insecticidal spraying of
cattle) that have a benefit to individual farmers and which can incorporate an element
of cost-recovery from the beneficiaries, rather than large-scale control programmes.
However, it is appreciated that centralised programmes may afford the best means of
controlling disease during epidemics (Molyneux, 2001b).
Since trypanosomiases were first documented in Uganda over a century ago,
numerous strategies have been employed to effect their control. The FITCA
intervention programme represents the most recent of the control strategies to be
used in Uganda. An evaluation of the impact of this programme is presented in the
following Chapters within this thesis.
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3 Chapter 3:
Assessment of FITCA Uganda intervention programme
on the prevalence of animal trypanosomes
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3.1 Introduction
Trypanosomiasis may be the most important constraint to livestock and mixed
farming in tropical Africa (Kristjanson et al., 1999). Approximately 50-70 million
cattle are at risk from tsetse transmitted trypanosomiasis (Geerts & Holmes, 1998) in
addition to millions of sheep, goats, donkeys, camels and horses (Reid et al., 1970).
In response to this threat it has been estimated that livestock owners in Africa
administer 35 million trypanocide doses annually (Geerts & Holmes, 1997). For a
rural African subsistence farmer, livestock, especially cattle, can have an enormous
impact on the productivity of their land and therefore the standard of living for the
entire family. Cattle can be used directly for milk or meat, ploughing the land for
cultivation while their manure can be used to improve the quality of the soil.
Consequently trypanosomiasis can impact not only on crop yields and the nutritional
status of the individual farmer but also on the total agricultural output of the country.
It has been estimated that animal trypanosomiasis costs US$1.3 billion annually to
both producers and consumers (Kristjanson et al., 1999).
In Uganda, the major pathogenic trypanosome species found in cattle are
Trypanosoma congolense, Trypanosoma vivax and to a lesser extent Trypanosoma
brucei brucei (Taylor & Authie, 2004). Whilst these species are important for
economic reasons, cattle can also act as a reservoir host for the zoonotic human-
infective parasite Trypanosoma brucei rhodesiense. T. b. rhodesiense leads
predominantly to an asymptomatic infection in cattle but is fatal in humans. While
sleeping sickness is not a national public health problem in Uganda when compared
to malaria and HIV, it does nevertheless have a serious impact in certain regions. It
is, therefore, essential to control the animal reservoir in order to improve human
health. The impact of the FITCA (Farming In Tsetse Controlled Areas) Uganda
programme on human disease will be discussed fully in Chapters four and five. This
Chapter will focus firstly on the success of the FITCA Uganda programme in
reducing the prevalence of pathogenic animal trypanosomes and secondly examine
the cost effectiveness of this programme.
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3.1.1 The importance of cost analysis
Economic evaluations of interventions against disease are a very useful tool to aid
decisions by policy makers on the effective use of scarce resources. A 2001 review
on economic appraisals stated that the published literature does not yet include many
examples of applications of economic evaluation on communicable diseases or on
the major health problems of developing countries (Hutubessy et al., 2001). The
available literature for these topics is focused on interventions relating to HIV,
hepatitis and a variety of immunisation programmes (Brenzel & Claquin, 1994). A
comprehensive review of the economics of African trypanosomiasis in 2004 states
that despite increases in the amount of information available about this disease it
remains difficult to ascertain the extent to which trypanosomiasis constrains the
pattern of rural development in Africa (Shaw, 2004).
The most common technique used in economic evaluation in areas other than
healthcare is cost benefit analysis (CBA), which measures the economic outcomes
(benefits) of a system against the costs of implementing this system (Hutubessy et
al., 2001). However, human health outcomes are difficult to quantify in monetary
terms and there are ethical concerns about the attempt to attribute economic value to
a life (Johannesson & Jonsson, 1991). Therefore CBA has not been used extensively
in the health sector, which has instead focused on cost effective analysis (CEA)
(Hutubessy et al., 2001); this is certainly true in the case of parasitic disease (Walker
& Fox-Rushby, 2000). In CEA, health outcomes are measured in physical units, for
example, cure rate of TB for different programmes (Saunderson, 1995) or number of
years of life saved by HIV infected pregnant women using antiretrovirals (Wilkinson
et al., 1998). A review by Walker and Fox-Rushby in 2000 shows a list of a total of
33 different outcomes used in CEA for parasitic disease (Walker & Fox-Rushby,
2000). A sub-set of CEA, known as cost-utility analysis uses both morbidity and
mortality as an output measure either as quality adjusted life year gained (QALY) or
disability adjusted life year averted (DALY) (Hutubessy et al., 2001).
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A study by Kapiriri and colleagues on the use of burden of disease (BOD) as a tool in
health planning in Uganda commented that health planners were not free to allocate
resources. Most resources for health were found to be available from donors with a
pre-set agenda or from central government in the form of grants for specific
programmes (Kapiriri et ciL, 2003). In fact Jeppson noted in 2001 that in Uganda,
district officials commonly felt it was more difficult to satisfy the needs of the health
sector than of any other sector at the district level. During the financial year of
1997/98 a total of 87% of funding for primary health care was contributed by donors
with specific requirements for the resources (Jeppson, 2001). Additional problems
can arise from centralised funding; human African trypanosomiasis can often be
overlooked at national level but can be a priority at district level (Kapiriri et al.,
2003).
3.1.2 Aims and objectives
To examine the effectiveness of the FITCA Uganda programme, prevalence of
different trypanosome species were measured in cattle (n = 3920) from four districts.
These districts all contained FITCA high-risk areas defined as sub-counties which
had high levels of animal trypanosomes by microscopy coupled with cases of human
sleeping sickness. Samples were collected from cattle at three time points: baseline,
three months post-intervention and one year post-intervention. The three month time
point was chosen to coincide with the end of the prophylactic period of the
predominantly administered trypanocide, isometamidium chloride, providing an
indication of the short-term effectiveness of the programme. Meanwhile, the
samples collected one year post-intervention provide an indication of the long-term
effectiveness of mass trypanocidal intervention. Prevalence data from the four
districts will be examined at different levels of resolution - individual sample site
level, district level and entire study area - at both post-intervention time points in
order to accurately assess the efficacy of the FITCA programme.
The second part of this chapter addresses the cost of the mass treatment campaign in
the four study districts. This is not a full cost-effective analysis but rather an
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investigation into the amount of money needed to implement this type of intervention
in Uganda in the context of the measured benefits in terms of reduction in
prevalence. The analysis will focus on expenditure at the district level in terms of
cost per person, per livestock owner, and per percentage reduction of trypanosome
prevalence in each area.
Chapter 3 72
3.2 Materials and methods
3.2.1 Study area
The FITCA programme area comprised the following districts: Bugiri, Busia, Iganga,
Jinja, Kamuli, Kayunga, Mayuge, Mukono, Pallisa, Soroti and Tororo (section 1.9).
Six of these districts (Kamuli, Iganga, Bugiri, Mayuge, Tororo and Soroti) were
identified by FITCA as containing at least one high-risk sub-country (section 1.9.1.1)
which consequently received mass trypanocide treatment. For the purposes of this
thesis all six districts could not logistically be included so the following four districts
were selected. Kamuli and Iganga were chosen as they were both part of the original
Busoga focus (Abaru, 1985). Similarly Tororo was chosen as it was the site of the
1988-1990 expansion of the original Busoga focus (Hide et al., 1996). Finally,
Soroti was chosen as it is currently undergoing a sleeping sickness epidemic (Fevre
et al., 2001). There is a general move towards the decentralisation of Uganda
administrative structures, therefore these districts are described as they existed in
2002 (Ugandan Bureau of Statistics, 2005).
3.2.1.1 Iganga district
Iganga district (see Figure 3.1)was originally part of Busoga but gained separate
district status in 1975 as South Busoga district before being renamed as Iganga in
1981. Iganga borders another of the districts in this study, Kamuli to the north, and
has an area of 4265 km2. The latest human census figures for Uganda show that the
district has a population of 708,690 with 94% of the population residing in rural
areas (Ugandan Bureau of Statistics, 2002). The main economic activity in the
district is agriculture comprising mainly subsistence farming with cotton, coffee, and
rice grown as cash crops. Similarly, industry is primarily agriculture-based
encompassing coffee processing, rice milling, and the manufacture of jaggery
(unrefined sugar). Aside from agriculture, the other main industry is brick making
(Ugandan Bureau of Statistics, 2005). The main administrative centre, Iganga town,
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is a growing commercial centre situated on the main overland route from Kenya
which has boosted business activity.
3.2.1.2 Kamuli district
Like Iganga, Kamuli was also part of the former Busoga district but gained separate
district status in 1975 as North Busoga district before being renamed as Kamuli in
1980. Kamuli district (see Figure 3.1) has an area of 4,302 km*" and lies to the south
of Lake Kyoga. It has a population of 707,332; 98% of whom live in rural areas
(Ugandan Bureau of Statistics, 2002). The main economic activity in Kamuli is
agriculture comprising mostly of subsistence farming with cotton, coffee and
sugarcane grown as cash crops. Small industries are based on rural activities and
include the manufacture of jaggery, brick making, maize milling, and cotton ginning
(Ugandan Bureau of Statistics, 2005).
3.2.1.3 Soroti district
Soroti district (see Figure 3.1) is a relatively new district, created in 1980 from part
of the South Teso district. It covers an area of 3,374 km2 and borders Lake Kyoga to
the South. The latest national human population census for Uganda recorded
369,789 people in Soroti, of which the majority, (89%) live in rural areas (Ugandan
Bureau of Statistics, 2002). The main economic activity is subsistence farming
where the only cash crop grown is cotton. Small industry is based on rural activities
and include milling of oil, flour, and millet, cotton ginning, bread baking, and
furniture making (Ugandan Bureau of Statistics, 2005).
3.2.1.4 Tororo district
Tororo district (see Figure 3.1) has been in existence since independence; it was
originally named Bukedi and was renamed Tororo in 1980. It covers an area of
1,849 km2 and borders Kenya to the East. Tororo has a population of 536,888, 93%
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of whom live in rural areas (Ugandan Bureau of Statistics, 2002). The main
economic activity is agriculture which is mostly subsistence level farming with
cotton comprising the main cash crop. Industry in this district includes agricultural
based enterprise such as oil milling and cotton ginning as well as other
manufacturing industries such as the production of corrugated roofing sheets,
cement, fertilizers, fungicides, and soap (Ugandan Bureau of Statistics, 2005). The
proximity to the Kenyan border means that the administrative headquarters, Tororo
town, has become a small commercial centre.
3.2.2 Sample collection and analysis
The impact of the FITCA programme was assessed by collecting blood samples from
cattle within designated sample sites at three time points: baseline, three months
post-intervention and one year post-intervention. Baseline sampling coincided with
administration of trypanocidal drugs by FITCA in November 2002.
3.2.2.1 Sample sites
Sampling sites were selected in each of the four study districts to monitor any change
in the prevalence of trypanosomes, during the mass intervention programme. As
previously mentioned, three species of trypanosome were monitored: T. vivax, T.
congolense savannah, which are the important animal trypanosomiases in this area
and T. brucei s.l., a sub-species of which is responsible for Rhodesian sleeping
sickness. The sampling locations were chosen, where possible, to be representative
of the selected districts. FITCA intervention sites had in all cases already been
selected, and as such a true randomised cluster sampling protocol (Thrusfield, 2005)
was not possible. In addition within the FITCA designated high-risk zones,
individual District Veterinary Officers (DVOs) were responsible for deciding on a
timetable for the local interventions. Due to the scale of the FITCA interventions,
cattle in the high-risk areas could not be treated simultaneously. The situation was
further complicated by the fact that the trypanocidal drugs used in the intervention
programmes (isometamidium chloride and diminazene aceturate) were distributed
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quarterly in 2002 and 2003. Consequently, village sampling sites had to be
compatible with the pre-existing intervention timetable and were, therefore, selected
with the assistance of the DVO. Ultimately in each district the sample sites were
located in a single high-risk sub-county. Figure 3.1 shows the location of the sample
sites.
i Sampling districts
j Dstricts included in FITCA programme
Areas of lake and swamp
0 15 30 60
iKilometers
Figure 3.1 - Map of FITCA districts showing the sampling sites for this study
In all villages within the FITCA intervention areas farmers were asked to present
their animals to a central point for treatment. In villages selected for this study, a
blood sample was taken from the ear vein of each animal before treatment. On
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subsequent visits to these villages, the incentive of a deworming treatment
(albendazole) was offered for those farmers who brought their animals for sampling.
Animals were sampled on a convenience basis in each study village at each time
point.
3.2.2.2 Interventions
The predominant treatment was isometamidium chloride, administered
intramuscularly and at the manufacturers recommended dose rate, 0.25-0.5mg/kg.
District veterinarians carried out this treatment as part of the FITCA intervention
programme. This drug is known to have a prophylactic effect and can remain active
in the animal blood stream for three months (Holmes et al., 2004). Diminazene
aceturate was also used as a treatment but largely for clinical cases, this was
administered at the manufacturers recommended dose rate, 3.5mg/kg.
3.2.2.3 Controls
No control villages were included in this study because of the nature of the
intervention programme which targeted areas subject to the highest risk for human
sleeping sickness. Consequently, it would have been highly unethical to withhold
treatment in order to 'ring fence' a village within these high-risk areas to act as a
scientific control. Areas outside of these high-risk zones could not act as suitable
controls because by definition they had low prevalence of trypanosomes and no cases
of sleeping sickness.
3.2.2.4 Sample size
Sample sizes within sub-counties were calculated with the Winepiscope programme
(Thrusfield et al., 2001), using the following equation:
n = (t*SD/L) 2
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where,
n = sample size,
t = students t-value,
SD = VP*(1-P), where P = prevalence,
L = the accepted absolute error or precision.
The values used in these calculations were, t = 1.96 (for the desired confidence level
of 95%), P = 4% (Waiswa et al., 2003; Magona et al., 2005), L = 5%. This formula
is valid when n is less than 10% of the total population size (winepiscope help)
(Table 3.1). The total population was taken as the number of head of cattle reported













Iganga Bulamagi 5529 60 352 6.4%
Kamuli Kitayunjwa 4425 60 340 7.7%
Soroti Pingire* 7589 60 262 3.5%
Tororo Osukuru 8070 60 366 4.2%
Table 3.1 - Table showing the numbers of samples taken in each district. *No FITCA livestock
census was completed therefore value is an estimation of cattle number from 2002 census, (s/c
denotes sub-county).
In Kamuli, three additional villages were sampled, two have been removed from the
analysis as they were located in a different sub-county and the other was removed as
it could not be sampled at each of the time points. In Soroti, one additional village
was sampled but was not included in the analysis as it was located in a different sub-
county. The sampling errors for each of the districts were calculated using














Iganga 360 1.96 336 2.03 321 2.08
Kamuli 409 1.81 291 2.18 319 2.07
Soroti 290 2.21 256 2.36 240 2.44
Tororo 360 1.98 378 1.93 360 1.98
Table 3.2 - Table showing the sampling error for each sampling point in each district -
assuming a 4% prevalence. (1) is the baseline (pre-intervention) sample point, (2) is three month
post-intervention sample point and (3) is one year post-intervention sample point.
Table 3.3 shows the number of samples collected at each site and the date of
collection over the duration of the study.
District Village








Iganga Budondo 12/11/2002 100 05/03/2003 120 10/11/2003 108
Bulowoza 16/11/2002 60 08/03/2003 75 12/11/2003 52
Bunyiro 14/11/2002 100 07/03/2003 116 11/11/2003 124
Nawanyingi 15/02/2002 100 06/03/2003 25 11/11/2003 37
Kamuli Bulagala 28/11/2002 120 22/03/2003 63 06/11/2003 108
Buwaiswa 27/11/2002 143 21/03/2003 126 05/11/2003 101
Nabigoagerya 27/11/2002 146 22/03/2003 100 05/11/2003 110
Soroti Amuria 18/11/2002 146 13/03/2003 120 31/12/2003 120
Okidi 19/11/2002 144 12/03/2003 136 20/12/2003 120
Tororo Kasipodo 02/12/2002 112 17/03/2003 86 13/11/2003 132
Kayoio 03/12/2002 108 18/03/2003 164 14/11/2003 100
Manikori 04/12/2002 140 19/03/2003 128 15/11/2003 128
Totals 1419 1261 1240
Table 3.3- Date and number of samples collected in all four study districts
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3.2.2.5 Assessment of treatment coverage
During both the post-intervention sampling points in all study sites, cattle owners
who presented their cattle for sampling were asked whether the animal had been
previously included in the FITCA mass treatment intervention. This data has
allowed estimates to be made on the coverage of the mass treatment programme in
the study areas used in this Chapter, the impact of which has been investigated.
3.2.2.6 Sample collection
The blood samples were collected onto Whatman FTA filter papers (Figure 3.2).
Whatman FTA® is the cellulose matrix pre-treated to allow fixation and long term
storage of genetic material. When samples are applied to FTA®-treated paper, cell
lysis occurs and high molecular weight DNA is immobilised within the matrix. The
system is designed to kill pathogens and prevent future colonisation by bacteria or
fungi thus protecting DNA from microbial and environmental degradation. As
bacteria and viruses are inactivated, the samples are rendered non-hazardous
meaning that they can be collected, transported and stored at room temperature. PCR
amplifications can be performed on biological samples stored on cards at room
temperature with a desiccant for over ten years (Whatman, 2004).
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Figure 3.2- Picture of an FTA card, showing where the discs have been removed for analysis.
Blood samples were obtained by qualified veterinarians from the ear vein of cattle
using a sterile lancet. Blood was collected into heparinised capillary tubes before
being spotted directly onto FTA cards. Whole blood was used to keep the sampling
process as simple as possible. After samples were collected, the cards were allowed
to dry completely before storage. Post drying, cards were stored in FTA supplied
multi barrier pouches with a desiccant. Five cards were stored in each pouch and
after the addition of desiccant, pouches were sealed and stored at room temperature
for transportation to the UK. All laboratory analyses were carried out by this author
at the University of Edinburgh in the Centre for Tropical Veterinary Medicine
(CTVM), Easter Bush.
The sex and age of each animal was recorded at the time of sampling. Cattle
included in the study were separated into 3 age groups: animals of less than 1 year,
animals of 1 to 2 years, and animals over 2 years. Where possible the baseline
samples were taken immediately prior to the administration of isometamidium
Chapter 3 81
chloride or diminazene aceturate, however, this was not possible in Tororo, in which
the animals were treated a week later.
3.2.2.7 Preparation of sample from FTA card for PCR
To prepare an FTA sample for PCR amplification, discs were first cut from the card
using a micro Harris 2.0 mm punch (Figure 3.2). Discs were transferred from the
micro-punch to individual microtubes for washing. When more than one disc was
cut from an individual sample, discs were washed together in the same microtube.
To ensure no cross contamination occurred between samples an equivalent number
of discs were taken from a blank filter card after each sample was cut and treated in
the same way as the sample punches (detailed below).
Discs from each sample were then washed by the addition of 200 p.1 of FTA
purification reagent per disc. Tubes were subsequently incubated at room
temperature for 15 minutes while being continually agitated. The FTA reagent was
removed and discarded using a fine tipped pastette. Pastettes were reserved for use
throughout the washing procedure taking care to ensure the same pastette was only
used for one sample to avoid cross contamination. After 2 washes with FTA reagent,
the samples were rinsed with 200pl of TE (lxTris-EDTA (lOmM Tris HC1, pH 8;
ImM EDTA)) per disc. Tubes were incubated for 15 minutes as before, after which
the TE was removed using a pastette. This was repeated such that each sample was
washed twice with FTA reagent and twice with TE. After the final wash, the disc
was carefully removed using a pipette tip and placed into a PCR tube. The disc was
then allowed to air dry at room temperature before amplification. A schematic
illustrating the washing procedure is shown in Figure 3.3. A blank disc was included























Transfer the disc to
a PCR tube and
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Figure 3.3 - Figure showing the washing procedure for samples stored on FTA cards
3.2.2.8 Detection of prevalence by PCR
Post washing and drying, discs were ready for PCR amplification. As the DNA
template remained bound to the FTA disc and PCR amplification was carried out by
adding the reaction mix to each sample directly without the need to isolate the DNA
first. PCR amplifications were carried out in 25 pi reaction volumes, each
containing a final concentration of 10 mM TrisHCl pH 8.3, 50 mM KC1, 1.5 mM
MgCb, 200 pM of each of the 4 deoxynucleoside triphosphates (dNTPs) 1 Unit of
REDTaq DNA polymerase (Sigma), with the required concentration of primer. Each
sample was analysed for the presence of T. brucei s.l., T. vivax and T. congolense
savannah using species-specific primers at concentrations of 0.8, 2 and 2 pM
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respectively (Picozzi et al., 2002). Primer sequences and PCR amplification
conditions are shown in Table 3.4; each reaction was heated for an initial
denaturation step of 3 minutes at 94°C and a final extension step of 5 minutes at
72°C. Reactions were carried out in a DNA Engine DYAD™ Peltier Thermal Cycler.


























Amplification conditions : [(30 cycles) 94°C for 60s, 55°C for 120s, 72°C for 120s]
Table 3.4 - Table showing the primer sequences and conditions of the PCRs, (Artama et al.,
1992; Masiga et al., 1996),(Masiga et al., 1992).
3.2.2.9 Agarose gel electrophoresis
Species identification was conducted based on different sized amplified DNA
fragments visualised using agarose gel electrophoresis with reference to size
standards. Examples of the gels produced using three separate sets of primers to
identify T. brucei s.l., T. vivax and T. congolense savannah, during this screening are
shown in Figure 3.4, Figure 3.5 and Figure 3.6. The double bands seen in Figure 3.4
(71 brucei s.l.) both the positive control and positive samples is consistent with
published results; this is explained by Artama and colleagues as resulting from the
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primers being extended through multiple tandem copies during each PCR cycle
(Artama et al., 1992). Gels were prepared at a concentration of 1.2% agarose in TBE
(Tris Borate EDTA, a composite buffer containing Tris base 89mM, Boric acid
289mM and EDTA 2mM at pH8.0) containing 5p.M ethidium bromide and were run
for 30 mins at 100 V. 25pl of sample PCR product was added to each well with one
well containing 5p.l of a 100 base pair ladder (Bioline) for band size comparison.
Gels were visualised under ultraviolet light using a Biorad Gel Doc 2000.
Figure 3.4 - Agarose gel showing the PCR products from T. brucei s.l. Lane 1 - ladder,
lanes a to x - samples; f, g, i, 1, m, o, p are positive for T. brucei s.l., lane 2 - negative control and
lane 3 - positive control.
Figure 3.5 - Agarose gel showing the PCR products from T. vivax, lanes a to x - samples; there
are no positives shown, lane 1 - negative control, lane 2 - positive control and lane 3 - ladder.
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Figure 3.6 - Agarose gel showing the PCR products from T. congolense savannah, lane 1- ladder,
lanes a to x - samples; there are no positive samples shown in this gel, lane 2 - negative control
and lane 3 - positive control.
3.2.3 Calculation of costs relating to the FITCA programme in selected
districts
3.2.3.1 Data Sources
All costs used in this analysis were taken from either internal FITCA reports or
personal communication from the relevant component managers. During the FITCA
programme each district had to submit quarterly progress reports to the main FITCA
office in Entebbe, Uganda. These reports were complied into quarterly progress
reports covering the whole of the FITCA project area. These reports were available
on request in Entebbe.
The cost analysis was done only for the mass treatment of cattle with trypanocides
within the four study districts. This treatment plan constituted only a part of the
overall FITCA programme in Uganda. Therefore the cost analysis completed for this
chapter is only a partial examination of the FITCA budget which relates only to the
mass treatment in Kamuli, Iganga, Soroti and Tororo.
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3.2.3.2 Included costs
The costs were divided into two groups - item costs and running costs - which
referred to the cost of the items used in the program and the ongoing cost of
implementing these items, respectively.
Item costs included the total cost of the trypanocides, distilled water, needles,
syringes and vehicles, a motorbike and 4-wheel drive for each district. Running
costs included the per diems paid to the veterinary staff to implement the
programme, the cost of supervision visits, office expenses, vehicle insurance and
fuel, for both implementation and supervision.
3.2.3.3 Excluded costs
Only the costs relating to the mass treatment programme in each of the study districts
were included in this analysis, any costs incurred in different parts of the FITCA
programme were excluded. This analysis is not intended to be an audit of FITCA
Uganda; it was done purely to give an indication of how much a large scale mass
treatment intervention would cost. The costs of distributing the supplies to the
district and general administration are not included.
3.2.4 Statistical analysis
3.2.4.1 Confidence intervals
All confidence intervals were calculated as binomial confidence intervals in R
version 2.4.0 (R project)(Figure 3.7).
round( 100*(binconf(baseline_tbrucei_by_district$tbrucei,baseline_tbrucei_by_district$number)), 1)
Figure 3.7 - Example of code used for calculating binomial confidence intervals in R, this
example was used to calculate the CI for T. brucei s.l. at the district level.
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3.2.4.2 Comparison of baseline data
To investigate any differences between the prevalence of T. brucei s.l., T. vivax and
T. c. savannah in the different study areas % tests were conducted in Minitab version
14 (Minitab, Inc.). Differences were considered to be significant at p<0.05.
3.2.4.3 Effect of the mass treatment campaign
To investigate if there were any significant differences within districts included in
the study pre- and post-intervention, paired t-tests were carried out using Minitab
version 14 (Minitab, Inc.). Differences were considered to be significant at p<0.05.
To investigate if there were any significant differences within individual sample sites
fisher exact tests were completed in R (Figure 3.8). Differences were considered to
be significant at p<0.05.





Figure 3.8 - Code used for analysis of differences between individual sample sites, the Fishers
exact test.
For analysis purposes, certain assumptions were made regarding normality and
independence of data. The rationale and limitations of these assumptions will be
examined in the discussion.
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3.3 Results
3.3.1 Description of samples
There were 3,920 cattle blood samples collected from four districts at three time
points over the whole study period. Of these, 1,419 were collected at the baseline
pre-intervention sampling (November 2002), 1,261 of these at the first post-
intervention sampling (March 2003) and lastly 1,240 at the second post-intervention
sampling (November 2003). During sampling some basic epidemiological
information was collected about each sampled animal, age in three categories (less
than one year, one to two years and more than two years) and sex was recorded. The
proportion of sampled animals in each age and sex category is shown in Table 3.5.
This shows that there were differences in the make up of the samples from the
different districts.
In Iganga and Kamuli district the majority of the animals sampled were female,
ranging from 73.2% to 79.3%. In Soroti district the sampled animals were made up
of almost equal numbers of males (44-50%) and females (50-56%)and in Tororo
district there were slightly more females (63-68%than males (32-37%). Overall in
each of the sampled areas the predominant age of the sampled cattle was over two
years. The exact proportions of each age category are shown in the Table 3.5. Over
time there is no significant difference in the proportions of cattle in each age group in
Iganga (-£ = 8.120, df = 4, p = 0.087) or Kamuli (%2 = 4.036, df = 4, p = 0.401).
However there are differences in the proportions sampled in Soroti and Tororo
districts, in both situations there are variations in the proportions of animals less than
two years old sampled at one of the time points. In Soroti at the final sampling point
there are more animals in the less than one year old category and in Tororo at the
baseline sample point there are fewer animals in the under one year old category.
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Iganga Nov 2002 16.9% 22.2% 60.8% 74.4% 25.6%
March 2003 12.5% 29.8% 57.7% 76.8% 23.2%
Nov 2003 15.9% 29.3% 54.8% 73.2% 26.8%
Kamuli Nov 2002 14.1% 20.5% 65.5% 79.3% 20.7%
March 2003 12.3% 23.9% 63.7% 78.9% 21.1%
Nov 2003 16.4% 27.1% 56.5% 76.8% 23.2%
Soroti Nov 2002 6.1% 22.1% 71.8% 49.7% 50.3%
March 2003 6.5% 21.1% 72.5% 55.3% 44.7%
Nov 2003 11.9% 13.6% 74.4% 56.1% 43.9%
Tororo Nov 2002 6.4% 30.3% 63.3% 62.8% 37.2%
March 2003 11.4% 21.7% 66.9% 64.3% 35.7%
Nov 2003 10.6% 20.3% 69.2% 68.6% 31.4%
Table 3.5 - Proportion of sampled animals at each age and sex category
3.3.2 Baseline pre-intervention results
Overall there were no statistically significant differences between age groups when
total prevalence of all trypanosome species were compared (x2=2.221, df=2,
p=0.329). When trypanosome species were examined individually, significant
differences were observed between age groups for T. vivax (%2=21.320, df=2,
p<0.001) but this was not the case for T. brucei s.l. (x2=1.714, df=2, p=0.425). T.
vivax prevalence was significantly lower in animals under one year of age
(jf=12.671, df=l, p<0.001) and those between one and two years (%"=17.084, df=l,
p<0.001). The prevalence of T. c. savannah at baseline was very low and as such it
was impossible to make any inferences regarding infection prevalence across any age
or sex groups.
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When the three trypanosome species combined were considered, there was a
significant difference in infection prevalence between the sexes (x =7.70, df=l,
p=0.006) with significantly more male cattle infected. When trypanosome species
were considered separately, T. vivax continued to display the same trend (x2=6.059,
df=l, p=0.014) while T. brucei s.l. was approaching significance (x"=3.283, df=l,
p=0.07).
3.3.2.1 Prevalence at sample site level
3.3.2.1.1 T. brucei s.l.
The baseline prevalence of T. brucei s.l. in each sample site is shown in Figure 3.9.
The prevalence by PCR detected in each of the study sites ranged from 0% to 33%,
the highest prevalence was found in Okidi in Soroti district where 33% of the
samples taken were positive for T. brucei s.l., the lowest prevalence was found in
Kasipodo and Kayoro in Tororo district where no T. brucei s.l. was detected.
50
Kamuli Iganga Soroti Tororo
Sample site
Figure 3.9 - Baseline prevalence of T. brucei s.l. at each sample site. Error bars shown on the
graph represent the binomial confidence intervals for each sample site.
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3.3.2.1.2 T. vivax
The baseline prevalence of T. vivax at each sample site is shown in Figure 3.10. The
detected prevalence ranged from 0% to 10%. The highest prevalence was seen in
Bunyiro in Iganga district where 10% of the samples tested were positive for T.
vivax, the lowest prevalence was found in Kasipodo in Tororo district where no T.
vivax was detected.
20
Kamuli Iganga Soroti Tororo
Sample site
Figure 3.10 - Baseline prevalence of T. vivax at each sample site. Error bars shown on the
graph represent the binomial confidence intervals for each sample site.
3.3.2.1.3 T. congolense savannah
As previously mentioned, very low levels of T. c. savannah were detected across all
sample sites (Figure 3.11). There was no T. c. savannah detected in eight of the
sample sites at the baseline while in the remaining four sites the prevalence varied




















































Figure 3.11 - Baseline prevalence of T. congolense savannah at each sample site. Error bars
shown on the graph represent the binomial confidence intervals for each sample site.
3.3.2.2 Prevalence at district level
3.3.2.2.1 T. brucei s.l.
The prevalence of T. brucei s.l. across the four districts is shown in Figure 3.12.
Significant differences in prevalence were observed across the districts (x~=82.204,
df=3, pcO.OOl) with the highest prevalence in Soroti (22.8%) and the lowest in
Tororo (1.4%). On closer examination, Soroti and Tororo were both shown to be
significantly different (pcO.OOl) from all other districts, as well as each other, while
















Figure 3.12 - Graph showing the prevalence of T. brucei s.l. pre-intervention, *** denotes
significance at p<0.001.
3.3.2.2.2 T. vivax
The prevalence of T. vivax in the four study areas was lower than that of T. brucei s.l.
however the patterns of infection across the districts remained similar with the
highest prevalence seen in Soroti (8.6%) and the lowest in Tororo (0.8%). The
results from all four districts are shown in Figure 3.13. Statistically there was a
difference across the districts (x2=22.742, df=3, p<0.001) which on closer
examination was due to the prevalence of infection in Tororo being significantly
lower than the other three districts. There was no difference between the prevalence








Kamuli Iganga Soroti Tororo
District
Figure 3.13 - Graph showing the prevalence of T. vivax pre-intervention, denotes significance at
p<0.001.
3.3.2.2.3 T. congolense savannah
Levels of T. c. savannah detected throughout all districts were very low (Figure
3.14). No T. c. savannah was found in Kamuli district while the prevalence varied
between 0.3% in Iganga district to 1.9% in Tororo district. No further analysis was














Figure 3.14 - Graph showing the prevalence of T. congolense savannah pre-intervention
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3.3.2.2.4 Trypanosome species combined
When the trypanosome species were combined and compared across the four districts
(Figure 3.15), a significant difference in prevalence levels was observed (x~=93.827,
df=3, p-value<0.0001). Soroti had a significantly higher prevalence of infection than
any other district (pcO.OOl) while Tororo had a significantly lower prevalence of
infection than any other district (p<0.001). The prevalence of infection in Iganga and
Kamuli were not significantly different.
40 i ***■
Kamuli Iganga Soroti Tororo
District
Figure 3.15 - Graph showing the prevalence of all tested trypanosome spp. pre-intervention,
*** denotes significance at pcO.OOl.
3.3.2.3 Comparison of pre-intervention prevalence: PCR and microscopy
PCR prevalence data were compared to FITCA microscopy prevalence data to assess
the correlation between the two diagnostic techniques. Table 3.6 shows a
comparison between the baseline prevalence taken by FITCA using microscopy and
the prevalence by PCR in the four study districts. Unfortunately the FITCA
trypanosomiasis survey was not completed in Soroti district so there are no values
available for microscopy. Prevalence data are shown for trypanosome species













Iganga Microscopy 1795 0.1% 2.0% 7.4% 10.4% 0.038
PCR 360 7.8% 6.1% 0.3% 14.2%
Kamuli Microscopy 1756 1.1% 0.1% 0.8% 2.8% <0.001
PCR 409 12.5% 4.7% 0 17.2%
Soroti Microscopy n/a n/a n/a n/a n/a n/a
PCR 290 22.8% 8.6% 0.7% 32.1%
Tororo Microscopy 1400 1.6% 2.6% 3.4% 8.2% 0.009
PCR 360 1.4% 0.8% 1.9% 4.2%
Table 3.6 - Baseline prevalence by PCR and microscopy. Microscopy and PCR total prevalence
compared by x2.
The total prevalence of all tested trypanosome species were compared rather than
individual species as it is possible for misdiagnosis to occur when using microscopy
(section 1.6). In Kamuli and Iganga, trypanosome prevalence was significantly
higher by PCR than microscopy with the largest difference seen in Kamuli (14.4%).
Conversely, prevalence was significantly higher by microscopy in Tororo compared
to PCR.
3.3.3 Impact of FITCA mass treatment intervention on animal
trypanosomiasis
3.3.3.1 Coverage of intervention
At the post-intervention sampling, cattle owners were asked if their animal had been
included in the FITCA mass treatment (see section 3.2.2.5). Figure 3.16 shows the
proportions of sampled animals at each post-intervention sampling which had been
treated under the FITCA programme. This data allows an estimation of the coverage
of cattle in treatment areas in each district, shown in Table 3.7. The district with the
highest coverage was Kamuli where 81.1% of animals sampled three months post-
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intervention had received treatment by FITCA. The district with the lowest coverage
was Iganga where 45.2% of animals sampled three months post-intervention had
received treatment by FITCA. In all circumstances, with the exception of Budondo
and Bulowoza villages in Iganga district and Amuria in Soroti district, fewer of the
sampled animals at the final post-intervention sampling had been included in the
original FITCA treatment intervention. This is not surprising given the fluid nature
of cattle keeping in these areas; animals are bought and sold regularly (pers. comm.
C. Waiswa, Makerere University, Kampala, Uganda) and the fact that some farmers
may not return for sampling.
Figure 3.16 - Percentage of sampled animals which had been covered by the FITCA mass
treatment at the first and second post-intervention sampling
District Proportion of sampled animals which had been treated by FITCA





Table 3.7 - The proportions of animals sampled in this study which were treated by the FITCA
mass intervention
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3.3.3.2 Impact of intervention across the study area
Figure 3.17 shows the combined prevalence of all trypanosome species in the entire
study area. Pre-intervention the prevalence was 16.1%, three months post-
intervention there was a significant reduction in the prevalence of all tested
trypanosome species to 9.1% (T=3.02, p=0.011). This significant reduction was
maintained over time and at one year post-intervention, the prevalence was 9.4%
(T=3.94, p=0.002).
Figure 3.17 - Graph showing the prevalence of all tested trypanosome spp. in all 12 study sites,
** denotes significance at p<0.01, * denotes significance at p<0.05.
The prevalence of the individual tested species; T. brucei s.l., T. vivax and T. c.
savannah are shown below in Table 3.8.
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Prevalence
Species Pre-intervention 3 month post-intervention 12 month post-intervention
T. brucei s.l. 9.7% (8.3-11.4) 6.1% (4.9-7.6) 5.8% (4.6-7.2)
T. vivax 4.9% (3.9-6.1) 2.9% (2.1-4.0) 3.4% (2.5-4.5)
T. c. savannah 0.7% (0.4-1.3) 0 (0-0.3) 0.2% (0.1-0.7)
Table 3.8 - Table showing the prevalence of T. brucei s.l., T. vivax and T. c. savannah for all 12
sample sites pre- and post-intervention. Binomial confidence intervals are shown in brackets
for each value.
The prevalence of T. brucei s.l. reduced from 9.7% to 6.1% at three months post-
intervention (T = 1.86, p = 0.090). One year post-intervention, prevalence continued
to drop to 5.8% which was a significant reduction from the pre-intervention
prevalence (T = 2.67, p = 0.022).
Pre-intervention the prevalence of T. vivax (Table 3.8) was 4.9%, this reduced to
2.9% three months post-intervention (T = 1.56, p = 0.147). One year post-
intervention, there was a slight increase in prevalence to 3.4% but this was not a
significant increase compared to three months post-intervention (T = 1.17. p =
0.267).
Pre-intervention the prevalence of T. c. savannah (Table 3.8) was 0.7%, three month
post intervention there were no cases of T. c. savannah detected (T = 1.81, p =
0.098). One year post intervention, cases were again detected although the
prevalence remained very low at 0.2% (T - 1.29, p = 0.222). As the detected
prevalence of T. c. savannah across the study area was very low it will not be
included in any future analysis.
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3.3.3.3 Impact of intervention at the district level
3.3.3.3.1 Combined trypanosome species
The prevalence of all tested trypanosome species over time in each of the study
districts show a similar trend with a reduction post-intervention in every district.
Figure 3.18 shows the pre- and post-intervention combined trypanosome prevalence
in each district. There is a similarity to the overall pattern in each of the districts
with the largest reduction in prevalence occurring three month post-intervention.
However this was only statistically significant in Kamuli, where the reduction three
month post-intervention was significant (T=8.56, p<0.05) and remained so a year
later (p<0.05). In Kamuli, Soroti and Tororo, a slight increase in prevalence was
observed between three months and one year post intervention, however, this
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Figure 3.18 - Graph showing the prevalence of all tested trypanosome spp. in each district both
pre- and post-intervention, * denotes statistical significance at p<0.05.
3.3.3.3.2 T. brucei s.I.
Figure 3.19 shows the pre- and post-intervention prevalence of T. brucei s.I. in each
of the sampled districts. In Kamuli, Iganga and Soroti, a reduction in prevalence is
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observed three months post-intervention, however, this was only significant in
Kamuli (T=4.38, p<0.05). In Soroti and Iganga there was a further reduction in T.











Figure 3.19 - Graph showing the prevalence of T. brucei s.l. in each district both pre- and post-
intervention, * denotes significance at p<0.05.
3.3.3.3.3 T. vivax
Figure 3.20 shows the pre- and post-intervention prevalence ol I. vivax in each of the
sampled districts. In Kamuli. Iganga and Tororo, reductions in prevalence can be
observed three months post-intervention, however, these were not statistically
significant. In Soroti, there was no difference in prevalence three months post-
intervention, however, the prevalence increased 12 months post-intervention
(p>0.05). Tororo district also showed a non-significant increase in prevalence 12
months post-intervention. In contrast to the other districts, both Iganga and Kamuli
continued to show further reductions 12 months post-intervention. Prevalence at 12




















Figure 3.20 - Graph showing the prevalence of T. vivax in each district both pre- and post-
intervention, * denotes statistical significance at p<0.05.
3.3.3.4 Impact of intervention at sample site level
Figure 3.21 shows the prevalence of T. brucei s.l. at each of the 12 sample sites pre-
intervention and post-intervention. For each sample site the pre-intervention
prevalence was compared with both the three month and one year post-intervention
prevalence using a fisher exact test. The p-values generated for each of these
comparisons are shown in the table below, significant results are highlighted. Seven
sites show a reduction in prevalence three months post-intervention and this was
significant in three cases; Bulagala, Numyiro and Okidi. There are four sites which
show an increase in prevalence; of which Kayoro is significant.
Figure 3.22 shows the prevalence of T. vivax at each of the 12 sample sites pre- and
post-intervention. Overall there has been no significant reduction in the prevalence
of T. vivax across any study sites. The only significant change is seen in Okidi where
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3.3.3.5 Coverage at individual sample site
While it may be hypothesised that sample sites receiving the highest levels of
trypanocide treatment coverage would lead to the greatest reduction in trypanosome
prevalence, this was not borne out statistically (Pearsons correlation=2.72, p=0.393).
Figure 3.23 - Graph showing the change in prevalence against the % coverage of treatment at
each study site. Sites which are shown to have a negative 'change in prevalence' in the Figure
are those sites where the overall prevalence of trvpanosomes increased post-intervention
3.3.4 Cost data
3.3.4.1 Item costs
All item costs were originally recorded in Ugandan shillings (UGS) and have been
converted in USD as shown in Table 3.9. These costs include: the cost of the two
trypanocides used, the equipment necessary to administer the drugs (distilled water,
needles and syringes) and the vehicles needed to transport the drugs to the
intervention sites.
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Item Unit Unit cost (USD)
Isometamidium
chloride
Packet (doses for 120 cattle) $62.02
Diminazene
aceturate
Packet (doses for 20 cattle) $3.95
Distilled water Litre $0.85
Needles Packet (12 needles) $1.69
Metal syringe 1 syringe $19.73
Motorbike $2,649.98
Awheel drive $24,639.15
Table 3.9 - FITCA item costs for the mass treatment of cattle in Uganda conversion rates from
Ugandan shillings (UGS) to USD were carried out using the average exchange rate over 2002
taken from the UN operational rates of exchange. The exchange rate was taken as 1773.60 UGS
to 1 USD
3.3.4.2 Running costs
All running costs which were considered in cost calculations are shown in Table
3.10. These costs include: the allowances to staff, vehicle insurance and
maintenance and fuel allowances.
Running cost Cost (USD)
Day rate $2.82
Night allowance (standard) $27.06
Night allowance (driver) $14.10
Motorbike insurance and maintenance $563.82
4WD insurance and maintenance $2,819.12
Fuel per day $2.82
Table 3.10 - Running costs for FITCA interventions. The exchange rate was taken as
1773.60 UGS to 1 USD
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3.3.4.3 Specific costs
The item and running costs for each of the four study districts, Kamuli, Iganga,
Soroti and Tororo varied slightly depending on the numbers of doses of drugs
distributed to each district and the number of staff involved in the intervention (Table
3.11). In all of the study districts the time period allowed for the intervention was 45
days, within that time five officers worked in Kamuli and Soroti, six in Tororo and
eight in Iganga. Night allowances were claimed by officials from each district
travelling to Entebbe for a workshop on the implementation of this intervention,
these allowances were paid for four individuals from Iganga, Soroti and Tororo and
for three individuals from Kamuli.

































No. litres of water
distributed
100 70 70 110
No. syringes
distributed
6 6 6 6
No. of field days 45 45 45 45
No. of officers
claiming day rate




3 4 4 4
Table 3.11 - Quantities for item and running costs per study district
The numbers of doses shown in Table 3.11 can be compared to the number of cattle
in each high risk sub-county in each of the study districts. The 19,000 doses of
trypanocides distributed to Kamuli is slightly less than the 19,758 heads of cattle
counted in the FITCA survey. Tororo district also received slightly less than the
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census dictated 23,000 doses for 23,659 heads of cattle. Iganga on the other hand
received 11,500 doses of trypanocide for 9,780 heads of cattle counted in the survey.
Unfortunately the FITCA livestock survey was not completed in Soroti.
3.3.4.4 Cost of the intervention
The cost of the intervention for each district was calculated using both item and
running costs values. As the vehicles were purchased for use in the whole of the
FITCA project, the values of the vehicles for use in this specific part of the FITCA
programme were considered on a cost per day basis. These values were calculated
separately for the 4-wheel drive and motorbike assuming a 10 year working life and
then calculating the cost of the 45 day intervention. These values were added to the
values for the numbers of doses of drugs used in each district, the cost of equipment
in each district and the running costs in terms of salaries and daily fuel use. The final
costs for each of the four study districts and the average cost over the study area
according to these calculations are shown in Table 3.12 in USD. Iganga district had
the lowest cost for the intervention at $11,589 and Tororo district had the highest at
$17,219. The average cost of the intervention across the four study districts was
$13,816.





Average cost over study area $13,816
Table 3.12 - Costs of the cattle treatment intervention in the study areas in US dollars. All
currency exchange rates were taken as the average exchange rate over 2002 from the UN
operational rates of exchange. The exchange rate was taken as 1773.60 UGS to 1 USD
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In an attempt to put these costs into context, Table 3.13 shows the cost per person,
this is also based on the population of the whole district not just those people residing
in areas which were covered by the intervention. This averages out across the four
districts as $0.02 per person. As 56.1% of the Ugandan population are children
(under 18 years of age) (Ugandan Bureau of Statistics, 2002), the cost has also been
calculated in terms of household. The mass treatment of cattle cost per household
between $0.08 in Iganga district and $0.16 in Soroti district, which averaged out at
$0.12 per household over the study area. The cost was also calculated in terms of
cost per livestock owning household, this averaged out across the study area as $0.50
per livestock owning household. It should be pointed out at this time that these
calculations have been based on the whole district not limited to the areas which
benefited from the FITCA mass treatment. Values for the entire district have been
used as the aims of the FITCA intervention were to impact on the whole district by
targeting their interventions on the most heavily affected areas, therefore the benefits
should be appreciated by all.




Kamuli $0.02 $0.12 $0.45
Iganga $0.02 $0.08 $0.49
Soroti $0.03 $0.16 $0.56
Tororo $0.03 $0.15 $0.51
Average cost
over study area $0.02 $0.12 $0.50
Table 3.13 - Cost of cattle treatment interventions by animal and human population and by
administrative unit. Population data collected from the 2002 census. All currency exchange
rates were taken as the average exchange rate over 2002 from the UN operational rates of
exchange. The exchange rate was taken as 1773.60 UGS to 1 USD.
The cost of the intervention has also been analysed in terms of cost per 1 % reduction
of all tested species of trypanosomes (T. brucei s.l., T. vivax and T. c. savannah).
Table 3.14 shows a summary of the prevalence of the tested species of trypanosome
at the three sampling time points in each of the four districts and the difference in
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prevalence between November 2002 and November 2003 (the first and last sampling
points). This difference in prevalence has been used to calculate the cost at the
district level per 1% reduction of T. brucei, T. vivax and T. c. savannah. It should be
noted at this point that these prevalence figures are from a small number of sample
sites within each of the districts and that these figures are being used to represent the
whole district. The largest reduction in prevalence occurred in Kamuli where there
was a 10.5% reduction in the prevalence of the tested trypanosome species between
the samples taken in November 2002 pre-intervention and the samples taken in
November 2003. This meant that in Kamuli each 1% reduction cost $1,408. On the
other hand in Tororo where one year post-intervention the difference in prevalence
was 0.5% the cost per 1% reduction of prevalence of the tested trypanosome species
was $34,338. Overall the average reduction in prevalence across the four study sites
was 6.3% which resulted in a $2,193 cost per 1% reduction of T. brucei, T. vivax and
T. c. savannah.
Prevalence (all tryp. spp.) Difference in
prevalence (all tryp.
spp.) Nov 02-Nov 03
Cost per 1 % reduction






Kamuli 17.1% 6.9% 6.6% 10.5% $1,408
Iganga 14.2% 7.7% 6.9% 7.3% $1,588
Soroti 32.1% 23.4% 25.4% 6.7% $1,742
Tororo 4.2% 2.4% 3.7% 0.5% $34,338
Average over
study site
16.9% 10.1% 10.6% 6.3% $2,193
Table 3.14 - Cost per percentage reduction of all trypanosome species in each of the study
districts. The exchange rate was taken as 1773.60 UGS to 1 USD.
Analysis was repeated to show the cost per 1% reduction of T. brucei s.l. and is
shown in Table 3.15. The cost per 1% reduction of T. brucei s.l. varied between
$1,133 in Soroti district to $4,636 in Iganga district with an average cost over the
study area of $2,872. No value was calculated for Tororo district as there was an
0.3% increase in T. brucei s.l. over the study period.
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Cost per 1 % reduction







Kamuli 12.5% 3.4% 6.0% 6.5% $2,274
Iganga 7.8% 5.4% 5.3% 2.5% $4,636
Soroti 22.8% 14.8% 12.5% 10.3% $1,133
Tororo 1.4% 2.1% 1.7% -0.3% n/a
Average over
study site
10.6% 5.9% 5.8% 4.8% $2,872
Table 3.15 - Cost per percentage reduction of T. brucei s.l. in each of the study districts. The
exchange rate was taken as 1773.60 UGS to 1 USD.
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3.4 Discussion
The main aim of the study presented in this chapter was to monitor, by PCR, the
effect of a large scale treatment programme against trypanosomiasis by determining
the prevalence of T. brucei s.l., T. vivax and T. congolense savannah over the course
of the programme in the cattle population. Overall the FITCA Uganda programme
appears to have been effective, the prevalence of all tested trypanosome species was
16.1% pre-intervention which was reduced significantly to 9.1% three months post
intervention and remained significantly reduced one year post-intervention. The
main control method used in this programme was a single dose of trypanocide, either
isometamidium chloride or diminazene aceturate to all animals in areas of south-east
Uganda which were deemed to be high-risk for human sleeping sickness. This study
is a unique investigation into the impact of a large scale real-life control programme,
using PCR to determine the effect on the prevalence of specific trypanosome species
within the cattle population in south eastern Uganda. The effect of this programme
on the zoonotic human infective T. b. rhodesiense will be covered in Chapter 4.
The results presented in this chapter look at the overall impact of this programme on
the prevalence of T. brucei s.l., T. vivax and T. c. savannah separately. As stated,
when these species are considered together there was a significant reduction in post-
intervention prevalence, however, this was not true for each individual species.
Three month post-intervention, the prevalence of each species showed a reduction,
however, none were statistically significant. The reduction in the prevalence of T.
brucei s.l. was nearing significance and one year post-intervention had showed a
significant reduction from the pre-intervention prevalence. There should be caution
in interpreting this reduction a year later as it cannot be proved that this was a direct
result of the intervention programme and could be a natural reduction over time. As
this study was monitoring a real-life control programme it would have been unethical
to withhold treatment from an area to allow for a control to monitor the natural
variations in the area (see section 3.2.2.3).
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3.4.1 District level
The results were broken down at a district level to allow for observation of any
differences between the districts included in the study. For all the tested species of
trypanosomes there was a statistically significant reduction in prevalence in Kamuli
both three month and one year post-intervention both Iganga and Soroti showed
reductions in prevalence but these were not significant. Finally in Tororo there was
an initial reduction three months post-intervention but this was negligible one year
post-intervention.
When the results were considered by district and species the only significant
reductions in prevalence were observed in T. brucei s.l. in Kamuli and Soroti. The
prevalence of T. vivax showed no significant changes post-intervention and in fact
there was a paradoxical increase in Soroti one year post-intervention although this
was not statistically significant. Overall, the prevalence of T. c. savannah was very
low across all sample areas which made it difficult to assess any impact of the
intervention. This low level of T. congolense spp. was mirrored in a study published
in 1998 on a naturally infected dairy herd in Mukono district in Uganda, where no T.
congolense spp. were identified by PCR (Clausen et al., 1998). In contrast, a study
in Nguruman in neighbouring Kenya, showed that T. congolense spp. was most
prevalent at 16.5%, followed by T. vivax at 4.95% and lastly T. brucei at 0.2%
(Tarimo-Nesbit et al., 1999). Interestingly the highest prevalence of T. c. savannah
in this study was detected in Tororo district (2%) which is geographically the closest
district to Kenya. The low prevalence of all tested trypanosome species in Tororo
may be a sampling artefact rather than a true result as all the sample sites chosen
were very close to Tororo town and the Livestock Research Institute (LIRI). Until
additional PCR prevalence studies become available for this area, this data can only
be compared to prevalence data determined by microscopy. In a recent study by
Waiswa et al, prevalence in cattle was assessed by microscopy in two of the districts
reported here, Kamuli and Tororo (Waiswa et al., 2003). These authors reported T.
brucei s.l. prevalence in Kamuli at 2.7%, compared with 12% (CI 9.1-14.9) in this
study. However, the prevalence of T. brucei in Tororo reported by Waiswa et al was
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6.7%, which is considerably higher than the prevalence detected by PCR in this study
1.4% (CI 0.2-2.6). This anomaly in prevalence levels suggests that selection of
different sampling sites may have yielded different results.
The lack of statistically significant changes witnessed in the prevalence of T. vivax
could be due to variations in the lifecycle of this species. The development of T.
vivax within the tsetse fly is restricted to only the proboscis (Stevens & Brisse, 2004)
which results in a shorter development period within the vector. This means that T.
vivax transmission will resume more rapidly after any intervention. It is therefore
possible that first post-intervention time point at three months was not early enough
to observe any reduction in the prevalence of T. vivax.
3.4.1,1 Treatment coverage
The differences in impact of this intervention at district level could be linked to the
estimates of coverage shown in the results. It is interesting to note that the most
significant reductions in overall trypanosome prevalence are observed in Kamuli
where coverage was estimated to be over 80%. This corresponds well to a recent
theoretical paper by Coleman and Welburn which calculated that a mass treatment
intervention would need to have a minimum coverage level of 80% to reduce the
parasite load in the animal reservoir (Coleman & Welburn, 2004). However, this
theory was not borne out when the change in prevalence at individual sample sites
were compared to the level of treatment coverage. There was no significant
correlation between reduction in prevalence and level of treatment coverage
estimated in this study.
The differences in coverage between the districts were most likely due to local
factors; Kamuli and Iganga districts were both part of the original Busoga sleeping
sickness focus and as such have had many years of experience implementing
trypanosomiasis control programmes. The differences in coverage between these
two districts may be due to differing management practices. The mass treatment
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campaigns were administered and implemented through the office of the DVO and
differences between the approaches of these stakeholders may have affected the
execution of the programme. From personal observation it was clear that Kamuli
veterinary department was headed by a DVO who placed great importance on the
implementation of the FITCA programme. However in Iganga, where sleeping
sickness is not such a public health problem (FITCA Quarterly report 2002), the
veterinary department had some problems of motivation amongst its staff and the
unfortunate ill health of the DVO may have had an adverse effect on the
management of the FITCA programme within the district. Soroti was included in the
FITCA programme late and therefore had not been included in the initial planning
and organisation stages of the project. Consequently, the original cattle number and
prevalence surveys were not completed in Soroti which may have had a knock on
effect on the volume of drugs that were supplied. In addition the late inclusion of the
district meant there was a delay in receiving the necessary resources to implement
the project.
3.4.2 Sample site level
When the results from the monitoring of the FITCA Uganda programme were
analysed at a higher level of resolution, i.e. at the individual sample site level, the
general patterns seen at a district level became indistinct. Within each district there
is very little consistency in the pattern of effect at the individual sample sites, with
the exception of T. brucei s.l. in Kamuli which showed a reduction in prevalence at
each site three months post-intervention, and then an increase at each site from three
months to one year post-intervention. These changes were not all statistically
significant due to the limitation in sample size when looking at the individual sample
sites (n= 25 to 164). It is important to observe these changes in prevalence at the
individual site to investigate if a single site has a disproportional impact on the
results of the district as a whole. In Soroti the effects observed at the district level
are driven by the Okidi sample site which experienced dramatic changes in both T.
brucei s.l. and T. vivax over the study period. The prevalence of T. brucei s.l.
showed a significant reduction from 32.6% pre-intervention to 16.2% three months
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post-intervention. However, it is difficult to be entirely certain that this significant
reduction can be due to the effect of the intervention alone. The level of treatment
coverage in the samples taken three months post-intervention was only 35.5%, which
was one of the lowest levels of coverage recorded in this study. Therefore it is
possible that the reduction was due to some other unmeasured effect, for example a
high turn over of animals at this particular site as animals are officially treated at the
point of sale (Fevre, 2001). Alternatively owners may have treated their animals
independently and been unwilling to reveal that for fear of being excluded from
further treatments.
3.4.3 Microscopy and PCR
Prior to commencing this intervention, FITCA Uganda carried out a comprehensive
cattle survey to determine where to target trypanocidal treatments. These data were
collected by microscopy and compared with the results from the PCR survey detailed
in this Chapter. As might be expected, there were a number of significant
differences between the prevalence determined by microscopy and the prevalence
determined by PCR (Picozzi et al., 2002). In particular, the prevalence of T. brucei
s.l. by microscopy was significantly lower than by PCR. For example, T. brucei s.l.
prevalence in Kamuli was 12.5% by PCR compared with only 1.1% by microscopy.
While PCR diagnosis of trypanosomes is known to be considerably more sensitive
than microscopy, the level of difference in prevalence seen in Kamuli by the two
methods is considerable. By comparison, studies show PCR trypanosome diagnosis
to be 2-3 times more sensitive than microscopical diagnosis (Clausen et al., 1998;
Solano et al., 1999). In addition, Duvallet et al, reviewed the use of PCR in West
Africa and noted that 50% of parasitologically negative cattle with a haematocrit
value of under 25% were shown to be positive for trypanosomes by PCR (Duvallet et
al., 1999).
Interestingly, the prevalence of trypanosome infection in Tororo was considerably
higher by microscopy than PCR. This anomaly is likely due to the different sample
sites used for each survey. The integrity of the sample sites used in this study appear
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to have been compromised by their proximity to LIRI, which as a research institute
has implemented trial control measures in this area. This confounding factor was
unfortunately not identified at the study outset.
3.4.4 Study limitations
Field-based research has inherent problems associated with it, not least the inability
to control all experimental parameters. As discussed previously, problems were
identified with the location of some sample sites, most specifically in Tororo. In
addition, the lack of control sites for ethical reasons meant that natural variation in
disease prevalence due to any confounding factors could not be accounted for.
Possible factors affecting the study outcomes may include: ongoing socio-economic
activities associated with subsistence farming such as the sale and slaughter of
livestock, unrecorded treatment of cattle, general use of insecticides and
environmental changes.
Analysis of the dataset proved complicated for a number of reasons, not least of
which was that the animals sampled in this study were not individually identified by
tagging. As a consequence, there was no way to account for the potential of
repeatedly sampled animals which meant the level of dependence between sample
times could not be determined. The animals could not be tagged as logistically and
financially there were no resources available to closely follow this number of
animals (n=3,920). Additionally there is an ethical issue when dealing with a
potentially lethal zoonotic pathogen as there is a moral obligation to give additional
treatment to any animal found to be harbouring human infective parasites. For these
reasons it was decided that the objective of the study would be to monitor the effect
of the intervention programme at the herd level at each study site. Unfortunately it
was very difficult to observe an effect at this level due to the sample sizes at
individual sites; therefore it becomes more meaningful to cluster the sites at the
district level. However, the sample number for analysis at the district level can only
be the number of sites (Kamuli n=3, Iganga n=4, Soroti n=2 and Tororo n=3) and
these low n values restrict the type of statistical tests which can be used thus reducing
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the power of any test. Consequently, certain assumptions regarding the normality
and independence of the prevalence data were made. Paired T tests were used to
compare prevalence within districts over the intervention time points; these tests
allow dependence between time points but do assume normality of the data. Fisher
exact tests were used to compare each sample site individually over time. Small
sample numbers necessitated the use of Fisher exact tests rather than conventional
chi-squared tests, however, these tests do assume independence of data.
3.4.5 Cost effectiveness of FITCA Uganda treatment intervention
The second aim of this Chapter was to examine the cost of implementing a mass
treatment programme in the four study districts. The main costs for each area were
the trypanocides, fuel, vehicles and wages. The first cost which varied by district
was the volume of drugs provided which was calculated by the number of areas to be
treated and the estimated number of cattle in those areas. The second was the
number of staff employed to deliver the intervention, although fuel and vehicle costs
remained constant some districts chose to employ more staff from the DVO to
implement treatment. The calculated costs were displayed per head of population,
per household and per cattle keeping household for each district, these were
calculated for the whole district not just the areas covered under FITCA as it was
accepted that any reduction in human or animal trypanosomiasis would benefit the
whole district. It was estimated that the FITCA treatment programme cost $0.50 per
livestock keeping household. This can be favourably compared with the cost of
treating an animal for trypanosomiasis, which costs approximately $1.00. However,
it is important to stress that the calculated costs for the FITCA programme did not
include administration or salary costs so the actual cost would be much greater. The
cost data were also analysed, in terms of cost per 1% reduction in the level of animal
trypanosomiasis in sampled cattle from each district. The most successful district in
terms of cost for result was Kamuli, where the cost was $1,408 per 1% reduction of
prevalence after one year. The least successful in terms of cost for benefit was
Tororo where the cost for a 1% reduction in animal trypanosomiasis was $34,338.
This figure is so high because one year post-intervention there was only a 0.5%
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reduction in prevalence. These reductions are based on the PCR results from the
sites sampled in this study which may not be representative of the district as a whole.
This is especially important in the analysis of Tororo as prevalence levels detected in
this study are considerably lower than other published results.
The cost assessment carried out in this Chapter was not a full cost-benefit analysis as
during the period of this research there was not the time nor financial support to
collect data on the general costs of livestock both healthy and those with
trypanosomiasis. Thus, no comment can be made on the relative health and economic
benefits of treating animals against trypanosomiasis. This meant that the cost of the
programme could not be offset against the benefits to small holder farmers to
establish whether the intervention could be deemed cost effective. It is important to
emphasise at this time that this was not a full audit of the FITCA Uganda programme
and the costs listed only referred to the mass treatment of cattle with trypanocides.
The final results shown in this chapter stated the cost per 1% reduction in overall
trypanosomiasis in the sampled cattle in each of the four districts. This result should
be interpreted with caution as without control sites; it cannot be categorically shown
that the reduction in prevalence was due to the intervention and not any other
confounding factors.
3.4.6 Conclusions
As with all control programmes in the developing world there is the issue of
sustainability. In most circumstances when the initial control operations are funded,
controlled or assisted by foreign donors the cessation of funding invariably results in
the collapse of the intervention effort. Local communities are either not motivated to
maintain control because they consider it a public health service or more commonly
are too poor to continue the work. Another pertinent issue is that for many
communities tsetse fly control and elimination of sleeping sickness are not the main
health concerns for the people living there. Malaria and HIV/AIDS have a far
greater impact on many of these communities (World Health Organization, 2004).
Chapter 3 120
The FITCA intervention assessed in this Chapter is an example of a top-down
approach; however, the treatment of cattle as a control method is recognised as a
strategy that can be implemented effectively by individual farmers. Unfortunately
the majority of subsistence farmers treat their animals only when they are sick and
not prophylactically. Consequently, local cattle breeds may harbour infection but not
exhibit clinical pathology. This scenario is most common when cattle are infected
with the potentially human-infective trypanosomes, T. brucei s.l.
Concerns do remain regarding the large-scale use of trypanocides leading to the
occurrence of drug resistance. There have been reports of drug resistance against
both diminazene aceturate and isometamidium chloride in Ethiopia (Codjia et al.,
1993; Leak et al., 1993; Rowlands et al., 1993) but so far there have been no studies
showing any significant levels of drug resistance in Uganda. However, concern may
be warranted as there were claims that in Ethiopia the emergence of drug resistance
in T. congolense spp. parasites was associated with the wide-scale use of
trypanocides (Codjia et al., 1993; Rowlands et al., 1993; Itty et al., 1995).
Analysing a working intervention programme is not a simple matter as it is not
possible to design or control many aspects of the study such as control sites or the
timing or choice of intervention sites. But the merits of this should not be
underestimated as it is an advantage to look at a true control programme with its
many real-life pitfalls rather than a study under a completely scientifically controlled
environment. It is important to look at the limitations of how and why things are
implemented as they are in the field and try to assess what impact a theoretically
'good' intervention programme will have when faced with the realities of
implementation in the developing world.
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4 Chapter 4:
Impact of the FITCA intervention programme on the




In Chapter 3, the impact of the FITCA Uganda intervention on the prevalence of
animal trypanosome species (T. brucei s.l., T. vivax and T. congolense) was
investigated. This Chapter carries on this assessment but focuses solely on the
prevalence of T. brucei s.l. and in particular T. b. rhodesiense. T. b. rhodesiense is a
serious human pathogen responsible for considerable morbitiy and mortality sub-
Saharan Africa (Fevre et al., 2006a). In Uganda, cattle represent a significant disease
reservoir and indeed results in Chapter 3 demonstrated that T. brucei s.l. represented
the most abundant trypanosome species. Without further investigation, however, it is
impossible to know what proportion of identified T. brucei s.l. are the human-
infective sub-species T. b. rhodesiense. Using PCR techniques this Chapter aims to
identify the proportion of T. brucei s.l. infected cattle which are harbouring human
infective T. b. rhodesiense.
4.1.1 T. brucei s.l.
There are three sub-species of T. brucei s.l.: T. brucei brucei, T. brucei rhodesiense
and T. brucei gambiense. T. b. brucei is found across sub-Saharan Africa, T. b.
rhodesiense is found in east and southern Africa, while T. b. gambiense is found in
west and central Africa (Pepin & Meda, 2001). Uganda is unique in that both species
of human-infective trypanosomes are present although their foci are currently distinct
with T. b. gambiense in the northwest and T. b. rhodesiense in the southeast of the
country (Welburn et al., 2001a). In the areas under investigation in this thesis only
T. b. rhodesiense is present. The three sub-species are morphologically identical but
they differ in host range, T. b. rhodesiense and T. b. gambiense infect and cause
disease in humans, while T. b. brucei cannot survive in human serum (Buscher &
Lejon, 2004). T. b. rhodesiense and T. b. brucei can both infect cattle but in native
African breeds the clinical symptoms are less pronounced and often the infection
goes undetected (Welburn et al., 2006).
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Humans are unusual amongst mammals in being resistant to T. b. brucei, this
resistance is due the presence of a trypanolytic factor. This trypanolytic factor was
recently established to be Apolipoprotein L-l (Vanhamme et ai, 2003), which
causes lysis through the formation of pores in the trypanosomes lysosomal
membrane (Perez-Morga et al., 2005). The human infective trypanosomes, T. b.
rhodesiense and T. b. gambiense have acquired resistance to this lytic factor,
enabling them to establish patent infections causing disease, although the
mechanisms to resistance differ. In T. b. rhodesiense, resistance to human serum is
linked to antigenic variation which appears to be found at one expression site (R-ES)
systematically selected for activity in human serum (Xong et al., 1998). This
expression site contains an ESAG termed SRA, which upon transfection into T. b.
brucei parasites conferred resistance to human serum (Xong et al., 1998). This
identified SRA as the gene responsible for T. b. rhodesiense resistance to human
serum. SRA is a truncated variant surface glycoprotein (VSG) with the region
encoding the surface-exposed epitopes missing (Vanhamme & Pays, 2004) and was
probably formed during DNA recombination of VSGs (Pays et al., 2006). SRA is
consistently found in human resistant stocks from across East Africa (Welburn et al.,
2001b; Gibson et al., 2002).
4.1.2 Fitness cost of T. b. rhodesiense
Where T. b. brucei and T. b. rhodesiense co-exist, epidemiological theory predicts
that the prevalence of T. b. rhodesiense would be higher than that of T. b. brucei due
to the fact that T. b. rhodesiense can survive in a wider range of hosts (Coleman &
Welburn, 2004). Based on Rogers general model for African trypanosomes (Rogers,
1988), assuming that the sub-species T. b. brucei and T. b. rhodesiense differ only in
human infectivity, the model would predict that the basic reproductive number (Ro)
of T. b. rhodesiense will be greater than that of T. b. brucei. Thus the prevalence of
T. b. rhodesiense in non-human hosts (e.g. a domestic cattle reservoir) should always
exceed that of T. b. brucei. This assumption has been investigated (Coleman &
Welburn, 2004) using data from southeast Uganda (Hide et al., 1996), which
predicted that there would be a three times higher prevalence of T. b. rhodesiense
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than T. b. brucei in the cattle reservoir and a 3.5 times higher prevalence within the
vector population (Coleman & Welburn, 2004). However field observations have
shown that this is not the case (Gibson & Wellde, 1985; Enyaru et al., 1993; Hide et
al, 1996; Welburn et al., 2001b; Waiswa et al., 2003) and in fact the opposite is true,
T. b. brucei always seems to predominate with a higher prevalence than T. b.
rhodesiense. This led Coleman and Welburn to hypothesise that there are fitness
costs associated with T. b. rhodesiense infections when outside the human host
(Coleman & Welbum, 2004). In Uganda, cattle are the main reservoir host of T. b.
rhodesiense and it is consequently of great epidemiological importance to able to
distinguish the two species within the cattle reservoir population.
4.1.3 Methods of detection
Historically, the first tests to establish whether T. brucei s.l. parasites were human
infective was to inoculate parasites found in an animal host into a human 'volunteer'.
Heisch and colleagues took parasites from a bushbuck and inoculated them into a
human volunteer, resulting in an infection (Heisch et al., 1958). In a similar
experiment, Onyango and colleagues took parasites isolated from infected cattle and
showed that an infection could be caused in humans (Onyango et al., 1966).
In 1970, the blood infectivity incubation test (BUT) was developed. This test
demonstrated the parasites ability to survive challenge with human serum in a mouse
model thereby eliminating the need for testing on humans (Rickman & Robson,
1970). The test was subsequently validated by Geigy and colleagues on wildlife
material. They tested blood from a variety of species and showed that blood taken
from a T. brucei s.l. infected Coke's hartebeest was positive using the BUT and
infectious to human volunteers (Geigy et al., 1973). The BUT technique is still in
use today and has shown the existence of T. b. rhodesiense in a variety of species;
reedbuck, waterbuck, spotted hyena and lion (Gibson & Wellde, 1985) as well as
domestic pigs (Waiswa et al., 2003).
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Since the advent of molecular methods of parasite characterisation, new ways have
been developed to detect T. b. brucei and T. b. rhodesiense: restriction fragment
length polymorphisms (RFLP) (Hide et al., 1994), analysis of variability in mobile
genetic elements by PCR (MGE-PCR) (Tilley et al., 2003) and minisatellite marker
analysis (MacLeod et al., 2000). All of these methods require significant amounts of
parasite DNA which means that the parasite material from a host animal must be
amplified in mice prior to application of the technique. However, not all T. brucei
s.l. collected in the field will amplify in mice; up to 50% of T. brucei s.l. field
samples collected in southeast Uganda are lost during mouse passage (Welburn, pers
com.). This has meant that estimates of the prevalence of both T. b. brucei and T. b.
rhodesiense using BUT, RFLP, MGE-PCR and minisatellite analysis are
underestimates (Welburn et al., 2005).
The SRA (serum-resistance-associated) gene is a single copy gene that can be used as
a marker to distinguish T. b. brucei from T. b. rhodesiense (Xong et al., 1998). It is
conserved in all known T. b. rhodesiense isolates (Gibson et al., 2002) as well as
within human and domestic animal reservoirs (Welburn et al., 2001b; Gibson et al.,
2002; Radwanska et al., 2002a) in East Africa. Consequently, the SRA gene has
been developed for use as a diagnostic marker for the identification of T. b.
rhodesiense infections (Welburn et al., 2001b). There are, however, problems with
using this gene as a PCR marker as SRA is a single copy gene and infections in the
animal reservoir can be chronic with low levels of parasitemia (Katunguka-
Rwakishaya, 1996). A negative result therefore, may be due to a lack of parasite
DNA rather than a true absence of T. b. rhodesiense infection. On the basis of this,
Picozzi and colleagues have developed a multiplex PCR which contains two different
sets of primers (Picozzi et al., In press). One set, targets the SRA gene as a
diagnostic for T. b. rhodesiense and one targets PLC, a phosopholipase C (GPI-PLC)
which is a single copy gene found in T. brucei s.l. (Hereld et al., 1988; Carrington et
al., 1989). The positive amplification of the PLC sequence indicates that there is
enough genetic material present in the sample to detect the presence or absence of
the T. b. rhodesiense SRA gene (Picozzi et al., In press).
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4.1.4 Chapter aims
The aim of this Chapter is to investigate the impact of the FITCA Uganda
intervention on the prevalence of human-infective T. b. rhodesiense in the cattle
reservoir. Samples which were identified in Chapter 3 as positive for T. brucei s.l.
were re-analysed using the PLC-SRA multiplex PCR at both pre- and post-
intervention time points. The levels of T. b. rhodesiense identified will be presented
as a percentage of T. brucei s.l. infections rather than a percentage of total samples
collected. However, the relative contribution of T. b. rhodesiense to the total
number of trypanosome infections identified within cattle in each district will be
discussed. In addition, this Chapter will present data collected from Soroti at a third
time point, 18 months post-intervention, to investigate whether any lasting impact of
the FITCA intervention could be detected.
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4.2 Materials and Methods
4.2.1 Impact of the FITCA intervention on prevalence of T. b.
rhodesiense
4.2.1.1 Sample collection
Blood samples were collected from cattle in four districts (Kamuli, Iganga, Soroti
and Tororo) and stored on FTA cards as described in Chapter 3. The samples were
collected at three time points to assess the effectiveness of the FITCA intervention
programme. Baseline samples were collected pre-intervention and then samples
were collected at 3 and 12 months post-intervention. The specific details of the study
sites and sample collection are detailed in Chapter 3, section 3.3.2. Any samples
which were found to be positive for T. brucei s.l. in Chapter 3 were selected for
inclusion in this study. These samples were then tested for T. b. rhodesiense using a
multiplex PCR for both T. brucei s.l. and T. b. rhodesiense.
4.2.1.2 Sample analysis
A multiplex PCR was used to detect the presence of the T. b. rhodesiense SRA gene
(Picozzi et al., In press). As mentioned, T. brucei s.l. PLC was amplified as a
positive control to ensure sufficient parasite DNA was present in the samples. PCR
amplifications were carried out in 25pl reaction volumes, each containing 1.5 Units
of HotstarTaq® DNA polymerase (Qiagen), 1.25 pi of rediload dye (Invitrogen), with
a final concentration of 3 mM MgCU, 200|iM of each of the 4 deoxynucleoside
triphospahtes and 0.2 pM of each primer. PCR products were separated by
electrophoresis using a 1.7% agarose gel electrophoresis (see section 3.2.2.9).











5'-GAA GAG CCC GTC AAG AAG GTT TG-3'
5'-TTT TGA GCC YYC CAC AAG CTT GGG-3'




5'-CGC TTT GTT GAG GAG CTG CAA GCA-3'
5'-TGC CAC CGC AAA GTC GTT ATT TCG-3'
325bp
Amplification conditions: 94°C for 15mins 1(42 cycles) 94°C for 30s, 63°C for 90s, 72°C for 70s] 72°C for
lOmins, storage at 4°C
Table 4.1 - Primer sequences, amplification conditions and product size of T. brucei s.l. and the
multiplex PCR for T. b. rhodesiense
atfc P31P"
Figure 4.1- Agarose gel picture illustrating the PCR products from the PLC-SRA multiplex, the
black arrow shows the PLC and the red arrow shows SRA. Lanes 1 and 5 are molecular ladder,
lanes 2 and 3 are negative controls, lane 4 is the positive control and lanes a - y are samples.
Lanes a-e, g-i, k, n, o, r-t and u-y are positive for PLC, lanes a, g, t and w are positive for SRA.
4.2.1.3 Blotting
Southern blotting was performed on each of the samples to increase the detection
sensitivity of T. b. rhodesiense and to ensure that the correct products were
identified. Southern blotting is a technique where DNA is transferred from a gel on
to a positively charged membrane. A labelled probe of the desired sequence is then
introduced to the membrane under strict conditions. The presence of the desired
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PCR sequence on the membrane is visualised by activation of the labelled probe that
has bound to the membrane.
4.2.1.3.1 Probe preparation
To obtain the probe, genomic DNA of T. b. rhodesiense (LIRI024) was amplified by
PCR as described in section 3.2.1.2, this amplification generated both SRA and PLC
material. The products were separated by gel electrophoresis (see section 3.3.10) and
the bands of SRA and PLC were excised. The DNA was then extracted using a
MiniElute Gel extraction kit (Qiagen) according to the manufacturers instructions,
following the centrifugation extraction protocol. The extracted SRA and PLC DNA
were then denatured at 100°C for 10 minutes and immediately cooled on ice. The
DIG-High Prime (Roche) labelling mix was then added in a 1:5 ratio and incubated
at 37°C for a minimum of 1 hour. This reaction was stopped by heating the DNA
and label to 65°C.
4.2.1.3.2 Probe yield estimation
A lOx dilution series was prepared from DIG-labelled control DNA provided by the
manufacturer, ranging from lng pi"1 to 0. lpg pi"1. A similar dilution series was
prepared using the newly labelled SRA and PLC probe, lpl of each dilution, both
control and freshly labelled SRA and PLC, DNA fragments were spotted onto a
positively charged nylon membrane and allowed to air dry. The probes were then
fixed to the membrane by a 5 minute exposure to UV light. The membrane was
washed twice with lx Washing buffer (0.1M maleic acid, 0.15M NaCl: pH 7.5, 0.3%
(v/v) Tween®20), then incubated for 30 minutes at room temperature in lx Blocking
solution (lg blocking reagent in 100cm3 washing buffer without the Tween®20).
This was followed by 30 minute incubation at room temperature with Anti-DIG-
alkaline phosphatase, diluted 1:5000 in blocking solution. The membrane was then
washed twice in lx Washing buffer for 2x15 minutes and then incubated with
detection buffer (0.1M Tris-HCl at pH 9.5; 0.1M NaCl) for 2 minutes. The colour
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substrate solution (80pl NBT/BCIP in 10cm3 detection buffer) was then introduced
to the membrane; colour development was carried out in the dark, without shaking.
The reaction was stopped by a 5 minute wash in H2O. Probe yield was estimated by a
visual comparison of colour development of the control and test probe dilutions.
4.2.1.3.3 Transfer
After agarose gel electrophoresis of the PCR products, the gel was soaked in
denaturing solution (0.5M NaOH, 1.5M NaCl) for 20 minutes at room temperature,
to ensure denaturation of the DNA within the gel to single strands. The gel was then
soaked in neutralising solution (0.5M Tris-HCl at pH 7.5; 3M NaCl) for a further 20
minutes also at room temperature. Transfer of DNA from the gel to the
nitrocellulose membrane was performed on a vacuum blotter (QBiogene). For the
transfer, the membrane was soaked in 20x SSC (3M NaCl, 0.3M sodium citrate, pH
7) which inhibits the re-naturation of the DNA. The membrance was placed on top
of a carrier filter paper (Whatman 3mm), which was also soaked in SSC, and place
between the vacuum blotter and the gel (Figure 4.2). Negative pressure of 65mbar
was applied on the vacuum blotter over 1 hour. Throughout the transfer procedure, it
was ensured that the gel was covered with 20x SSC to prevent air bubbles blocking
the DNA transfer. After the transfer the position of the wells was marked on the
membrane by punching through the wells with a pipette tip. The DNA was
permanently bound to the membrane by a 5 minute exposure to UV light; this cross¬
links the DNA to the membrane. During exposure to UV light the membrane was
placed on a filter paper (Whatman 3mm) soaked with lOx SSC, to avoid drying.
After UV cross-linking, the membrane was washed in double distilled water and
allowed to air dry, at this point the membrane can be stored at 2-8°C.
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Figure 4.2 - Diagram showing the arrangement for southern blotting
4.2.1.3.4 Hybridisation
The nitrocellulose membrane was pre-hybridised in a standard hybridisation buffer
(Roche) at 42°C for 1 hour. This prepared the membrane by blocking any non¬
specific nucleic acid binding sites.
The DNA probes was denatured, by heating at 100°C for 10 minutes, then directly
transferred on to ice. The probes were then diluted to 25ng cm-3 in preheated
hybridisation buffer and introduced to the membrane. Hybridisation with the probes
took place overnight at 42°C. The membrane was then washed twice, 2x5 minutes,
in 2x SSC (0.3M NaCl, 30mM sodium citrate, pH 7, 0.1% (w/v) SDS) at room
temperature, which removed any unbound probe. The membrane was then washed
twice, 2x15 minutes, in 0.5 x SSC ( 75mM NaCl, 7.5mM sodium citrate, pH7, 0.1
(w/v) SDS) at 68°C. Regions of hybridisation were detected as described in section
4.2.1.3.2 estimation of probe yield.
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4.2.1.4 Screening using 5 repeats of each sample
On the FTA card, parasite material will not be uniformly distributed over the surface
of the card, so five 2mm diameter circular punches were taken from each sample on
the card to maximise the chance of amplifying parasite material. If after five
punches no amplification of PLC was observed it was assumed that the parasitemia
was too low to correctly distinguish between T. b. brucei and T. b. rhodesiense.
Only those samples that were PLC positive were included in this analysis.
4.2.2 Soroti district follow up study 1
A follow up study was carried out in Soroti district in April 2004, 18 months after the
mass administration of isometamidium chloride and diminazene aceturate by FITCA
Uganda. Blood samples were taken from cattle in areas that had been included in the
FITCA intervention and also from areas which had not.
4.2.2.1 Sampling sites
Sampling sites were selected in Soroti to assess the continued effectiveness of the
FITCA intervention programme. Three sites were selected from an area which had
been included in the FITCA intervention programme; each of these three sites had
reported cases of sleeping sickness pre-intervention. An additional three sites were
selected that had not been included in the FITCA intervention; these sites were
selected on the basis of a recent reported case of sleeping sickness (January-April
2004). In addition samples were collected from a livestock market within the
district, Brookes Corner, which had been at the centre of the original reported
outbreak starting in 1998 (Fevre et al., 2001).
(' Work presented in this section was published in (Fevre et al., 2005))
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4.2.2.2 Sample collection
Farmers were asked to present their animals to a central point for sampling at which
point blood samples were taken from ear veins and blood was spotted directly onto
FTA cards (see section 3.2.2.). 51-56 animals were sampled at each site (Table 4.2).
The incentive of a de-worming treatment was offered for participating farmers and
animals were sampled on a convenience basis.
Site description Name of site Sample number








Market Brookes Corner 51
Table 4.2 - Number of samples collected in the Soroti follow-up study
Exact details regarding the sampling methodology and analysis can be found in
Fevre et al, 2005 (shown in appendix).
4.2.3 Statistical analysis
4.2.3.1 Confidence intervals
All confidence intervals were calculated as binomial confidence intervals in R
version 2.4.0 (R project)(Figure 3.7).
round(100*(binconf(baseline_tbrucei_by_district$tbrucei,baseline_tbrucei_by_district$number)),l)
Figure 4.3 - Example of code used for calculating binomial confidence intervals in R, this
example was used to calculate the CI for T. brucei s.l. at the district level.
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4.2.3.2 Comparison of baseline data from all districts
To investigate any differences between the prevalence of T. brucei s.l. and T. b.
rhodesiense in the different study areas tests were conducted in Minitab version 14
(Minitab, Inc.). Differences were considered to be significant at p<0.05.
4.2.3.3 Comparison of pre- and post-intervention
To investigate if there were any significant differences within districts included in
the study pre- and post-intervention, paired t-tests were carried out using Minitab
version 14 (Minitab, Inc.). Differences were considered to be significant at p<0.05.
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4.3 Results
4.3.1 Description of the samples
T. brucei s.l. positive samples were tested for SRA to determine the prevalence of T.
b. rhodesiense. Table 4.3 shows the number of T. brucei s.l. samples successfully
tested by the multiplex PCR and the number from which PLC was amplified. As
discussed, only those samples positive for PLC were confirmed as containing enough
DNA to detect the single copy SRA gene.
District No. tested by
multiplex
No. positive for PLC
T. brucei s.l. marker
(%)
Kamuli 60 51 (85%)
Iganga 47 38 (81%)
Soroti 124 113 (91%)
Tororo 13 13 (100%)
Table 4.3 - Detection rate of single copy marker (PLC) for T. brucei s.l.
4.3.2 Baseline pre-intervention results
Figure 4.4 shows the prevalence of T. b. rhodesiense as a percentage of total T.
brucei s.l. positive samples. Kamuli and Soroti were found to have the highest
proportion of T. b. rhodesiense - 56% and 28% respectively. Prevalence was 20% in
Tororo but this represents only one positive sample out of five T. brucei s.l. samples.
Iganga as a district had a considerable portion of T. brucei s.l. samples (see Chapter
3) but unfortunately many of these did not amplify well in the multiplex PCR. As a
result, out of the nine successful amplifications, the prevalence of T. b. rhodesiense
in Iganga was shown to be 11%.
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Kamuli Iganga Soroti Tororo All
n = 27 n = 9 n = 60 n = 5 n = 101
Figure 4.4 - Graph showing the minimum baseline prevalence of T. b. rhodesiense, n represents
the total number of samples positive for T. brucei s.l. marker. Error bars represent 95%
binomial confidence intervals.
It is clear from Figure 4.4 that T. b. rhodesiense makes up a considerable portion of
T. brucei s.l. infections at baseline in each of the studied districts. Figure 4.5
illustrates the overall minimum prevalence of T. b. rhodesiense within the total
sampled population at baseline. The highest prevalence of T. b. rhodesiense is in
Soroti - 6%, followed by Kamuli where the overall prevalence is just under 4%. In
both Tororo and Iganga the prevalence of T. b. rhodesiense detected in the collected
samples was significantly lower than the prevalence found in Kamuli (for Iganga •£ =






















Figure 4.5 - Minimum prevalence of T. b. rhodesiense across the districts at baseline, n
represents the total number of samples in each district Error bars represent 95 % binomial
confidence intervals.
4.3.2.1 Impact of the intervention
4.3.2.1.1 All districts
Figure 4.6a shows the combined prevalence of T. brucei s.l. in all districts at each
sampled time point. Figure 4.6b shows the prevalence of T. b. rhodesiense detected
from those samples positive for T. brucei s.l. at each sampled time point. The
prevalence of T. brucei s.l., as determined by the presence of PLC, reduces step-wise
at each consecutive time point. The pre-intervention prevalence of 7.5% reduces to
4% one year post-intervention (p<0.05) (Figure 4.6a). Pre-intervention, 33% of the
of T. brucei s.l. was found to be T. b. rhodesiense, this reduced significantly three
months post-intervention to under 10% (p<0.001)(Figure 4.6b). However, despite a
continued decrease in the overall prevalence of T. brucei s.l. one year post-
intervention, there was an increase in the relative percentage of those infections
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n = 67 n = 47
Figure 4.6 - Graphs showing the prevalence of (a) T. brucei s.l. (yellow) confirmed by
amplification of the PLC marker as a percentage of the total number of samples collected in all
sites and (b) T. b. rhodesiense (red) as a percentage of the total number of T. brucei s.l. positive
samples in all sample sites, n represents the total number of samples positive for the specific
trvpanosome species displayed. Error bars represent 95% binomial confidence intervals.
4.3.2.1.2 Kamuli
If we look more closely at the results, some variations in the prevalence of T. b.
rhodesiense at the district level can be observed. Figure 4.7a shows the prevalence
of T. brucei s.l. in Kamuli district at each sampled time point. The pre-intervention
prevalence of T. brucei s.l., confirmed by the amplification of PLC, reduced three
months post-intervention and then increased slightly one year post-intervention.
Figure 4.7b shows the prevalence of T. b. rhodesiense within the T. brucei s.l.
positive samples in Kamuli. Pre-intervention, 55% of the 27 tested T. brucei s.l.
samples were shown to be T. b. rhodesiense. However, at both three and twelve

























Figure 4.7 - Graphs showing the prevalence of (a) T. brucei s.l. (yellow) confirmed by
amplification of the PLC marker as a percentage of the total number of samples collected in
Kamuli and (b) T. b. rhodesiense (red) as a percentage of the total number of T. brucei s.l.
positive samples in Kamuli at each time point, n represents the total number of samples
positive for the specific trypanosome species displayed. Error bars represent 95% binomial
confidence intervals.
4.3.2.1.3 Iganga
Figure 4.8a shows the prevalence of T. brucei s.l. in Iganga at each sampled time
point. Pre-intervention, the prevalence of T. brucei s.l., confirmed by the
amplification of PLC was very low compared to other districts - under 3%. Post-
intervention, the prevalence of T. brucei s.l. increased in the initial three months
before decreasing one year post-intervention; however, neither change was
significant. Figure 4.8b shows the prevalence of T. b. rhodesiense within the T.
brucei s.l. positive samples. Very low numbers of T. b. rhodesiense were detected
both pre- and three month post-intervention, one and three respectively, while no
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Figure 4.8 - Graph showing the prevalence of (a) T. brucei s.l. (yellow) confirmed by
amplification of the PLC marker, as a percentage of the total number of samples collected in
Iganga at each time point and (b) T. b. rhodesiense (red) as a percentage of the total number of
T. brucei s.l. positive samples in Iganga at each time point, n represents the total number of
samples positive for the specific trypanosome species displayed. Error bars represent 95%
binomial confidence intervals.
4.3.2.1.4 Soroti district
Figure 4.9a shows the prevalence of T. brucei s.l. within sampled cattle in Soroti.
The pre-intervention prevalence of T. brucei s.l., confirmed by the amplification of
PLC, was 21%. This reduced at both three months and one year post-intervention
(p<0.01). Figure 4.9b shows the prevalence of T. b. rhodesiense within the T. brucei
s.l. positive samples. Pre-intervention, 28% of T. brucei s.l. samples were confirmed
as T. b. rhodesiense. This reduced dramatically three months post-intervention to
less than 10% (p<0.05). One year post-intervention, despite a continued decrease in
the prevalence of T. brucei s.l. (Figure 4.9a), there was a dramatic increase in the
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Figure 4.9 Graph showing the prevalence of (a) T. brucei s.l. (yellow) confirmed by amplification
of the PLC marker, as a percentage of the total number of samples collected in Soroti at each
time point and (b) T. b. rhodesiense (red) as a percentage of the total number of T. brucei s.l.
positive samples in Soroti at each time point, n represents the total number of samples positive
for the specific trypanosome species displayed. Error bars represent 95% binomial confidence
intervals.
4.3.3 Soroti follow up study
Figures 4.10a and 4.10b show the prevalence of T. brucei s.l. and T. b. rhodesiense
18 month post-intervention in Soroti. Sites where the FITCA interventions took
place are grouped together as intervention sites and sites where no intervention took
place are grouped as non-intervention sites. The results from the samples collected
at Brookes Corner market are shown separately.
18 months post-intervention there was no significant difference between sites which
had been included in the FITCA intervention and those that had not (x2=0.056, DF =
1, p>0.05). The prevalence of T. brucei s.l. in both intervention and non-intervention
villages was then compared to that found at Brookes Corner market shown in Figure
4.10a. Overall the prevalence at the market was significantly higher than the
intervention villages (x~=24.269, df=l, p<0.0001) and non-intervention villages
(X2=21.401, df= 1, p<0.0001) (Fevre et al., 2005).
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Similarly there were differences in the prevalence of T. b. rhodesiense found in the
market samples (48%) compared to the intervention villages (30%) and non¬
intervention villages (36%). However there was no difference in the prevalence of T.




n = 21 n = 37 n = 35
Figure 4.10 - (a) Graph showing the prevalence of T. hrucei s.l. (yellow) in Brookes Corner
market, intervention and non-intervention sites as a percentage of the total number of samples
collected, (b) The prevalence of T. b. rhodesiense (red) in Brookes Corner market, intervention
and non-intervention sites as a percentage of positive T. brucei s.l. samples.
The percentage of T. brucei s.l. observed 18 months post-intervention in both
intervention (22%) and non-intervention (19%) sites was similar to the prevalence
seen pre-intervention in the original study in Soroti (21%). However, one year post-
intervention the prevalence was 8% which was lower than that observed 18 months
after infection. Interestingly the prevalence of T. b. rhodesiense within the T. brucei
s.l. positive samples was similar pre-intervention (28%), one year post-intervention
(32%) in the original study and 18 months post-intervention in both intervention































The aim of this chapter was to investigate the impact of the FITCA Uganda
intervention programme on the prevalence of T. b. rhodesiense in cattle in the study
area. This was completed by determining the prevalence of T. b. rhodesiense within
the positive T. brucei s.l. samples. All the T. brucei s.l. prevalence described in this
chapter are from the samples in which the single copy gene PLC was amplified. The
single copy PLC was amplified in over 80% of T. brucei s.l. positive samples. This
is a fairly successful amplification rate when compared to the amplification of other
single copy gene PCRs in trypanosomes, e.g. study by Macleod et al showed that
single copy genes can be hard to find, only 56% of samples containing a single
trypanosome were successfully amplified for the single copy gene TIM
(triosephosphate isomerase) found in T. brucei s.l.(MacLeod et al., 1997).
Overall there was a significant reduction in the prevalence of T. b. rhodesiense
within the T. brucei s.l. samples three months post-intervention, from 33% pre-
intervention to less than 10% three months post-intervention. Interestingly, although
the prevalence of T. brucei s.l. within the total sample population continued to
decrease one year post-intervention, the prevalence of T. b. rhodesiense within these
T. brucei s.l. samples increased to 15%. The results presented in this Chapter firstly,
investigated the pre-intervention prevalence of T. b. rhodesiense both within T.
brucei s.l. samples and the prevalence within the total sample populations. These
results were then compared with the prevalence both three months and one year post-
intervention within each sampled district.
4.4.1 Baseline prevalence of T. b. rhodesiense
Pre-intervention there were significant differences in the prevalence of T. b.
rhodesiense within the T. brucei s.l. positive samples. The highest levels of T. b.
rhodesiense were detected in Kamuli and Soroti. In Kamuli 55% of T. brucei s.l.
samples were confirmed as T. b. rhodesiense, this was by far the highest prevalence
within T. brucei s.l. samples across any district. Overall, 33% of all T. brucei s.l.
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infections, confirmed by the amplification of PLC, were determined to be human-
infective T. b. rhodesiense. The prevalence of T. b. rhodesiense across the study
corresponds well to the ratio of 1:3 (T. b. rhodesiense-. T. brucei s.l.) presented in the
review by Coleman and Welburn (Coleman & Welburn, 2004). Overall there was a
2.5% population prevalence of T. b. rhodesiense in all sampled cattle across the
study site. This compares to a prevalence of 4.9% T. vivax and 0.7% T. c. savannah.
There are few other published studies on the prevalence of T. b. rhodesiense within
the cattle reservoir. The first field based study on the prevalence of T. b. rhodesiense
in cattle in Uganda was carried out in 2001. In Soroti district 45% of the sampled
cattle (n = 200) tested positive for T. brucei s.l. and 40% of these were characterised
as T. b. rhodesiense (Welburn et al, 2001b). Another more recent study in 2006
study in Uganda showed that using SRA as a diagnostic marker (Gibson et al., 2002;
Radwanska et al., 2002a) 11.5% (n = 87) of parasitologically positive cattle were
infected with T. b. rhodesiense in Kaberamaido district (Enyaru et al., 2006).
4.4.2 Effect of FITCA intervention on prevalence of T. b. rhodesiense
As previously mentioned there was a significant reduction in the prevalence of T. b.
rhodesiense within the T. brucei s.l. positive samples three months post-intervention
however, there were variations at the district level. The most dramatic differences
post-intervention were in Kamuli, pre-intervention 55% of T. brucei s.l. samples
were found to be T. b. rhodesiense. However, post-intervention no further T. b.
rhodesiense were identified in T. brucei s.l. positive samples (three month post-
intervention, n = 9 and one year post-intervention n = 15). The lasting T. b.
rhodesiense reductions observed in Kamuli were not detected in Soroti. In Soroti,
28% of T. brucei s.l. samples were identified as T. b. rhodesiense pre-intervention
this reduced to lower than 10% three months post intervention but increased to 33%
one year post-intervention. It is worth noting that the 1:3 (71 b. rhodesiense-. T. b.
brucei) ratio is present pre-intervention in Soroti and although this decreases
dramatically three months post-intervention to 1:10, ultimately one year on the 1:3
ratio has recovered corroborating the views of Coleman and Welburn (Coleman &
Welburn, 2004). The increase in the percentage of T. b. rhodesiense one year post-
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intervention occurred despite an overall reduction in the prevalence of T. brucei s.l.
Interestingly the recovery of the proportion of T. b. rhodesiense within T. brucei s.l.
samples one year post-intervention is only observed in Soroti where there is currently
an epidemic of human sleeping sickness (Fevre et al., 2005).
4.4.2.1 Soroti follow-up study
It was particularly important to complete a follow up study in Soroti due to the
continuing epidemic of sleeping sickness in that area. By this time it was becoming
clear that human sleeping sickness had continued to spread in Soroti (this is detailed
in Chapter 5) and had in fact spread from Soroti to the neighbouring district of
Kaberamaido leading to further concerns about the overlap of T. b. rhodesiense and
T. b. gambiense (Picozzi et al., 2005). As it seemed likely that the continued
northward spread of T. b. rhodesiense originated from Soroti district it was important
to complete a follow up study to determine the long term impacts of the FITCA
programme in reducing T. brucei s.l. and specifically T. b. rhodesiense. Overall
when the intervention and non-intervention sites were compared there was no
significant difference in the prevalence of either T. brucei s.l. or T. b. rhodesiense.
There was also no difference in the proportion of T. brucei s.l. samples which were
T. b. rhodesiense, this was consistent at approximately 30% in each group. This
follow-up study suggests that there was no lasting impact of the FITCA intervention
in this district.
The prevalence in these villages was then compared to the prevalence at a local
livestock market within the district called Brookes Corner. This market was
considered to be the introduction point of T. b. rhodesiense into this district (Fevre et
al., 2001). The prevalence of T. brucei and T. b. rhodesiense were shown to be
significantly higher in the samples collected in the market than either of the groups
of villages. Additionally approximately 50% of T. brucei s.l. cases were determined
to be T. b. rhodesiense', this was considerably higher than the other sample groups.
This result highlights that livestock markets continue to be a risk factor in the spread
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of disease to new areas and the maintenance of the disease in the local area. It is
government policy to treat all cattle which are sold in a markets, the animal should
be given a dose of trypanocide at the point of sale (Fevre, 2001). However in
practice this treatment is rarely given (C. Waiswa, pers. com.) which means these
animals can be moved into uninfected areas and have the potential to spread sleeping
sickness into a new area. Overall there was no lasting impact of the FITCA
intervention in the sampled areas in Soroti district after 18 months and there was still
a higher prevalence of T. brucei s.l. and T. b. rhodesiense at the market highlighting
the continued risk of disease spread.
4.4.3 Study limitations
There are similar limitations to the study presented in this Chapter as discussed in
section 3.4.4 (Chapter 3), in addition there are implications of sample size. These
limitations are due to the fact that when a species complex such as T. brucei s.l. is
broken down there are very low infection levels. To try to illustrate the changes
observed in the prevalence of T. b. rhodesiense, infection levels have been shown as
percentage of the total positive T. brucei s.l. samples. Additionally the PCR for a
single copy gene was relying on moderate parasite parasitemia in these cattle to
allow detection of T. b. rhodesiense (Picozzi et al., In press). It is therefore possible
that false negatives occurred due to a low parasitemia or the uneven spread of DNA
on the cards. In an attempt to compensate for these problems multiple punches were
taken from each sample however, this does reduce the amount of sample available
for repeats. The multiplex PCR also attempted to account for potentially low
parasitemia by ensuring the amplification of a single copy marker for T. brucei s.l.
{PLC). However, this could not inform about the presence of mixed infections of T.
b. brucei and T. b. rhodesiense, meaning that the level of T. b. rhodesiense could still
be very low. Despite these limitations it is clear that over course of the FITCA
intervention, there was a significant decrease in the prevalence of T. b. rhodesiense
within the T. brucei s.l. positive samples.
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4.4.4 Final comments
The results showed that three months post-intervention there was a significant impact
on the prevalence of T. b. rhodesiense within the T. brucei s.l. positive samples.
However, one year post-intervention the prevalence of T. b. rhodesiense within the T.
brucei s.l. positive samples had shown an increase despite the continued decline in
the prevalence of T. brucei s.l. This implies that although single dose of trypanocide
may have an initial impact on the prevalence of T. b. rhodesiense, this is not
maintained over time. This is corroborated by the 18 month follow up study in
Soroti district which showed no significant differences in the prevalence of T. brucei
s.l. and T. b. rhodesiense in sites where the FITCA intervention had taken place and
those that had not. This follow up study also highlighted the continued importance
of livestock markets as a route for spreading T. b. rhodesiense, almost 50% of T.
brucei s.l. infected cattle carried human infective T. b. rhodesiense. This emphasises
the need for the stringent upkeep of the policy to treat animals sold at markets with a
trypanocide, which is a key strategy in reducing the potential transmission of T. b.
rhodesiense to new areas. Although there were regional differences in the
effectiveness of this intervention it is clear that overall a one off trypanocide
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It is well established that in Uganda cattle form an important reservoir for human
infective Trypanosome brucei rhodesiense (Welburn et al, 2001b). Furthermore,
movement of infected cattle has been implicated in the recent outbreak of sleeping
sickness in Uganda (Fevre et al., 2001). Based on mathematical modelling it has been
proposed that mass trypanocidal treatment of cattle, such as that undertaken as part of
the FITCA programme, may form the most effective way to control sleeping sickness
caused by T. b. rhodesiense (Welburn et al., 2001a). The effect of the FITCA Uganda
mass treatment programme on the prevalence of the trypanosomiases in cattle has
been examined in the previous two chapters. Observations in Chapters 3
demonstrated that the overall prevalence of T. brucei s.l., T. vivax and T. c. savannah
was reduced after the intervention by FITCA and Chapter 4 showed a reduction of T.
b. rhodesiense in the cattle population sampled post-intervention. In this chapter the
number and distribution of the reported human sleeping sickness cases in two of the
study districts (Soroti and Kamuli) covered by the intervention programme are
examined to determine if the programme had any impact on the incidence of human
trypanosomiasis.
5.1.2 Soroti and Kamuli districts
Soroti and Kamuli districts are situated on the northern and southern shores of Lake
Kyoga respectively. Although separated by Lake Kyoga, these two districts share
similar demographics; both are comprised predominantly of rural populations with
89% of people in Soroti and 98% of people in Kamuli involved in subsistence
agriculture (Ugandan Bureau of Statistics, 2002). Due to the increased contact with
tsetse flies associated with this employment, it is the working population that is at
greatest risk of contracting sleeping sickness. Consequently the potential socio¬
economic impact of HAT on the collective community can be dramatic (Fevre, 2002).
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5.1.3 History of sleeping sickness in Soroti
Prior to 1998 there was only one reported case of sleeping sickness in Soroti, which
was diagnosed and treated in the Ugandan Trypanosomiasis Research Organisation
Hospital in Tororo in 1967. The female patient claimed to have lived in Soroti on the
shores of Lake Kyoga all her life, but had recently travelled to and from Tanzania, a
journey that would have required her to pass through endemic sleeping sickness areas.
(Onyango, 1967). The case prompted an extensive survey of trypanosome infection
of people (n = 650), tsetse flies (n = 1800) and cattle (n = 2444) in the area (Persoons,
1967; Mwambu, 1969b; Mwambu, 1969a). No T. brucei s.l. infections in either
humans or cattle was identified but 2 tsetse flies (0.1 %) were found to be infected
with parasites that displayed characteristics considered by the authors to be indicative
of T. brucei s.l. (Persoons, 1967).
In the current epidemic of sleeping sickness the first case was identified in Soroti in
December 1998 at Serere hospital (Fevre et al., 2001) in the south of the district.
Since that time, there have been over 500 reported cases of sleeping sickness in Soroti
district (Fevre et al., 2005) with the source of the outbreak linked to the movement of
cattle into the area, and in particular to a specific cattle market at Brookes Corner
(Fevre et al., 2001). Extensive cattle movement into the district at this time was due
to a major cattle restocking programme to replace those lost in cattle raids (Fevre,
2002). Since 1998, the disease has spread from the point of introduction throughout a
larger part of the district.
5.1.4 History of sleeping sickness in Kamuli
At independence, Kamuli district was part of Busoga district and as such is part of the
established Busoga focus of sleeping sickness (Langlands, 1967). The first cases of
sleeping sickness were identified at the turn of the 19th century on the shores of Lake
Victoria before spreading across the Busoga district (Christy, 1903). This epidemic
was not brought under control until the late 1920's by which time it had claimed more
than a quarter of a million lives (Mbulamberi, 1990). A further epidemic occurred in
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this area between 1939 and 1945 followed by an outbreak in neighbouring Iganga
district in 1976 which expanded to include some areas of Kamuli through the 1980's
(Berrang-Ford et al., 2006). In 1990, Mbulamberi et al. produced a detailed account
of the numbers of cases reported in affected sub-counties within Kamuli
(Mbulamberi, 1990). Throughout the 1990's small number of sleeping sickness cases
continued to be reported in Kamuli, but in 2001 there was a substantial increase with
>100 cases reported (Gould, 2003).
5.1.5 Spatial analysis
Examining data sets in the context of their spatial distribution is a method that has
been used extensively in epidemiology and can refer to anything from simple maps to
complicated mathematical analysis. In one of the most famous early epidemiological
studies, John Snow identified the source of a cholera outbreak in the Soho district of
London in 1854 by mapping the location of confirmed cases. His simple but detailed
spatial analysis revealed clustering of the cholera cases around a specific water pump
and earned Snow a place amongst the most famous scientists of that era (Snow, 2002).
The development of geographical information systems (GIS) since the 1980's as a
method of storing and displaying spatial data has meant that analysis of spatial data is
now quicker, easier and more sophisticated (Longley et al., 2001). The concurrent
development of readily available and portable global positioning system (GPS)
devices has permitted the rapid and accurate acquisition of reliable data from the field.
5.1.5.1 Spatial clustering analysis
A simple definition of disease clustering is "the occurrence ofa disease within a
particular area at a frequency greater than that expected by chance" (Robinson,
2000). Many statistical tests aim to characterise spatial clustering of disease cases and
a detailed description of the mathematical principals underlying these different
clustering algorithms are beyond the scope of this thesis (comprehensive discussions
are given in (Wakefield et al., 2000)).
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Besag and Newell (1991) identified 3 types of tests for clustering (Besag & Newell,
1991). (i) Tests for clustering - which describe the existence of spatial clustering
within a dataset but do not define the location or size of clusters. The use of such tests
is restricted to studies in which the location of clusters is not of primary concern, for
example in investigating whether or not a disease is infectious e.g. (Moran, 1948). (ii)
Tests for the detection ofclustering focused' - which are designed to test whether
there is clustering around a pre-specified putative health-hazard e.g. incidence of
cancer around a nuclear power station. Examples of the application of such tests are
given in (Schulman et al., 1988; Stone, 1988; Waller et al, 1992). (iii) Tests for the
detection ofclustering 'generalised' - which are capable of specifying the size and
location of clusters over a large study region in which there are no preconceived
notions of the location of clusters.
The geographical analysis machine (GAM) developed by Openshaw and colleagues
was the first major attempt to describe clusters of a rare disease over a large region
using a 'generalised' test for the detection of clustering. The GAM utilises multiple
overlapping circles of a fixed radius laid out on a fine regular lattice as quadrats.
Observations on the case counts in overlapping quadrats and separate significance
tests for each quadrat facilitate identification of potential clusters (Openshaw et al.,
1988). Although the GAM represented a significant advance in tests for the detection
of clustering under 'generalised' conditions, it doesn't satisfactorily quantify the
significance of identified clusters (Turnbull et al., 1990; Besag & Newell, 1991).
Based on the Openshaw method, Turnbull and colleagues developed the cluster
evaluation permutation procedure (CEPP). The CEPP also uses overlapping circles as
quadrats, but with the radius of each circle fixed for population size rather than
geographical distance. The incorporation of a Monte-Carlo simulation in the CEPP
also permitted the statistical significance of apparent clusters to be quantitatively
assessed (Turnbull et al., 1990).
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5.1.5.2 Spatial scan statistic
Modifications of the CEPP by Kulldorff and Nagarwalla led to the creation of the
spatial scan statistic (Kulldorff & Nagarwalla, 1995). The spatial scan statistic works
by centring a circular quadrat over each point in a dataset and allowing it to vary in
size during each iteration of the analysis, thereby evaluating potential clustering
around each point within the area defined by numerous radii. The maximum size of
the circle is normally defined so as to include no more than 50% of the points in the
data set (Kulldorff et al., 1998). For each circle of each size at each location the
observed number of cases is determined and compared to the number that would be
expected under the null hypothesis (i.e. that there are no clusters). The applicability
of the null and alternative (i.e. that there is clustering) hypotheses for each circle are
compared by a likelihood ratio calculation. The spatial scan statistic identifies
clusters as quadrats expressing the highest likelihood ratio for the alternative
hypothesis and permits the identification of secondary as well as primary clusters
within a data set, which are ranked according to their likelihood ratio (Kulldorff,
1997). A large number of replications using a Monte-Carlo simulation are used to
determine the probability that a detected cluster arose by chance and gives a
corresponding p-value. Only clusters demonstrating p-values <0.05 are considered to
be significant. Hence the final output from the spatial scan statistic defines the
location, size and an indication of the significance of detected clusters. Although the
location of the cluster is given as a fixed point, this should not be interpreted too
literally - the true central point of the cluster will lie within the radius of the cluster
(Kulldorff & Nagarwalla, 1995). The adoption of the likelihood ratio test permits the
spatial scan statistic to be applied to study areas in which the population density is
heterogenous (Kulldorff & Nagarwalla, 1995). The spatial scan statistic can be
applied to data conforming to either a Poisson-based model (e.g. where the number of
cases in a geographical area is Poisson-distributed, according to the known underlying
population at risk) or a Bernoulli model (e.g. with the binary data generated in case-
control studies) as discussed in (Kulldorff, 1997).
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5.1.5.3 Applications of the spatial scan statistic
Since its inception the spatial scan statistic has been used in numerous human and
veterinary epidemiological studies (http://www.satscan.org/references). It has been
widely used in infectious disease investigations to assess the importance of potential
aetiological factors (Odoi et al., 2004), evaluate risk factors associated with disease
(e.g. (Bakker et al., 2004; Brooker et al., 2004), monitor disease outbreaks (e.g.
(Norstrom et al., 2000; Pearl et al., 2006)) and evaluate the effect of intervention
programmes (e.g. Washington et al 2004). As envisaged by (Kulldorff & Nagarwalla,
1995), an important application of the spatial scan statistic has been the identification
of statistically significant clustering of disease cases as an approach to rationally
allocating resources for disease control. The spatial scan statistic has been adopted in
disease surveillance programmes (e.g. (Mostashari et al., 2003) and a variety of
studies employing this method have provided results that can inform the most
efficient use of healthcare and disease control provision ( e.g. (Sankoh et al., 2001;
Jennings et al., 2005; Tiwari et al., 2006). The spatial scan statistic has been used in
two studies into the epidemiology of sleeping sickness in Uganda. Berrang-Ford et al
(2006) used the spatial scan statistic to define clusters of sleeping sickness cases in
south east Uganda from 1970 to 2003 (Berrang-Ford et al., 2006) and demonstrated
the expansion of the sleeping sickness focus during the 1970's and the subsequent
infiltration into new areas in the 1980's and 1990's. Fevre et al (2001) used the
method to illustrate the association between cattle movements and the origins of the
1998 outbreak of the disease in Soroti (Fevre et al., 2001).
5.1.6 Chapter aims
As described previously, the main component of the FITCA Uganda programme was
the mass treatment of cattle in east Uganda with a single dose of trypanocide
completed in November and December 2002. The aim of this Chapter is to assess if
this intervention had any impact on the number and distribution of sleeping sickness
cases in the programme area.
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To achieve this aim a combination of descriptive statistical analysis and the spatial
scan statistic was used to analyse the sleeping sickness cases reported over a five and
a half year period (January 2000 - July 2005) in two of the districts (Soroti and
Kamuli) within the FITCA programme area. In the first half of the chapter the data
was analysed on an annual basis and in the second half of the chapter comparisons are
made between the data for the pre- and post-intervention periods. The results of this
analysis suggest that the impact of the FITCA intervention on the number and
geographical distribution of sleeping sickness cases was negligible. Possible
explanations for the level of impact are discussed in section 5.4 (Chapter discussion).
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5.2 Materials and Methods
5.2.1 Study area
Prior to instigation of the programme, FITCA Uganda completed a sleeping sickness
and animal trypanosomiasis survey throughout all districts in the FITCA programme
area. The results indicated that Soroti and Kamuli districts had the highest reported
numbers of sleeping sickness cases, and to maximise the potential for statistically
significant observations to be made, these two districts were selected for this analysis.
Both districts had three sub-counties categorised as high-risk; in Soroti these were
Pingire, Kateta and Kyere sub-counties and in Kamuli these were Bumanya,
Kitayunjwa and Namwendwa sub-counties (Figure 5.1). FITCA interventions in
Soroti and Kamuli were preferentially targeted within these sub-counties, with the
location of intervention sites selected by the respective DVOs.
Legend
■ High nsk sub-counties
Medium nsk sub-counties
m Low nsk sub-counties
j Outline of Kamuli and Soroti sub-counties
1 FUCAdistncts
| Lakes and 9*amps
Figure 5.1- Map showing FITCA high, medium and low risk sub-eounties within Soroti and
Kamuli districts, other FITCA districts shown in pale green.
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There were 25 intervention sites selected by the DVO in Soroti district. These sites
were situated across seven sub-counties: Bugondo, Serere, Pingire, Kateta, Kyere,
Asuret and Atiira (Figure 5.2). In Kamuli 22 intervention sites were selected by the
DVO. The majority of these sites were situated in Namwendwa sub-county with the
addition of one site in Kiatyunjwa sub-county very close to the border with
Namwendwa (Figure 5.2). A single dose trypanocide treatment of cattle, either
isometamidium chloride or diminazene aceturate (Chapter 3, section 3.2.2.2) was
carried out at these sites from November 2002 to December 2002. However, to
permit analysis it was assumed that the time of intervention was at the end of
December 2002.
Figure 5.2 - Map showing the location of the intervention sites in Soroti and Kamuli districts.
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5.2.2 Data collection
In Soroti, all sleeping sickness cases are recorded by Serere Hospital, the only
sleeping sickness diagnostic centre in the district. In Kamuli, there are three active
sleeping sickness diagnostic centres located in Bulopa, Nankandulo and Namwendwa.
Data for all cases of sleeping sickness reported in Soroti and Kamuli districts from
January 2000 through to July 2005 were collected retrospectively during visits to the
diagnostic centres in August 2005. Sleeping sickness diagnosis was based on the
WHO criteria of detection of trypanosomes in the blood or cerebrospinal fluid (World
Health Organization, 1998a). Details including (i) village, parish and sub-county of
residence, (ii) the admission date and (iii) stage of disease were obtained, where
possible, for every individual case of sleeping sickness reported. All cases were
considered for inclusion in the study and data were digitized and stored in Excel.
However, all records are hand written (Figure 5.3) and a small number of cases (n=5)
had to be excluded from spatial scan statistic analysis due to missing/illegible data
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Figure 5.3 - Picture showing sleeping sickness records
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5.2.3 Data geo-referencing
5.2.3.1 Geo-referencing maps (image warping)
Paper maps covering the study areas were scanned and then geo-referenced using the
image warp version 2.0 for ArcView version 3.1 Geographical Information System
software (ERSI Systems, Redlands, CA, USA). Image warp version 2.0 is an
extension to ArcView which was used to geo-reference the 1:50,000 maps. This
process takes a digital image and accurately positions it in geographical space. To
ensure accurate geo-referencing from each of the original maps the latitude and
longitude co-ordinates of 8 reference points were established. During an image
warping session the error in the location of these reference points on the digitised
maps generated were calculated and the map image accordingly warped using the
nearest neighbour method to rectify the error. Final warped maps had an error within
30 metres.
The following 1:50,000 maps were digitised and geo-referenced (i) for Soroti;
Bugondo (series Y732, sheet 42/4, edition 1-U.S.D.1963), Kelle (series Y732, sheet
42/3, edition 1-U.S.D. 1964), Kumi (series Y732, sheet 53/2, edition 1-U.S.D. 1963),
Kyere (series Y732, sheet 53/1, edition 1-U.S.D. 1964), Sambwa (series Y732, sheet
52/2, edition 1-U.S.D. 1969) and Soroti (series Y732, sheet 43/3, edition 1-U.S.D.
1968) and (ii) for Kamuli; Balawoli (series Y732, sheet 52/3, edition 1-U.S.D. 1963),
Kamuli (series Y732, sheet 62/1, edition 3-U.S.D. 1998), Namwendwa (series Y732,
sheet 62/2, edition 3-U.S.D. 1998) and Nawaikoke (series Y732, sheet 52/4, edition 1-
U.S.D. 1963).
5.2.3.2 Village location
The locations of all villages in the study areas were taken from the 1:50,000 maps
detailed above (section 5.2.3.1). For each village the latitude and longitude co¬
ordinates were established on the digitally manipulated maps. Using the ESRIXY
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coordinates extension function of ArcView version 3.1 (ESRI systems , Redlands,
CA, USA), the co-ordinate location for each village was transformed for the input
projection detailed in Table 5.1 and the co-ordinate data stored in a Excel spreadsheet








Table 5.1 - Projection details for the Ugandan maps
5.2.3.3 Intervention site location
The locations of the sites at which the FITCA interventions were completed in both
districts were provided by the relevant DVOs. The geographic co-ordinates of these
sites had been collected by veterinary officers attending the interventions using a hand
held Garmin GPSII+ device (Garmin Europe Ltd. Romsey, Hants., UK) and reflected
the position of the animal crush pens used. The co-ordinate data was entered into an
Excel spreadsheet (Microsoft Office XP, Redmond, USA) and any required
geographical manipulations of this data were carried out in ArcView version 3.1




Mann Whitney U tests, conducted in Minitab version 14 (Minitab, Ltd. Coventry,
UK) were completed to permit comparisons of the median number of monthly cases
reported in different years. A p-value <0.05 was considered significant. Median
values were used for analysis to limit any skewing effect that may have been
introduced by outlying values.
The incidence of reported sleeping sickness was calculated using the 2002 census data
for sub-county and parish populations (Ugandan Bureau of Statistics, 2002). In
absence of more recent census data it was assumed that there were no significant
changes in populations within the study districts in the years subsequent to 2002.
5.2.4.2 Cluster detection
The spatial scan statistic (Kulldorff & Nagarwalla, 1995; Kulldorff, 1997)
implemented by SaTScan version 5.1.3 (http://www.satscan.org) was used to
investigate spatial clustering of sleeping sickness in Soroti and Kamuli during the
study period. Analysis was performed assuming a Bernoulli distribution. Villages
with residents that reported as sleeping sickness cases were categorised as 'case
villages', with due regard given to villages in which multiple residents reported with
sleeping sickness. All other villages in the districts (which did not have any reported
cases of sleeping sickness within the time-frame of the study) were considered to
represent 'control villages'. The maximum cluster size was set at 50% of the dataset
points as is convention (Kulldorff & Nagarwalla, 1995) and the analysis was run to
identify areas of clustering ('high rates') rather than areas with no clustering
(Kulldorff et al., 1998). The analysis was run with 9999 Monte-Carlo iterations.
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5.3 Results
5.3.1 Descriptive statistical analysis of the numbers of sleeping sickness
cases reported
Between January 2000 and July 2005 there were 403 cases of sleeping sickness
reported in Soroti district and 283 cases reported in Kamuli district. The number of
sleeping sickness cases reported each month in Soroti and Kamuli during the study













Figure 5.4 - Graph showing the number of reported sleeping sickness cases per month during the
study period from January 2000 to July 2005 in (a) Soroti and (b) Kamuli districts. Red arrows
indicate the time point of the intervention
Visual observation suggests that the number of cases recorded each month in Soroti is
subject to seasonal variation, with a peak in February/March (particularly notable in
2002 and 2003, Figure 5.4a). However, this variation is not evident in all years e.g.
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2004. Disregarding these peak months in 2002 and 2003, the number of cases
reported in Soroti appears relatively consistent throughout the study period. Seasonal
variation appears to be absent from the data collected for Kamuli district (Figure
5.4b). Except for the high numbers of cases reported in April, July and October 2001,
in the months from January 2000 until the middle of 2002 the number of cases
reported is comparatively stable. In the subsequent months there is a general trend of
declining number of cases reported and from the middle of 2003 until the end of the
study cases are only reported intermittently.
Using the Mann-Whitney U test, the median monthly number of cases reported in
each year was used to statistically describe the year-by-year changes in the number of
cases reported in the two districts (Figure 5.5 and Table 5.2). As there was not data
for the full year in 2005 it was excluded from this part of the analysis. In Soroti, the
median number ofmonthly cases remained fairly stable throughout the five-year
period (Figure 5.5a). Only the increase seen between 2001 and 2002 was statistically
significant (p = 0.017), although the decrease from 2003 to 2004 was nearing
significance (p = 0.057). In Kamuli, there was an increase in the median monthly
number of cases from 2000 to 2001, which was followed by a continual decrease in
the subsequent years (Figure 5.5b). Application of Mann-Whitney U test (Table 5.2b)
indicated that only the decrease seen between 2001 and 2002 was statistically
significant (p = 0.003), although the decrease between 2003 and 2004 was
approaching significance (p = 0.061).
Comparison of the median monthly number of cases reported in the first year (2000)
and the last complete year (2004) of the study indicates that there were no statistically
significant differences in Soroti (p = 0.686), but that in Kamuli a statistically
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Figure 5.5 - Box plots showing the number of sleeping sickness cases reported each month in
2000 - 2004 in (a) Soroti and (b) Kamuli. Horizontal black lines denote the median monthly
number of cases reported for each year. Data for 2005 has not been shown as the complete
dataset for the year was not collected.* denotes outlying data points.
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Comparison p-value (Mann Whitney U) Significant change
2000 to 2001 0.6442 None
2001 to 2002 0.0166 Significant increase
2002 to 2003 0.8852 None
2003 to 2004 0.0567 Nearing significance
2000 to 2004 0.6861 None
Pre- to post-intervention 0.9671 None
(c)
Comparison p-value (Mann Whitney U) Significant change
2000 to 2001 0.0783 None
2001 to 2002 0.0029 Significant decrease
2002 to 2003 0.4025 None
2003 to 2004 0.0606 Nearing significance
2000 to 2004 0.0001 Significant decrease
Pre- to post-intervention 0.0002 Significant decrease
Table 5.2 - Statisitical analysis of numbers of sleeping sickness cases reported in Soroti and
Kamuli in 2000 - 2004. (a) Annual median monthly number of sleeping cases reported. Year-by-
year comparison of the annual median monthly number of sleeping sickness cases reported in (b)
Soroti and (c) Kamuli districts. Pre-intervention incorporates the years 2001 and 2002 combined
and post-intervention the years 2003 and 2004 combined.
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5.3.2 Geographical distribution of sleeping sickness cases
5.3.2.1 Soroti District
In Soroti, the 403 sleeping sickness cases reported during the study period came from
77 villages which are distributed over six of the seventeen sub-counties in the district
(Asuret, Atiira, Kateta, Kyere, Serere/Olio and Pingirie). These sub-counties form a
contiguous group in the south of the district (Figure 5.6).
Figure 5.6 - Map of Soroti showing which sub-counties have been affected by sleeping sickness
during the study period January 2000 to July 2005.
In different years within the period of study there was a degree of variation in the
distribution of cases reported at both the sub-county (Figure 5.7) and village level
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(Figure 5.8). Cases were reported from Asuret, Kateta, Kyere and Pingirie in each
year of the study and in Serere/Olio in every year except 2004, whilst in Atiira cases
were only reported in 2001 and 2004. There is no identifiable trend across the
different sub-counties for changes in number of cases reported annually (Figure 5.7).
The peak number of cases reported in 2003 appears to be attributable to the continued
high number of cases from Pingire and an increase in cases reported from Asuret for
that year (Figure 5.7).
Figure 5.7 - Graph showing the number of sleeping sickness cases reported in the six affected
sub-counties and the total number of cases in Soroti district from January 2000 to July 2005.









Analysis with the spatial scan statistic identified significant clustering of sleeping
sickness cases in each year of the study (Figure 5.8 and Table 5.3). In 2000 a single
primary cluster of laige radius (17.52km) covered most of Kateta and Kyere sub-
counties. In the following two years (2001 and 2002) a significant cluster was located
further west, being centred on the border between Kateta and Pingire sub-counties. In
2003 a secondary cluster was located in the same area, but the primary cluster was
situated to the north-east, in Asuret sub-county. In 2004 the primary cluster returned
to Kateta and Kyere sub-counties before relocating once again westwards to the
Kateta/Pingirie border in 2005.
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Figure 5.8 - Geographical distribution of sleeping sickness eases and significant clusters in Soroti
district in the years 2000 - 2005. Villages reporting sleeping sickness cases are shown according to the
legend above, control village are not shown. Significant clusters of cases as determined by application
of the spatial scan statistic are shown by the circles. Detailed outputs of the spatial scan statistic are






























































































In Kamuli. the 283 sleeping sickness cases reported between January 2000 and July
2005 came from eleven out of the twenty-three sub-counties in the district. These
included the four sub-counties in the far east of the district (Namugongo, Bumanya,
Gadumire and Namwiwa), a group of six centrally located sub-counties (Bugaya,
Bugulambya, Balawoli, Kitayunjwa, Nabwigulu and Namwendwa) and Kisozi sub-
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Figure 5.9- Map showing the sub-counties in Kaniuli which have heen affected by sleeping
sickness from 2000 - 2005.
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Notably only three sub-counties consistently reported sleeping sickness cases
throughout the study period. Namwendwa had cases every year of the study and
Bugaya and Kitayunjwa had cases in every year except 2005. In the other sub-
counties, sleeping sickness was only reported in one or two years of the study (Figure
5.10). Of particular note is that 79% of all sleeping sickness cases reported in Kamuli
district were from Namwendwa sub-county and that a subset of villages (Kyeeya,
Kinu, Ndalike and Isingo) consistently reported sleeping sickness cases in each year
from 2000 - 2003 (Figure 5.11). The dominance of Namwendwa sub-county in
Kamuli is demonstrated by the close approximation between the number of cases



































Figure 5.10 - Graph showing the number of sleeping sickness cases reported in each affected sub-
county in Kamuli district from January 2000 to July 2005.
Spatial scan statistic analysis demonstrated a statistically significant primary cluster of
sleeping sickness cases in all years of the study except 2005 (Table 5.4). From 2000 -
2003 a cluster was detected with a radius of 5.76 - 8.14km which was centred in the
north-west of Namwendwa sub-county (Figure 5.11). In 2004 the cluster was of a
larger radius (13.85km) and the gradual northward migration of the cluster that was
evident during the course of the study had moved its centre into southern Bugaya
(Figure 5.11).
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Figure 5.11 - Geographical distribution of sleeping sickness cases and signiticant clusters in
Kamuli district in the years 2000 - 2004. Villages reporting sleeping sickness cases are shown
according to the legend above, control villages are not shown. Significant clusters of cases as
determined by application of the spatial scan statistic are shown by the circles. Detailed outputs
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5.3.3 Comparison of incidence and distribution of sleeping sickness cases
pre- and post-intervention
5.3.3.1 Soroti
Comparison of the average annual incidence of sleeping sickness cases in the pre-
intervention (January 2000 - December 2002) and post-intervention (January 2003 -
July 2005) periods of the study show there was an increase from 3.82 to 4.50 cases
reported per 10,000 people in the six sub-counties. Similarly, the median monthly
number of cases reported in the two years after the intervention (2003 and 2004) was
higher than that reported in the two years immediately prior to the intervention (2001
and 2002); however the results of a Mann-Whitney U test (Table 5.2b) indicates that
this difference was not statistically significant (p = 0.9671).
Examination of the incidence of reported sleeping sickness cases at the parish level
(the smallest administrative unit in Uganda) permitted a higher resolution comparison
of the pre- and post-intervention periods and revealed a complex pattern. Whilst
some parishes demonstrated decreased annual incidence of reported sleeping sickness
cases in the post-intervention period compared to the pre-intervention period, others
demonstrated either an increase or no change (Figures 5.12). This inconsistent pattern
was replicated in the fourteen parishes in which the intervention sites were located,
with five showing no change, four showing an increase and five a decrease in
incidence in the post-intervention period compared to the pre-intervention period
(Table 5.5).
In the parishes which hosted an intervention site the average incidence of reported
sleeping sickness cases increased from 1.27 cases per 1000 head of population in the
pre-intervention period (January 2000 - December 2002) to 1.59 cases per 1000 head
of population in the post-intervention period (January 2003 - July 2005), despite the
latter period being 6 months shorter. By comparison, the average incidence of
sleeping sickness in parishes which reported cases but did not host intervention sites
showed a smaller increase - from 1.55 cases per 1000 head of population in the pre-
intervention period to 1.58 cases per 1000 head of population in the post-intervention
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period. Therefore, it would appear that intervention sites didn't exert a local effect
that reduced the incidence of reported cases.
Description of reported case clustering by application of the spatial scan statistic
implies that the intervention had minimal impact on the geographical distribution of
sleeping sickness cases in Soroti district (Table 5.5). In both the pre- and post-
intervention periods a primary cluster of cases was approximately centered on the
Kateta/Pingirie border whilst a secondary cluster was located to the north-east in
either Kyere (pre-intervention) or neighboring Asuret (post-intervention) sub-counties
(Figures 5.12).
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Bugondo Kangeta 1 0 0 -
Serere Okulonyo 1 0 1 T
Osuguro 1 14 13 I
Oburin 1 0 2 T
Pingire Aaropoo 1 0 0 -
Labori 3 0 0 -
Pingire 4 1 43 T
Kadapakol 3 1 1 -
Kateta Kateta 1 51 22
Ojetenyang 1 4 4 -
Kamusala 3 7 4 4
Kyere Kelim 1 9 6 4
Kyere 1 8 4 4
Asuret Mukura 1 5 25 T
Alma Atiira 2 0 0 -
Total 25 100 124 T
Table 5.5 - Location and number of FITCA intervention sites in Soroti district by sub-county
and parish. The numbers of reported sleeping sickness cases from parishes containing an
intervention site is also shown. The relative change in numbers of reported cases in these areas is
shown as J, for a decrease and f for an increase in the number of reported cases.
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5.3.3.2 Kamuli
The average annual incidence of reported sleeping sickness cases in the eleven sub-
counties in Kamuli which reporting sleeping sickness cases during the study
decreased from 2.03 to 0.36 cases per 10,000 people from the pre- (January 2000-
December 2002) to the post- intervention period (January 2003 - July 2005). This is
reflected in the statistically significant decrease identified in the median monthly
number of cases seen in the two years immediately after the intervention compared to
the two years immediately prior to it using the Mann-Whitney U test (p = 0.0002 -
Table 5.2c).
Analysis of the incidence of sleeping sickness cases reported at the parish level
emphasizes that in Kamuli a disproportionate number of cases were reported from a
geographically small area. In the pre-intervention period two parishes in the north¬
east of Namwendwa sub-county (Keeya and in particular Ndalike) had markedly high
incidence rates and accounted for a high proportion of the reported cases. Ndalike
parish alone reported 109 cases in the pre-intervention period (54% of the total cases
reported in Kamuli during this period) and had an incidence of 15.9 cases per 1000
head of population. Notably in the post-intervention period no parishes in Kamuli
exhibited such dramatically high incidence rates (Figure 5.13b).
In the nine parishes that hosted intervention sites in Kamuli there was a substantial
decrease in the incidence of reported sleeping sickness cases from 5.54 cases per 1000
head of population in the pre-intervention period to 0.76 cases per 1000 head of
population. A decrease in numbers of cases reported was evident in the majority of
the parishes in which an intervention site had been located, with only Nawansaso
parish demonstrating an increase in numbers of cases reported in the post-intervention
period (Table 5.6). A decrease in the incidence of reported cases was also seen in the
parishes which had reported cases of sleeping sickness within the study period but did
not host an intervention site with a drop from 0.37 cases per 1000 head of population
pre-intervention to 0.01 cases per 1000 head of population post-intervention.
Chapter 5 179
clual*iofs eep ngicknessbeforethin erve tio sleepinqicknessp r1000headofpopulation
ofolocpingcickntftrgper1000h dpopulation
1-60casesofsleepingsickne sp r.0 0h adpopulation
I81100casesofsle pingickne sp r000headofopul I14I-60casesofsle pingickne sper000headofpopi FfTCAiirieivenlionsales. Lakendswamp
inificantclusterofsleepingickn ssa t rterv ntion
Extentofsignificantclusterepingcknessbeforint rvention
|Parishboundaries
Ilo-i■20caSesofsleepingsickn ssp r1000headopulat on HHI"21-40casesofsleepingickn ssper000headpopulation AFITCAinterventionsit s Lakendswamp 048162432 ■■Kilometers
Figure5.13-Mapsshowingtheincidenceofreportedsl epingsickn sscasnK mulidu in( )t pr int rv tioer o(Ja ary2000-De mb r2) and(b)thepost-i terventioneriodJ uary2003-uly05 .An lincid ncefl pingsick esscasachp risahowc rdinthleg above. Chapter5180













Namwendwa Kyeeya 4 44 4 1
Ndalike 4 109 5 1
Isingo 1 15 4 1
Namwendwa 1 6 0 I
Kidiki 2 0 0 -
Bulange 3 0 2 T
Makoka 2 0 0 -
Bulogo 4 14 0
Kitayunjwa Nawansaso 1 9 12 t
Total 22 197 27 1
Table 5.6 - List of FITCA the location and number of intervention sites in Kamuli district by
sub-county and parish. The numbers of reported sleeping sickness cases from parishes
containing an intervention site is also shown. The relative change in numbers of reported cases
in these areas is shown as j. for a decrease and 1 for an increase in the number of reported cases.
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5.4 Discussion
Cattle are recognised as the most important reservoir host for the human infective T.
b. rhodesiense in Uganda (Welburn et al., 2001b). Based on mathematical modelling
it has been proposed that chemoprophylactic treatment of the animal reservoir may
form an effective method in control of T. b. rhodesiense sleeping sickness in humans
(Welburn et al, 2001a). Under the FITCA Uganda programme a mass treatment on
cattle was completed at the end of 2002. By examining the number and distribution
of sleeping sickness cases reported in two of the districts (Soroti and Kamuli)
included within the FITCA programme area over a five and a half year period
(January 2000 - July 2005) this chapter aimed to assess the impact this intervention
had on the incidence of human disease.
5.4.1 Sleeping sickness in Soroti and Kamuli districts during the study
period
The analysis completed in this chapter has provided descriptions of very different
scenarios in Soroti and Kamuli districts. In Soroti the reported sleeping sickness
cases all came from a block of six sub-counties in the south-east of the district;
Asuret, Atiira, Kateta, Kyere, Pingire and Serere/Olio. Although the annual number
of sleeping sickness cases reported in the district remained relative consistent from
2000 through to 2004, the number of cases reported from individual sub-counties
showed marked annual variation (Figure 5.7). This was reflected in the substantial
movement of significant clusters of reported cases identified in different years of the
study period by application of the spatial scan statistic (Figure 5.8).
In contrast to Soroti, the number of cases reported in Kamuli varied substantially
over the study period; after an initial increase from 2000 to 2001, the number of
cases reported progressively decreased in the subsequent years (Figure 5.5b). Cases
were reported in geographically distant and discrete parts of the district ranging from
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Gadumire sub-county in the far north-east to Kisozi sub-county in the extreme south¬
west of the district. However, in most of the sub-counties cases were only reported
intermittently. The exceptions to this were the adjoining sub-counties of Bugaya,
Kitayunjwa and Namwendwa located in the centre of the district, which reported
cases in most/all years of the study period. The most notable feature in Kamuli
district was the dominance of Namwendwa sub-county, where 78% (222 out of 287)
of all cases in Kamuli during the study period were reported. This dominance is
demonstrated by the similar trends in annual numbers of cases reported in Kamuli
district and Namwendwa sub-county (Figure 5.10). When examined at a parish level
it was evident that within Namwendwa a large proportion of the cases originated
from just two parishes (Keeya and Ndalike) in the north-east of the sub-county. As a
consequence of this, reported cases in Kamuli were significantly clustered around the
north-east of Namwendwa from 2000 - 2003. To understand the highly localized
nature of this outbreak detailed village level analysis would need to be completed (T.
Zoller, in prep).
The different scenarios described in Soroti and Kamuli most likely represent the
differences in the contemporary history of sleeping sickness in these two districts.
Sleeping sickness was only introduced into Soroti four years prior to the beginning of
this study when an epidemic was initiated following movement of infected cattle
(Fevre et al., 2001), whereas it has been endemic in Kamuli for at least a century
(Mbulamberi, 1990; Koerner et al., 1995). The continuous reporting of a
high/moderate number of cases over a geographically defined area in Soroti, with a
high degree ofmotility in the focus of clustered disease is consistent with an ongoing
unstable epidemic. In contrast, the reporting of a large number of cases from a small
area, complemented by the sporadic reporting of low numbers of cases from other
locations, as seen in Kamuli, is suggestive of a significant recrudescence (and then
decline) of disease from one of numerous endemic loci. The reasons for these
localized outbreaks remain unclear but may be triggered by changes in tsetse
numbers or changes in vector-human exposure (Berrang-Ford et al., 2006).
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In Soroti an element of seasonal variation was evident in the number of cases
reported, an observation that has been made previously in this district (Fevre, 2002)
and is currently under further investigation (E. Fevre, pers. comm.). Intriguingly
evidence of seasonal variation in the number of cases reported appears to be absent
in Kamuli despite the geographical proximity and similarities in demographics and
ecology of the two districts.
5.4.2 Assessment of the impact of the FITCA Intervention
The results from the comparison of the pre- and post-intervention periods in Soroti
indicate that the intervention had minimal impact on the numbers of cases reported,
with the annual incidence of reported sleeping sickness cases actually higher in the
post-intervention period (n = 218) than in the pre-intervention period (n = 185). This
reasons for this are unclear, however, it could be due to an increasing awareness
about sleeping sickness promoted by the FITCA interventions. Analysis with the
spatial scan statistic suggests the intervention also had negligible impact on the
geographical distribution of cases, with the significant clusters of reported disease
being similarly located in the pre- and post-intervention periods (Figure 5.12). This
lack of effect was also evident at the local level, with parishes hosting intervention
sites showing a greater increase in incidence of reported cases post-intervention (n =
127) than parishes in which no intervention sites were located (n = 86).
In Kamuli comparison of the pre- and post-intervention period indicates that the
intervention was associated with a significant decrease in the numbers of sleeping
sickness cases reported. However, it is evident from Figure 5.4b and 5.5b that the
number of cases being reported in Kamuli had already begun to decline prior to the
intervention. Indeed, it was between 2001/2002 (i.e. a year before the intervention)
that a significant decrease in the annual median monthly number of cases (Mann
Whitney U Test p > 0.01) was recorded. Hence, it would appear that the intervention
was co-incidental with, rather than the cause of, the reduction in the number of
reported cases in Kamuli district. Similarly the dramatic decrease in reported case
incidence seen in parishes hosting intervention sites (from 197 to 27) is probably an
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artifact and attributable to the location of most of the intervention sites in
Namwendwa.
5.4.3 Study limitations
Accurately assessing the impact of large scale interventions implemented in the
'field' is subject to numerous difficulties. Prominent amongst these is the
unquantifiable effect of the many uncontrolled factors that may be concurrently
affecting the epidemiology of a disease. In the case of human sleeping sickness
caused by T. b. rhodesiense ecological factors associated with the tsetse fly (e.g.
weather conditions and changes in land usage causing alteration in the vegetation
habitat of the fly), and changes in reservoir host populations (e.g. the continuing re-
introduction of potential infected cattle into study areas (Fevre et al., 2006b)) will
obviously have the potential to influence the epidemiology of HAT. Furthermore,
socio-political disturbances which cause large scale movement of people and their
livestock, such as that following the presence of the Lord's Resistance Army (LRA)
in Soroti during 2003, are also known to promote cases of sleeping sickness
(Maudlin, 2006; Welburn et al., 2006). Another factor to be considered is that the
study used reported rather than actual number of sleeping sickness cases to evaluate
the impact of the intervention and it is known that in Uganda there is substantial
under-reporting of the disease (Odiit et al., 2005).
The ability to control or quantify the impact of these factors or instigate an active
case finding programme were beyond the scope of this study. However, it is
important that the effects of intervention programmes are assessed under 'real-life'
conditions rather the under strictly controlled conditions that can not be realistically
replicated in the 'field'. Although the results of the study indicate the intervention
had negligible impact on HAT it is important to appreciate that it isn't possible to
determine how the pattern of disease would have been different in the absence of the
intervention. Establishment of control sites in which no intervention occurred was
not an option within the FITCA programme and the district-specific scenarios of
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HAT incidence described would have made comparison between control and
intervention areas difficult to interpret.
5.4.4 Conclusions
Reducing the size of the animal reservoir of zoonotic pathogens is a control strategy
employed for various diseases including leishmaniasis (Gramiccia & Gradoni, 2005),
rabies (Cleaveland, 1998) and schistosomiasis (Guo et al., 2006). It has been
suggested that reducing the prevalence of T. b. rhodesiense in the cattle reservoir
may be an effective method of controlling human East African sleeping sickness
(Welburn et al., 2001b; Welburn et al., 2006).
The work completed in this Chapter provides the first analysis on the impact that
mass trypanocidal chemoprophylaxis of cattle has on the incidence of human
sleeping sickness. The results indicate that in both study areas, the impact of this
intervention was negligible. However, the intervention in Soroti was implemented
during the course of an epidemic outbreak and in Kamuli at a time when the human
disease was already remitting. Thus, the intervention may have had an impact that
was masked by these events. However, it is certain that the FITCA intervention did
not prevent the spread of T. b. rhodesiense into previously unaffected districts
beyond Soroti. In 2004 the first cases of sleeping sickness were reported in
Kaberamaido and Lira districts to the west and north of Soroti (Picozzi et al., 2005).
Modifying the way in which mass treatment of cattle interventions were
implemented may provide more satisfactory results. In Soroti the percentage of the
cattle population treated was approximately 40%, (Chapter 3) which was
substantially below the 80% which the mathematical model suggests would be
effective (Coleman & Welburn, 2004), and use of serial rather than a single dose
regime may have more substantive effects. Various other HAT control strategies
have been employed in Uganda, (see Chapter 2), but few have assessed the impacts
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in terms of the sleeping sickness incidence in the human population. In a recent
review, Welburn and colleagues present numbers of reported sleeping sickness cases
during the 1980's and 90's pinpointing when aerial spraying occurred in the region,
the numbers of human cases decrease dramatically but it appears that the peak of the
epidemic occurred before the spraying was implemented (Welburn et al., 2006). It is
therefore difficult to make comparisons between the effectiveness of the FITCA
programme and alternative control policies. In future, integration of control
programmes that concurrently target the animal reservoir, tsetse vector and human







Farming in Tsetse Controlled Areas (FITCA) is a regional EU funded programme
designed to promote sustainable agriculture in areas where trypanosomiases is
prevalent. In Uganda the programme predominantly took the form of a mass
treatment of cattle with trypanocidal drugs, administered in November/December
2002. The aim of this thesis was to evaluate the impact of this intervention on the
prevalence of bovine and human trypanosomiases in the treated districts and provide
comparative data on real-world, large scale interventions. The main conclusions
obtained from the results of this thesis are:
1. Mass treatment of cattle with trypanocidal drugs effected a significant
reduction in the prevalence of pathogenic trypanosome species in the sampled
cattle population. The prevalence of T. brucei s.l, T. c. savannah and T. vivax all
decreased at both three months and one year post-intervention. Although decreases in
prevalence were seen in all districts, the effects varied across districts with Kamuli
the only district demonstrating a significant decrease.
2. There was a significant reduction in the proportion of human infective T.
brucei rhodesiense detected in the cattle population after mass treatment. In
Soroti where epidemic conditions exist, this effect appeared to be temporary with a
reduction in prevalence evident three months post-intervention before returning to
pre-intervention levels one year post-intervention. In contrast, this effect was more
persistent in Kamuli, with no T. b. rhodesiense detected at either three months or one
year post-intervention.
3. Despite the reduction observed in T. b. rhodesiense within the cattle reservoir
there appeared to be no impact on the incidence and distribution of reported
cases of human sleeping sickness following the FITCA intervention. This was
studied in two districts: Soroti which is experiencing an epidemic of sleeping
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sickness and Kamuli which is within an area endemic for sleeping sickness.
Although the incidence of human disease and distribution of disease varied
considerably between the districts, the intervention appeared to have negligible effect
in either.
In summary, although the FITCA intervention reduced the prevalence of tested
trypanosome species within the sampled cattle population, and specifically, the levels
of T. b. rhodesiense within the cattle reservoir, there was no associated reduction in
the incidence of reported human sleeping sickness cases. The intervention therefore
did not have a public health benefit.
6.1.1 The FITCA Uganda programme
As the name implies, FITCA, was initially intended as a programme to promote
sustainable agriculture practices of which tsetse related issues were a part. However,
faced with the reality of the situation in Uganda, these priorities changed under
pressure to address specifically, the problem of sleeping sickness within eastern
Uganda. Thus, measures to control trypanosomiasis were accepted as part of the
programme and consequently, the methods used to implement the control strategies
may not have been optimal.
One of the first problems with the FITCA study design was the decision to restrict
control measures to designated high-risk areas. These high-risk areas were
determined prior to treatment by compiling a risk map based on the location of
reported human sleeping sickness cases coupled with a microscopy survey of cattle
throughout the area (Figure 6.1). In theory the decision was shrewd as limited
resources were available for the intervention, meaning that cattle in all areas could
not be treated, but unfortunately a number of problems arose. The first of these was
the time delay between the completion of the human and cattle trypanosomiasis
surveys (carried out in 2000) and the launch of the intervention (2002).
Unfortunately, in the intervening years the range of the disease increased, meaning
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that the FITCA interventions were not always targeted to the correct areas - this was
most apparent in Soroti which was latterly added to the programme. Considerable
under reporting of sleeping sickness cases across eastern Uganda (Odiit et al., 2005)
may also have affected the accurate identification of high risk areas. Additionally,
the construction of the risk map based on administrative structure, using the sub-
county, meant that in some circumstances high-risk areas were situated adjacent to
low-risk areas (Figure 6.1) in which no interventions occurred. Obviously, in reality
the spread of sleeping sickness is not limited by administrative boundaries therefore
sub-counties adjacent to high-risk areas must have had a higher level of risk.
While under reporting of human sleeping sickness cases no doubt affected the
accuracy of the risk map, so too the decision to use microscopy to screen cattle for
disease as it is considerably less sensitive than PCR for trypanosome detection (as
demonstrated in Chapter 3). This survey was also not carried out in all sub-counties
within the FITCA area, resulting in areas of unknown risk (shown as white in Figure
6.1).
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The FITCA Uganda interventions were implemented in a top-down strategy through
the administration structures of the individual districts within the FITCA areas. The
ongoing decentralisation of Ugandan veterinary services resulted in the FITCA
project money being used to support these under-resourced decentralised structures
rather than the intervention activities themselves. Ceding responsibility for the
administration of FITCA to the veterinary services in each district led to numerous
district to district differences in the way that interventions were implemented. This
was clearly illustrated in Kamuli district where the decision was made to target
almost all interventions to a single high-risk sub-county, Namwendwa, while in
Soroti the intervention sites were distributed across all the high-risk sub-counties
(shown in Chapter 5). Differences in implementation between districts may also
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account for the difference in treatment coverage - results in Chapter 3 showed that
Kamuli achieved a coverage rate of over 80% in each of the sample sites, almost
double that found in the other districts.
Another factor hampering the implementation of the FITCA project in Uganda was
administrative delays. It is clear from FITCA Uganda quarterly reports, that the
programme suffered from administrative delays at every level, for example, there
were delays in the arrival of money from the EU to the country programme, which
resulted in planning delays in-country, which in turn resulted in delaying the flow of
resources to the districts. Despite these problems with the design and
implementation of the FITCA project in Uganda, the mass treatment of cattle with
trypanocidal drugs was shown in Chapter 3 and 4 to have a significant impact on the
prevalence of trypanosomes within the sampled cattle population. This success
highlights how effective the mass treatment of cattle could be as a trypanosomiasis
control strategy under a different implementation regime.
Beyond the study period covered in this thesis, FITCA continued working in eastern
Uganda. After the implementation of the mass treatment programme, the focus of
FITCA returned to the original aims of promoting sustainable farming practices,
including encouraging farmers to use animal traction for ploughing, encouraging the
use of zero grazing units and the forming of insecticide spraying cooperatives. The
spraying cooperatives were based in the designated high-risk areas; livestock keepers
were encouraged to form farmer groups and construct spraying crushes. Each group
was then given one litre of Decatix® and hand pump sprayers were provided to be
shared between a number of groups. The groups were informed they should charge
an amount for each animal sprayed to allow the purchase of the next batch of
insecticide. It has been observed by this author that in the majority of cases spraying
was discontinued when the supplied insecticide was finished. In one situation in
Kamuli, where farmers groups had the dedicated support of the local animal
husbandry officer (AHO), some of the groups managed to acquire enough funds to
purchase more insecticide. However, in many cases this had required the direct
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intervention of the AHO, for example, in situations when money had gone missing
from within the group or when problems had arisen in the sharing of the spray unit
(Dr Waako, DVO Kamuli, pers. com.). At the time of writing FITCA was
continuing to operate in eastern Uganda, in a partnership with a British NGO, Send a
Cow, providing netting for the zero grazing units necessary for the housing of the
exotic cross breed animals provided by Send a Cow (S. Gould, technical advisor for
FITCA Uganda, pers. com).
6.1.2 Control options for trypanosomiasis in Uganda
Over the past 100 years many strategies have been employed to control both human
and animal trypanosomiasis, of which some have been detailed in the historic review
in Chapter 2. In the past, just as today, methods of trypanosomiasis control have
been influenced not only by scientific advances but also by economics and politics.
The most controversial, complicated and expensive solution currently available is the
sterile insect technique which despite many concerns among tsetse and
trypanosomiasis researchers (Molyneux, 2001a; Torr et al., 2005) is currently
supported by PATTEC as the best solution for tsetse control across Africa (Kabayo,
2002; Kabayo, 2005). However, the prohibitive cost and concerns regarding its
practicality, cost, safety, and public acceptance make it increasingly likely that in the
twenty first century we will continue to rely on low tech solutions and in particular,
the use of insecticides and trypanocides.
One of the current methods for trypanosomiasis control in Uganda is the use of
insecticide treated traps which are required at a density of ten traps per square
kilometre to be effective at reducing fly densities sufficiently to interrupt the
transmission of sleeping sickness (Lancien, 1991). Changing attitudes of donor
organisations in the 1990's shifted the emphasis of tsetse control to the local
community level (Torr et al., 2005). Subsequently, limited success has been
demonstrated with community-based trapping in Tororo using locally produced
materials (Okoth et al., 1991) however, these are unlikely to achieve the coverage
required. The success of such community based approaches are governed by the
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ability of farmers groups to cooperate and these types of community-based
approaches are often dependant on the use of farmers private resources for a 'public'
good (Torr et al., 2005). Consequently, the constraints faced by poor rural
communities in terms of financial wealth and a lack of technical advice have resulted
in traps not being optimally utilised (Dransfield & Brightwell, 2004).
An alternative to the use of traps is insecticide treated cattle which act as live bait for
the tsetse. However, this can only be effective in areas where there is a high
concentration of cattle and can result in patchy coverage (Hargrove et al., 2000). As
shown in this thesis the mass trypanocidal treatment of cattle can be an effective
strategy to reduce the prevalence of trypanosomes within cattle population and
combined with the simultaneous use of some form of tsetse control, for example
insecticide spraying of cattle, the effect could be even greater. However, farmers
will probably only adopt regular insecticide spraying of cattle if it is made
affordable. This has become a reality with the use of restricted application of
insecticides to tsetse predilection sites, namely the legs and belly (Torr & Mangwiro,
2000), reducing the cost of treatment to less than US$1 per animal (Vale & Torr,
2005). Coordinated activities resulting in the implementation of integrated control,
targeting cattle, humans and tsetse requires co-ordination between veterinary and
medical authorities. Such cross-sectorial collaborations could also assist in targeting
emerging sleeping sickness problem areas, where rapid communication between the
health and veterinary sectors could result in the implementation of cattle treatments
and spraying to prevent further spread. As shown in this thesis, treatment of the
cattle reservoir must be an important part of any sleeping sickness control
programme in Uganda as cattle are a significant reservoir of sleeping sickness caused
by T. b. rhodesiense and have been implicated in the spread of disease (Fevre et al.,
2001).
6.1.3 Immediate future
The FITCA mass treatment of cattle failed to stem the northward spread of sleeping
sickness, however, this mass treatment was shown to reduce the cattle reservoir of T.
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b. rhodesiense. There is currently great concern in Uganda concerning the overlap of
the T. b. rhodesiense focus with the T. b. gambiense focus of sleeping sickness in the
north west of the country (Picozzi et al., 2005). This situation is becoming more
acute given the potential resolution of the ongoing civil disturbances in the north of
the country. There have been T. b. rhodesiense sleeping sickness cases reported
from an internally displaced peoples (IDP) camp in Aloi in northern Lira (A.
Mpairwe, Medical officer, Lwala hospital, Uganda) and these people are now being
encouraged to return to their homes in northern Uganda leading to a potential spread
of T. b. rhodesiense sleeping sickness to areas further north. Although, a greater
potential risk factor is the movement of cattle with the returning IDPs, as recent
surveys have shown the presence of T. b. rhodesiense within the cattle population in
Lira (B. Wissmann, unpublished). This risk will undoubtedly increase with the
peaceful resolution to the current conflict as the Ugandan government/ World Bank
aid administered through the Northern Uganda Social Action Fund (NUSAF) is
already seeing cattle restocking as a major part of re-building the northern economy
(C. Laker, pers. com). It is therefore essential for the cattle sold at markets as well as
those belonging to returning IDPs to be treated.
In areas newly affected by sleeping sickness there is a lack of knowledge about the
disease, which can be confused with HIV/AIDS. In one situation a local official
described how an elderly widow had become ostracised from her community as it
was suspected that she was suffering from HIV/AIDS and only after the intervention
of a distant family member was it was revealed to be sleeping sickness. This
confusion leads to a reluctance to seek treatment resulting in unnecessary suffering
and without treatment certain death. It is therefore, essential that education about the
symptoms of sleeping sickness is part of any control programme, this is especially
true in the areas in which the disease is new and there is little knowledge of the
disease and its symptoms.
Currently in Uganda there is an ongoing control programme established by a public-
private partnership to stop the spread of T. b. rhodesiense further north. The Stamp
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Out Sleeping sickness (SOS) campaign is targeting the cattle reservoir using similar
methods to those described in this thesis. Mass treatment using diminazene aceturate
was completed in three districts - Kaberamaido, Lira and Apac - treating all cattle in
these areas, involving approximately 220,000 animals. As discussed above, it is
difficult to accurately target high-risk areas, thus, the best way to ensure maximum
effect is to treat all cattle and include all areas at risk from the spread of sleeping
sickness, not just areas where cases have already occurred. The SOS programme is
multi-pronged with cattle treatment accompanied by the simultaneous spraying of
insecticide to target the tsetse population. The combined use of trypanocides to clear
the cattle reservoir and insecticides to reduce the tsetse population is anticipated to
prevent any further spread of T. b. rhodesiense, and hopefully prevent the merging of
the T. b. rhodesiense focus with the north western T. b. gambien.se focus. A public
health communication project aimed at disseminating information about sleeping
sickness through local media and local leaders has also been implemented to help
educate and change perceptions about the disease.
Trypanosomiasis remains a neglected disease but with human disease burdens a mere
shadow of its infamous compatriots such as malaria, HIV, and tuberculosis, the lack
of investment in its control is understandable. However, trypanosomiasis places
more of a toll on human welfare than is immediately apparent from looking at
morbidity and mortality figures alone. Nagana is a devastating disease of cattle
placing immeasurable constraints on agricultural production and consequently socio¬
economic development across vast swathes of sub-Saharan Africa. With limited
resources available for disease control it is therefore, imperative that the best
strategies are employed in order to gain maximum benefit.
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Abstract
We present the results of a study to determine the value of central point sampling in cattle markets as a means of estimating
the trypanosomiasis (71 brucei s.l.) prevalence in the surrounding landscape in Uganda. We find that in the epidemic area studied,
central point sampling is a good predictor of prevalence in surrounding villages, but not in endemic areas. We also find that animals
infected with trypanosomiasis are more likely to be brought for sale in livestock markets in endemic areas; we discuss these results
in relation to the prevention of the spread of sleeping sickness.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Sleeping sickness, caused by the zoonotic try-
panosome Trypanosoma brucei rhodesiense, affects
large areas of eastern Africa. In southeast and eastern
Uganda, the disease occurs in discrete foci, although in
recent years there has been an expansion into previously
unaffected districts. In the virtual absence ofwildlife in
these areas ofUganda, domestic livestock—in particular
cattle—have become an important reservoir for the para¬
site, and a significant source of bloodmeals for the tsetse
host (Clausen et al., 1998; Okiria et al., 2002). This has
been recognized both in the persistence of sleeping sick¬
ness during endemic periods (Waiswa et al., 2003), and
* Corresponding author. Tel.: +44 131 650 8850;
fax:+44 131 651 3903.
E-mail address: Eric.Fevre@ed.ac.uk (E.M. Fevre).
in the epidemic zones ofsouth-eastern (Hide et al., 1996)
and more recently eastern Uganda (Fevre et al., 2001),
where 18% ofcattle were found to be harbouring human-
infective parasites (Welburn et al., 2001). The current
epidemic in eastern Uganda is spreading northwards,
with cattle movements a likely driving factor (Fevre et
al., 2005).
In areas affected by T.b. rhodesiense sleeping sick¬
ness, particularly during epidemics, a rapid response to
reducing the prevalence in the reservoir is essential to
prevent widespread transmission. However, it is often
only the passive surveillance ofsleeping sickness at treat¬
ment centres that provides the first indication ot disease
resurgence or spread, and reporting to health centres
is beset with problems (Odiit et al., 2004). Outbreaks
may occur in areas covering many hundreds of square
kilometres, so that assessment of the extent of infection
in the animal reservoir can be problematic. Strategies
designed to assess the degree of the problem without
0001-706X/S - see front matter © 2005 Elsevier B.V. All rights reserved,
doi: 10.1016/j.actatropica.2005.11.005
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requiring sampling from many disparate geographical
locations would therefore greatly improve efficiency and
reduce costs. In contrast to other infectious diseases of
livestock such as foot- and -mouth disease, animal move¬
ment restrictions are not put in place to prevent sleeping
sickness and livestock are brought to market regularly
from across risk areas.
Using PCR based methods for identification of ani¬
mals infected with T. brucei s.l., we investigated the
value of central point sampling strategies; we tested
the hypothesis that livestock markets could be used as
central point sampling locations representative of the
surrounding area. This study was carried out prior to a
large-scale sleeping sickness control programme which
targeted livestock in this region.
2. Methods
2.1. Study design
Surveys were conducted in three districts in Uganda:
Soroti district, where sleeping sickness is currently epi¬
demic, and Tororo and Kamuli districts, both endemic
areas. In Uganda, each district operates one or two major
livestock markets in which animals from across the dis¬
trict are traded, and a number of smaller ones dealing
mainly with inter-village trade. We sampled each of the
major markets in the districts studied. Cattle were also
sampled in four to six typical and arbitrarily chosen vil¬
lages from the surrounding area in each district. This was
a cross-sectional study, conducted in the first quarter of
2003; in both the markets and villages, we sampled all
the cattle present on the sampling day, with a minimum
of 50 animals in each location, sufficient to detect an
effect in a village/market with an estimated maximum
cattle population of 100 animals and an expected preva¬
lence of up to 4% for T. brucei s.l. (Waiswa et al., 2003;
Magona et al., 2005), with a 95% confidence level.
2.2. Sample analysis
Bovine ear vein blood was collected into heparinised
capillary tubes and applied directly onto Whatman FTA
cards (Whatman Inc., NJ, USA). These were analysed
for the presence of T. brucei s.l. using species specific
primers, as described by Picozzi et al. (2002). Differ¬
ences in the number of T. brucei s.l. positive and negative
animals among markets and villages in the epidemic and
endemic districts were assessed using generalised linear
models with binomial errors in S+ (Insightful, Seattle,
USA).
3. Results
Fig. 1 shows the PCR-based prevalence for T. bru¬
cei s.l. in cattle from markets and villages within the
three districts studied. The epidemic area of Soroti
had a significantly higher prevalence of T. brucei
s.l. than the endemic areas of Kamuli and Tororo
Endemic Endemic Endemic Endemic Epidemic Epidemic
Kamuli Kamuli Tororo Tororo Soroti Soroti
Market Village Market Village Market Village
Fig. 1. Box plots of the prevalence of 71 brucei s.l. in markets and villages in Kamuli (two markets; four villages), Tororo (two markets; four villages)
and Soroti districts (two markets; five villages) ofUganda. Soroti is denoted as an epidemic zone, Kamuli and Tororo as endemic. Whiskers represent
range of data, while bars and boxes the 25-75% percentile.
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(x? = 18.37; p< 0.001); however, there was an inter¬
action between epidemic/endemic status and sampling
location (x|= 10.78; /? = 0.001). There was no signif¬
icant difference between T. brucei s.l. prevalence in
markets and villages within Soroti district (xj = 0.001;
p = 0.967); this study was undertaken prior to the imple¬
mentation of control activities in that region. Within this
epidemic area, prevalence determined for markets pro¬
vided reasonable estimates ofprevalence in surrounding
villages. In contrast, in the endemic areas, markets did
not accurately reflect village 71 brucei s.l. prevalence;
markets had a significantly higher proportion of infected
animals (xj =29.20; p< 0.001).
4. Discussion
The data presented suggest that prior to the implemen¬
tation of sleeping sickness control in the epidemic area
studied (Soroti district), 71 brucei s.l. prevalences in cat¬
tle at markets could be used to estimate the prevalence
of the parasite in the surrounding area; Soroti was the
only 71 b. rhodesiense sleeping sickness epidemic area in
Uganda at the time of this study. In the endemic zones
studied, market prevalences were not representative of
those in the surrounding area; however, for assessment
of the extent of 71 brucei s.l. prevalence in livestock dur¬
ing sleeping sickness epidemics, markets may be used as
a convenient central point. This has benefits in terms of
reducing costs and improving the efficiency of screening
programmes, and might be applied in emerging epidemic
areas to which sleeping sickness has recently spread
(Fevre et al., 2005). Sampling of cattle would not, how¬
ever, replace the need to screen humans in an effort to
identify and treat patients infected with T.b. rhodesiense.
The treatment of cattle at markets in epidemic areas
would also prevent the spread of T.b. rhodesiense in the
animal reservoir, though this should be accompanied by
monitoring for the possible development of drug resis¬
tance (Barrett, 2001). Our results also show that while
the market as a central point approach is inappropriate in
endemic areas, there is a need for researching and test¬
ing cost-effective strategies for efficient sampling where
cattle and human trypanosomiasis are well established.
Improving our understanding of the levels of infection
in reservoir populations where sleeping sickness per¬
sists should have important impacts on the efficiency
of reservoir-targeted interventions.
At present, microscopy is the best diagnostic tool
available for the identification of trypanosomes in the
field, and the detection of the SRA gene—the marker
for T.b. rhodesiense (Welburn et al., 2001; Gibson et al.,
2002) is not field-adapted. While T. brucei s.l. prevalence
continues to be used as a proxy for T.b. rhodesiense,
Coleman and Welburn (2004) have shown that the ratio
of T. b. brucei: T.b. rhodesiense in a given population is
fairly constant, at 3:1. The level of T. brucei s.l. preva¬
lence in a reservoir population in a sleeping sickness
affected area is thus indicative of the prevalence of T.b.
rhodesiense in that same reservoir population.
T. brucei s.l. does not result in severe clinical disease
in local (primarily zebu) breeds of cattle. However, it is
likely, that animals carrying T. brucei s.l. infections are
also infected with other, more pathogenic species of try-
panosome such as T. vivax and T. congolense (Magona
et al., 2003), and the overt clinical signs associated with
these infections may encourage farmers to attempt to
sell animals, accounting for infection rates at markets in
endemic areas higher than those in the surrounding vil¬
lages. In addition, if animals infected with pathogenic
trypanosomes are brought to market on the basis ofpoor
performance (e.g. loss of body condition), such animals
may not be rapidly sold to traders; farmers and traders
have a tendency of returning to the market with the
unsold animals on subsequent market days, leading to
a build up of infected animals in the market—which
may greatly contribute to the high prevalence recorded.
The preferential sale of potentially infected animals in
areas serving as a source of livestock for country-wide
restocking programmes has implications for disease con¬
trol policy (Fevre et al., 2001), and emphasises the need
for a better understanding of the livestock trade and for
control measures designed specifically for preventing the
long-range spread of zoonotic diseases.
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A burgeoning epidemic of sleeping sickness in Uganda
E A/I Fevre, K PicozziJ Fyfe, CWaiswa, A/I Odiit, P G Coleman, S C Welburn
The epidemic of Trypanosoma brucei rhodesiense sleeping sickness in eastern Uganda, which began in 1998 as a result
ofmovements of the livestock reservoir of the parasite, has continued to spread. An additional 133 000 people have
been put at risk of infection in Kaberamaido, another newly affected district. The few resources committed to control
interventions in Soroti district have failed to contain the epidemic. The high prevalence of the parasite in cattle
presents a significant risk for transmission to human beings and further spread of this neglected zoonotic disease.
Targeted interventions are urgently needed to control epidemics and reduce the high mortality resulting from
sleeping sickness.
There are two areas in Uganda affected by sleeping
sickness; Trypanosoma brucei rhodesiense occurs in the
east of the country and T b gambiense in the northwest.
The geographic distribution of these parasites is
separate, although there are concerns that an overlap
might occur.1 In 2001, we reported on the origins and
causes of a newly described outbreak of T b rhodesiense
sleeping sickness in Serere county, Soroti district, lying
to the north of historical endemic foci.2 The greatest risk
factor for infection at the start of the outbreak was
proximity to a livestock market; cattle are the principal
reservoir of the zoonotic T b rhodesiense parasite in this
ecosystem, and we have shown that livestock
movements into Soroti resulted in the spread of the
parasite to the area.2
Here, we report on the current extent of the sleeping
sickness situation in Soroti district. Before control
activities were undertaken across the affected area, up to
18% of cattle in some parts of Soroti were shown to be
carrying human infective parasites.2 The primary
response to outbreaks such as this in Uganda is to treat
human patients (treatment in the early stage of the
disease with suramin, while melarsoprol is used in the
late stage). Second, to prevent further transmission to
human beings, both vector control (tsetse flies of the
genus Glossina) and mass treatment of the livestock
reservoir with anti-trypanocidal drugs is undertaken.
Such control interventions have taken place in a few
areas of Soroti; however, this region has also been
plagued by violence and instability since 2003, which has
had a substantial negative effect on the general health of
the population.2
Interventions were put in place between January, 2000,
and December, 2003, and consisted ofmass treatment of
livestock with long-acting trypanocides and some vector
control. In April, 2004, domestic cattle in six villages
(51-56 animals per village; total sample size=335) in the
areas of Soroti affected by sleeping sickness were
screened for trypanosome infections. Three villages in
the non-intervention area were selected based on a
history of recent (<3 months) sleeping sickness
reporting, and three villages known to have reported
sleeping sickness before the interventions were selected
in the intervention area. Additionally, 51 animals were
screened at the livestock market that had been at the
centre of the originally reported outbreak.2 All animals
were screened by PCR for both T brucei sensu lato and
T b rhodesiense (table 1).' Cattle at the local livestock
market were also sampled on one market day. We
calculated CI using binomial regression, taking account
of the clustering of cattle at the village level, producing
robust estimates of the standard errors; x' values are
uncorrected. The mean prevalence of human infective
T b rhodesiense in the cattle population in areas with
interventions is not significantly different from in those
areas where there had been no intervention (x'=0-167,
df=l, p=0-6829). To be effective, mass treatment
interventions need to cover enough of the livestock
population to prevent the transmission of parasites to
tsetse. Similarly, effective tsetse control must reduce
vector challenge sufficiently to effect transmission to
human beings. The prevalence of T b rhodesiense in cattle
at the livestock market was higher than in villages in
both the intervention (x2=7-609, df=l, p=0- 0058) and
non-intervention (x2=5-864, df=l, p=0• 0155) zones. The
very high prevalence of T b rhodesiense in cattle at the
market, which are imported mainly from endemic
sleeping sickness areas,2 indicates that the trade and
resultant movement of animals infected with
T b rhodesiense continues. While T brucei si is not highly
pathogenic to local cattle breeds, co-infections with other
more pathogenic livestock-infective trypanosomes are
common, and farmers might be choosing to sell their
sick or less productive animals. The risk of spreading
sleeping sickness via this reservoir host in the area
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T brucei sensu lato T b rhodesiense alone
Intervention area
Village 1 (Obur) 8/56 (14%) 0/56 (0%)
Village 2 (Obar) 13/55 (24%) 5/55 (9%)
Village 3 (Akoroi) 16/56 (29%) 6/56 (11%)
Total 37/167 (22%; 95% CI 150-31-5) H/167 (7%; 95% CI 2-4-17-0)
Livestock market
Brookes Corner 21/51 (41%; 95% CI 28-6-55-0) 10/51 (20%; 95% CI 10 9-32-7%)
Non-intervention area
Village 4 (Omagoro) 22/56 (39%) 8/56 (14%)
Village 5 (Odunguru) 9/56 (16%) 3/56 (5%)
Village 6 (Ayepe) 4/56 (7%) 2/56 (4%)
Total 35/168 (21%; 95% CI 7-8-45-1%) 13/168 (8%; 95% CI 3-3-17-2%)
Table 1: Prevalence of T brucei
diagnosed by PCR
sensu lato and T b rhodesiense in livestock in Soroti district in 2004,
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Figure 1: Number of cases of sleeping sickness during each month of the epidemic in Serere, from the time the disease was first recognised (December, 1998)
to March, 2005
continues to be a public-health challenge. Livestock for
sale are required to be treated at their point of origin or
before sale; this requirement forms part of the well
designed national policy for trypanosomiasis control,
but has proved difficult to implement at a local level with
increasing decentralisation of public services.
From the first reported case in 1998, and up to April,
2004, 428 cases of sleeping sickness presented at the
only health facility equipped to diagnose and treat the
disease in Soroti district (Serere Health Centre; figure 1).
There was a marked seasonal peak in case reporting; this
could indicate increased parasite transmission by tsetse
during the preceding wet season, which occurs between
September and November (the late stage of infection
typically develops after 3-6 months). Of the reported
cases, 103 were early stage cases, 287 were late stage, and
38 were not staged. The mortality rate in the hospital was
4% (18/428 deaths). 67% of staged cases were in the late
stage of sleeping sickness, indicative of poor early
detection of the disease by both the health system and
communities. A deterministic model has been
developed to estimate the proportion of undetected
T b rhodesiense cases in a given population on the basis of
knowledge of the early to late ratio.' Application of the
model to the Soroti data suggests that an additional
299 unreported cases (95% CI 170-438), or 0-7
(0 ■ 4—1 ■ 02) unreported cases for each reported case,
might have occurred in the communities in the Serere
Health Centre catchment area up to April, 2004.
Untreated cases have almost 100% fatality rate. Sleeping
sickness tends to affect the poorest and most
disenfranchised rural communities with the least access
to health care. Public-health messaging and extension
Figure 2: Map of Uganda showing established Trypanosome brucei
rhodesiense-affected areas in the south and east (red), and T fa gambiense-
affected areas in the northwest (green)
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health services are needed to improve knowledge and
reporting of this disease.
From April, 2004, onwards, patients with
T b rhodesiense sleeping sickness have also been
reporting from areas outside the catchment area of
Serere hospital, and a new sleeping sickness focus has
become established in Kaberamaido District, to the
north-west of Soroti across a major branch of the Lake
Kyoga drainage system (figure 2). Disease control has
not been effective in Soroti and, as a result, the parasite
has spread to Kaberamaido district; there are also reports
of T b rhodesiense transmission in the southern part of
Lira district. Between February, 2004, and January, 2005,
144 cases presented from this area, which is more
remote and less well equipped to handle the situation
than Soroti, and has also suffered from civil unrest. The
direction of spread of T b rhodesiense sleeping sickness in
Uganda over the past 5 years, towards the T b gambiense
foci in northwestern Uganda and southern Sudan,
increases the risk of a geographic overlap of the two
causative organisms. Since treatments and diagnostic
methods for the two diseases differ, any convergence in
their range will have important implications for patient
care and national control policy. As livestockmovements
result in the spread of T b rhodesiense, controlling such
movements or treating livestock before movement is a
matter of urgency. Where livestock migration can be
monitored, such as at livestock markets, control
activities should be targeted there. Additionally, given
the human population movements consequent upon
civil instability,4 and their possible role in T b gambiense
spread, it would be prudent to monitor for the presence
of T b gambiense in those areas where only T b rhodesiense
occurs at present. Outbreaks of T b rhodesiense in new
areas are conceptually straightforward to prevent with
effective veterinary interventions but, once established,
very difficult to control. T b rhodesiense will probably
become endemic in Soroti with long-term consequences
for the rural population. Like other zoonoses, this
disease stretches the capacity of veterinary and medical
services affecting those sections of society least able to
deal with the problem.
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Abstract
Direct PCR analysis of trypanosome infected blood samples in the quantities required for large scale epidemiological study has
always been problematic. Current methods for identifying and differentiating trypanosomes typically require several species-specific
reactions, many of which rely on mouse passaged samples to obtain quality concentrated genomic DNA. As a consequence impor¬
tant epidemiological information may be lost during the sample preparation stage. Here, we report a PCR methodology that reduces
processing and improves on the sensitivity of present screening methods. The PCR technique targets the gene encoding the small
ribosomal subunit in order to identify and differentiate all clinically important African trypanosome species and some subspecies.
The method is more economical, simple, and sensitive than current screening methods, and yields more detailed information, thereby
making it a viable tool for large-scale epidemiological studies.
© 2005 Elsevier Inc. All rights reserved.
Index Description and Abbreviations: Trypanosomiasis; Epidemiology; PCR; Diagnosis; Human African sleeping sickness; Ribosomal DNA;
Whatman FTA; DNA, deoxyribonucleic acid; ITS, internal transcribed spacer; PCR, polymerase chain reaction; RNA, ribonucleic acid
Keywords: Trypanosomiasis; Epidemiology; PCR; Diagnosis; Human African sleeping sickness; Ribosomal DNA; Whatman FTA
I. Introduction
The African trypanosomes comprise a group of
important and complex pathogens, affecting animal and
human health in much of sub Saharan Africa. The caus¬
ative organisms are represented by a variety of species
and subspecies of a heteroxenous parasite of the genus
Trypanosoma, some of which are zoonotic, causing dis¬
ease in man and animals (domestic and wild). Animal
trypanosomiasis, or nagana, costs livestock producers
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E-mail address: Sue.Welburn@ed.ac.uk (S. Welburn).
0014-4894/S - see front matter © 2005 Elsevier Inc. All rights reserved.
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and consumers an estimated $1340 million annually, this
figure excludes indirect livestock benefits such as manure
and traction (Kristjanson et al., 1999). Human African
trypanosomiasis occurs in endemic foci across East and
West Africa. The human infective Trypansoma brucei
rhodesiense subspecies is maintained in wild animals
(van Hoeve et al., 1967) and domestic livestock (Hide et
al., 1996; Onyango et al., 1966) from where it may play a
significant role in the generation of acute sleeping sick¬
ness epidemics in east Africa (Fevre, 2001; Hide et al.,
1996; Welburn et al., 2001). Effective disease control and
management depends heavily upon knowledge of the
epidemiology of the disease, which in turn relies upon
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methods that incorporate screening of both animal and
human populations (Hutchinson et al., 2003).
Methods of epidemiological screening include direct
parasite examination using traditional dark ground
microscopy, examination of buffy coat and more
recently molecular methodologies based on the polymer¬
ase chain reaction (PCR). Microscopy is labour intensive
and can lack sensitivity under field conditions due to
routinely low peripheral parasitaemia in infected live¬
stock (Picozzi et al., 2002). PCR based diagnostic meth¬
ods have largely overcome difficulties associated with
sensitivity and specificity. A number of methods have
been developed for the following species and subspecies
of Trypansoma-Trypanozoon (Artama et al., 1992; Kab-
iri et al., 1999), Trypanosoma congolense (Riverine/For¬
est) (Masiga et al.. 1992), T. congolense (Kilifi) (Masiga
et al., 1992), T. congolense (Savannah) (Masiga et al.,
1992), Trypanosoma vivax (Masake et al., 1994, 1997),
Trypanosoma simiae (Masiga et al., 1992), Trypanosoma
evansi (Artama et al., 1992), T. congolense (Kenya Coast)
(Masiga et al., 1992), and Trypanosoma theileri (Rodri-
gues et al., 2003). Using these approaches accurate spe¬
cies/subspecies differentiation requires up to eight
different PCRs per sample, which increases the costs and
impacts on the practical application of the technique for
large-scale epidemiological studies. Furthermore, many
of the PCR techniques developed in recent years are
based on complex protocols requiring samples to be
mouse passaged, and therefore mouse adapted, a process
which some trypanosome isolates do not survive (Hoare,
1972; Masiga et al„ 1992) resulting in loss of species or
strains and selection and sampling bias (Coleman and
Welburn, 2004).
Recent developments in matrices for sample collec¬
tion and archive, which permit direct PCR identification
from tissue/fluids may overcome such bias. Simplified
protocols incorporating these improved sample collec¬
tion techniques, together with rapid PCR-based screen¬
ing methodologies for the direct analysis of field samples
are therefore required. The internal transcribed spacers
(ITS) located within the ribosomal RNA genes have
been used to establish relationships and differentiate spe¬
cies in an extremely wide range of organisms (Mai and
Coleman, 1997; Samuel, 1998; Schlotterer et al., 1994;
Wesson et al., 1992). A high copy number combined with
inter-species length variation makes the ITS region a
useful marker for species differentiation in trypano-
somes, as has been recently demonstrated (Desquesnes et
al., 2001; McLaughlin et al., 1996; Njiru et al., 2004).
However, this technique was shown to be relatively
insensitive and in some cases was problematic for detec¬
tion of T. vivax (the principal pathogenic species in cat¬
tle) in either concentrated genomic DNA or DNA
extracted from field samples. Here, we report the devel¬
opment of a simple nested PCR method, which detects
the inter-specific length variation of the ITS regions of
ribosomal genes and thereby produces a unique size of
PCR product for each species of trypanosome. The tech¬
nique is able to detect the following African trypano¬
some species. (Trypanozoon, T. congolense (River/
Forest), T. congolense (Kilifi), T. congolense (Savannah),
T. vivax , T. simiae, T. evansi, T. congolense (Kenya
Coast), and T. theileri). It is able to detect a single try¬
panosome and has been optimised for PCR amplifica¬
tion of blood applied to filter paper (Whatman FTA)
permitting direct PCR analysis of field material.
2. Materials and methods
2.1. Samples
Field samples consisted of 245 samples of bovine
blood taken from two villages in the Soroti and Tororo
districts of Uganda and collected on Whatman FTA
cards. Genomic DNA stocks are as detailed in Table 1.
2.2. Primer design
Sixteen trypanosome ribosomal DNA sequences were
selected from the NCBI database (http://www.ncbi.
nlm.nih.gov/entrez/query.fcgi?db = Nucleotide). T. bru-
cei AF306771, AF306772, AF306773, AF306774, AF30
6775, AF306776, AF306777, and X05862; T. congolense
U22315; T. congolense (Kilifi) U22316; T. congolense
(River/Forest) U22317; T. congolense (Tsavo) U22318;
T. vivax U22319, T. simiae U22320. Two additional
sequences (Trypanosoma cruzi AY362826 and Trypano¬
soma rangeli AY230240) were selected for comparison as
out-groups to ensure optimal specificity of the primers.
Sequences were aligned with CLUSTALX software
(ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX) (Thompson
et al., 1997) and viewed using the Bioedit programme
(Hall, 1999). A set of nested primers targeting the ribo¬
somal gene locus was selected using PRIMER3 web
Table 1
Details and origin of trypanosome genomic DNA used in the develop¬
ment of the ITS-PCR protocol
Species Stock code Origin
T. bruceibrucei BUTF.RA135 Tororo, SE
Uganda, Cow, 1990
T. brucei rhodesiense BUG H2 Kamuli, Uganda,
Human, 2000
T. brucei rhodesiense DO Katerema, Uganda
Human, 1990
T. congolense (Savannah) IL1180 (ILNat3.1) Serengeti, Tanzania
T. congolense (Forest) IL3900 Burkina Faso
T. congolense (Kalifi) IL45.1 Kilifi, Kenya
T. vivax ILDattl.2 Kenya
T. brucei OBURC19 Soroti, Uganda,
Cow, 2000
T. congolense (Forest) TSW103 Liberia, Pig
T. simiae TV008 Unknown
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Table 2
Expected and obtained band sizes for amplification using nested ITS
primers as calculated from the sequences present in bioinformatic dat¬
abases
Species Expected band Band sizes
size from NCB1 obtained (bp)
database (bp)
T. congolense (Forest) 1513 1501
T. congolense (Kilifi) 1422 1430
T. congolense (Savannah) 1413 1408
T. congolense (Tsavo) 954 951
T. brucei 1207-1224 1215
T. simiae S50 847
T. vivax 611 620
T. theileri 988 998
primer selection software (http://www.broad.rnit.edu/
cgi-bin/primer/primer3_www.cgi). Primers were evalu¬
ated using NETPRIMER software available at (http://
www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.
html). The specificity of the primers was evaluated using
a BLAST search against human and mouse genomes
(http://www.ncbi.nlm.nih.gov/BLAST). The outer primer
sequences were ITS1 (5'-GAT TAC GTC CCT GCC
ATT TG-3'), and ITS2 (5'-TTG TTC GCT ATC GGT
CTT CC-3') (MWG Biotech), and inner primer
sequences ITS3 (5'-GGA AGC AAA AGT CGT AAC
AAG G-3'), and ITS4 (5'-TGT TTT CTT TTC CTC
CGC TG-3') (MWG Biotech). All PCR conditions were
optimised using modified 'Taguchi' methods (Cobb and
Clarkson, 1994). Expected band sizes were calculated
from the distance between the primer locations as deter¬
mined from the sequences for each trypanosome species
present in bioinformatic databases. The expected band
sizes are shown in Table 2.
2.3. Amplification ofDNA
Blood and genomic DNA samples were applied to
Whatman FTA cards and allowed to dry for a mini¬
mum of 24 h at room temperature. A 2mm diameter
punch was cut from the cards and was washed accord¬
ing to the following protocol; three washes of lOmin in
Whatman FTA reagent followed by two washes of
5 min in 1 mM TE buffer. The punches were dried at
room temperature for a minimum of 90 min then placed
directly in the PCR tubes for the first round of PCR.
The reaction volume of 25 pi contained the following
components. Super-Taq PCR buffer from FIT Biotech¬
nologies, Cambridge (final concentrations of lOmM
Tris-HCl, pH 9.0, 1.5mM MgCl2, 50mM KC1, 0.1%
Triton X-100, and 0.01%(w/v) stabilizer), 2pM of each
outer primer ITS1 and ITS2, 1 mM total dNTP's and
1.25 U of Biotaq (Bioline, London). The reaction condi¬
tions were as follows: 1 cycle of 95 °C for 7 min followed
by 35 cycles of 94 °C for 1 min, 55 °C for 1 min, and
72 °C for 2 min, the thermal cycling was carried out on a
Stratagene Robocycler. For the second round reaction
1 pi of the PCR product from the first round reaction
was placed in a fresh tube and 24 pi of the reaction mix¬
ture was added as detailed for the outer primers, with
the exception of the substitution of the outer primers
(ITS1 and 2) with the inner primers. (ITS3 and 4) The
reaction conditions were as detailed previously. Ten
microlitres of the PCR product was run on a
30cm x 20cm 1.5% agarose gel run at 100 V. The gel
was stained with ethidium bromide and visualised using
a Flowgen Alpha 1220 gel imaging system.
3. Results
To differentiate important species (and some subspe¬
cies) of African trypanosome a nested PCR was devel¬
oped which amplified the variable ITS region of the
ribosomal gene locus, using primers designed to the con¬
served flanking sequences (Fig. 1).
3.1. Specificity
Amplification of genomic DNA from trypanosome
stocks (Table 1) resulted in a specific size band for each
species, which was within the bounds of measurement
error and was in complete agreement with the expected
band sizes (Table 2). Control DNA samples were not
available for some trypanosome species (e.g., T. theileri),
therefore when unexpected band sizes appeared in field
samples the bands were cut out, sequenced, and compared
with database sequences to confirm species identity (data
not shown). The specificity of the primers was further
tested by PCR amplification with host DNA (human,
cow, and mouse), which produced no visible bands.
3.2. Sensitivity
To investigate the sensitivity of the nested PCR, the
technique was tested on a dilution series of whole try-
Fig. I. The structure of part of the ribosomal RNA gene locus. Ribo¬
somal genes are present in tandem arrays of around 100-200 copies
per trypanosome. Each gene consists of a number of conserved coding
regions and non-coding spacer regions. Large boxes represent con¬
served coding regions (SSU. small sub-unit; LSU, large subunit) and
small boxes represent spacer regions. The two spacers, internal tran¬
scribed spacers (ITS) 1 and 2 are known to vary in size between species
and occasionally subspecies. A set of nested primers designed to the
conserved regions are represented by black arrows (outer primers)
ITS1 and ITS2 and white arrows (inner primers) 1TS3 and 1TS4.
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panosomes (diluted in phosphate-buffered saline) on
Whatman FTA cards and a dilution series of genomic
DNA (diluted in water) in liquid form and also applied
to Whatman FTA cards. In the two dilutions of genomic
DNA positive amplification was detected at a DNA con¬
centration of 49pgml~' (or less than a single trypano-
some equivalent). To investigate the efficacy of the
technique on samples containing host material, trypano-
somes were diluted in bovine blood (UK origin) and
applied to Whatman FTA cards to mimic field samples.
Positive amplification was detected at DNA a concentra¬
tion of 55pgml_1, which is again equivalent to less than
a single trypanosome.
3.3. Application to field samples
Application of the nested ITS primers to 245 samples
of bovine blood taken from the Tororo and Soroti Dis¬
tricts of Uganda and collected on Whatman FTA cards
resulted in successful amplification of the target ITS
region as shown by species specific band sizes (Fig. 2).
This technique was also able to show samples infected
with multiple species (e.g., Fig. 2; lanes 2, 16, and 19), as
shown by the presence of multiple bands.
3.4. Technique evaluation
The efficacy of the technique was tested against the
most widely used screening method; individual species
specific PCR's (Artama et al., 1992; Clausen et al„ 1998;
Majiwa et al., 1994; Masake et al., 1997; Masiga et al,
1992), using samples collected from two different villages
in Uganda (Cow blood applied to Whatman FTA
cards). Analysis of the 245 samples using the individual
species-specific PCR screening method demonstrated a
low prevalence of trypanosomes in cows from the first
village and a high prevalence of trypanosomes cows
from the second village. The new nested PCR analysis
method showed that a comparable prevalence and
greater number of species were detected in each case
(Table 3).
4. Discussion







Fig. 2. Representative gel showing bands obtained from PCR amplifi¬
cation (using nested ITS primers) of 19 blood samples (on Whatman
FTA cards) taken from cattle in the Tororo district of Uganda. Sam¬
ples 2. 3, 8. 16. and 19 are all positive for T. brucei. Samples 2, 9, 16, 18,
and 19 are positive for T. theileri. Sample 17 is positive for T. simiae,
sample 5 is positive for T. vivax, and samples 1, 6, 7, 10, 11, 12, 13, and
14 are negative. Lane M represents a marker graduated in 100 bp
intervals (band sizes illustrated). Mixed species infections were found
in lanes 2, 3,4, 5,16, and 17.
Existing methods for screening samples for detection
and differentiation of trypanosomes are not suited to
large-scale epidemiological analysis. This study
addressed the requirement for improved techniques that
simplify the sample analysis process but maintain the
sensitivity and specificity required for directly analysing
field samples.
We developed, a new nested PCR targeted to include
both internal transcribed spacers of the ribosomal RNA
genes (ITS PCR), that was capable of detecting trypano¬
somes in the presence of host DNA and the PCR inhibi¬
tors present in blood (Heme, Lactoferrin IgG and non-
target DNA). This nested technique was found to be sen¬
sitive enough for detection of a single parasite in blood
samples and has been shown to be able to differentiate all
important African trypanosome species and some subspe¬
cies. To simplify the sample collection and processing
methodology, we investigated the storage of samples on
treated filter paper cards, which make possible the direct
Table 3
Evaluation of detection of trypanosome DNA from Whatman FTA cards containing blood from low and high prevalence villages in the Tororo and
Soroti districts of Uganda, using a nested PCR amplification, compared with utilisation of individual species specific primers (Artama et al„ 1992;
Clausen et al., 1998; Majiwa et al., 1994; Masake et al., 1997; Masiga et al., 1992)
Species Low prevalence village prevalence (%) High prevalence village prevalence (%)
Species specific PCR method 1TS-PCR Species specific PCR method ITS-PCR
T. brucei 5 7 32 33
T. theileri ND 3 ND 47
T. congolense 0 1 1 5
T. vivax 1 1 8 5
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analysis of biological samples, in addition to circumvent¬
ing the requirement for mouse passage. When the nested
technique was evaluated against the current single PCR
per species screening method, using a complete sample set
containing positive and negative samples, it was found to
have a similar level of detection, but was capable of
detecting a greater number of species in both high and low
prevalence sample sets.
The epidemiology ofAfrican trypanosomiasis is com¬
plex and poorly understood and requires large-scale field
based investigation. This technique has greatly simplified
epidemiological studies involving sample screening. As a
result the costs and time involved in screening samples
for the eight major species/subspecies of trypanosome
have been reduced by a factor of four (conservative esti¬
mate). This nested PCR technique can be used to screen
large numbers of biological samples directly, quickly,
and accurately, making it a simple, cost effective, robust,
and reliable tool for investigating the complex epidemi¬
ology of African Trypanosomiasis.
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